<SEC-DOCUMENT>0001390478-14-000061.txt : 20141103
<SEC-HEADER>0001390478-14-000061.hdr.sgml : 20141103
<ACCEPTANCE-DATETIME>20141103163249
ACCESSION NUMBER:		0001390478-14-000061
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20141103
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141103
DATE AS OF CHANGE:		20141103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Galena Biopharma, Inc.
		CENTRAL INDEX KEY:			0001390478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33958
		FILM NUMBER:		141189873

	BUSINESS ADDRESS:	
		STREET 1:		4640 SW MACADAM AVENUE
		STREET 2:		SUITE 270
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97239
		BUSINESS PHONE:		855 855 GALE

	MAIL ADDRESS:	
		STREET 1:		4640 SW MACADAM AVENUE
		STREET 2:		SUITE 270
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97239

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RXi Pharmaceuticals Corp
		DATE OF NAME CHANGE:	20110926

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GALENA BIOPHARMA, INC.
		DATE OF NAME CHANGE:	20110922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RXI PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20110921
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gale-201409308xk.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>GALE-2014.09.30 8-K</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s3C9F01678F83140BB0573EF7A41289DE"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:center;"><hr></div><div style="line-height:120%;text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;font-weight:bold;">UNITED STATES <br>SECURITIES AND EXCHANGE COMMISSION  <br>WASHINGTON, D.C. 20549 </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="216px"></td><td width="18px"></td><td width="216px"></td><td width="16px"></td><td width="216px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">FORM 8-K</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="216px"></td><td width="18px"></td><td width="216px"></td><td width="16px"></td><td width="216px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;font-weight:bold;">CURRENT REPORT <br>PURSUANT TO SECTION 13 OR 15(d) OF THE <br>SECURITIES EXCHANGE ACT OF 1934 </font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of report (Date of earliest event reported): November 3, 2014</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="216px"></td><td width="18px"></td><td width="216px"></td><td width="16px"></td><td width="216px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:18.5pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:18.5pt;font-weight:bold;">GALENA BIOPHARMA, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="216px"></td><td width="18px"></td><td width="216px"></td><td width="16px"></td><td width="216px"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10.5pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="216px"></td><td width="18px"></td><td width="216px"></td><td width="16px"></td><td width="216px"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">001-33958</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">20-8099512</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction of incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission <br>File Number)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(I.R.S. Employer <br>Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">4640 S.W. Macadam Avenue</font></div><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Suite 270</font></div><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Portland, Oregon 97239</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices) (Zip Code)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Registrant&#8217;s telephone number, including area code: (855) 855-4253</font></div><div style="text-align:center;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10.5pt;padding-left:0px;"><font style="font-family:Wingdings;font-size:10.5pt;">o</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10.5pt;padding-left:0px;"><font style="font-family:Wingdings;font-size:10.5pt;">o</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10.5pt;padding-left:0px;"><font style="font-family:Wingdings;font-size:10.5pt;">o</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10.5pt;padding-left:0px;"><font style="font-family:Wingdings;font-size:10.5pt;">o</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:inherit;font-size:10.5pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s3C9F01678F83140BB0573EF7A41289DE"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="11%"></td><td width="89%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;2.02</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations and Financial Condition.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 3, 2014, Galena Biopharma, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;company&#8221;) issued a press release announcing our financial results for the third quarter ended September 30, 2014 and an update of recent business developments. A copy of the press release is attached to this Report as Exhibit 99.1 and is incorporated herein by reference.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information furnished under this Item&#160;2.02, including the accompanying Exhibit 99.1, shall not be deemed to be &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any subsequent filing by the company under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as specifically stated in such filing.</font></div><div style="line-height:120%;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="11%"></td><td width="89%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9.01</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;Exhibits. The following exhibit is filed as a part of this Report:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="16%"></td><td width="1%"></td><td width="7%"></td><td width="76%"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit&#160;No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press Release of Galena Biopharma, Inc. dated November 3, 2014.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s3C9F01678F83140BB0573EF7A41289DE"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td width="8%"></td><td width="2%"></td><td width="30%"></td><td width="2%"></td><td width="5%"></td><td width="13%"></td><td width="5%"></td><td width="2%"></td><td width="33%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GALENA BIOPHARMA, INC.</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 3, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Mark W. Schwartz</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark W. Schwartz, Ph.D.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President and Chief Executive Officer</font></div></td></tr></table></div></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>gale-20140930ex991.htm
<DESCRIPTION>EXHIBIT
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>GALE-2014.09.30 EX99.1</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s9862C997253A9F42B53F3EF7A60662BA"></a><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><br><div style="line-height:120%;"><img src="earningsreleasegraphic.jpg" style="height:78px;width:106px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">Galena Biopharma Reports Third Quarter 2014 Results</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Clinical programs advance on multiple fronts, with trial initiation, trial enrollment, data and IP milestones achieved and anticipated</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commercial strategy reinforced with product acquisition and upcoming commercial launch</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Abstral&#174; (fentanyl) sublingual tablet net revenue was $1.6 million in Q3 2014 and $6.1 million to date this year, with reiterated guidance of $8-$10 million for the full year 2014 </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Zuplenz&#174; (ondansetron) Oral Soluble Film U.S. rights licensed; launch expected in Q1 2015</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Conference call scheduled for 5:00 pm E.T. today with details below</font></div></td></tr></table><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Portland, Oregon, November 3, 2014</font><font style="font-family:inherit;font-size:10pt;">&#32;- Galena Biopharma, Inc. (NASDAQ: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today reported its financial results for the quarter ended September 30, 2014 and provided a business update.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;The company continues to make excellent progress on our clinical programs, and we continue to build our commercial franchise,&#8221; said Mark W. Schwartz, Ph.D., President and Chief Executive Officer.  &#8220;I believe we have turned the corner on the corporate challenges we faced this year, and we are fully focused on the progress of NeuVax&#8482; and its portfolio of clinical trials, our development pipeline and our commercial programs including the upcoming launch of Zuplenz&#174;.  Over the next six months, we will report results from the ongoing trials with GALE-301 and GALE-401, and our NeuVax platform will expand with the initiation of two new trials plus the completion of enrollment in our pivotal, Phase 3 PRESENT study.  The launch of Zuplenz in Q1 2015 enhances our commercialization efforts and we believe we will see significant sales growth for that business line in 2015.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Galena will host a conference call today at 2:00 p.m. P.T./5:00 p.m. E.T. to discuss financial and business results.  The call can be accessed by dialing (844) 825-4413 toll-free in the U.S., or (973) 638-3403 for participants outside the U.S. The Conference ID number is: 23451769.  The conference call will also be webcast live and available under the Investors section/Events and Presentations on the Company's website at </font><font style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;">www.galenabiopharma.com</font><font style="font-family:inherit;font-size:10pt;">. The archived webcast replay will be available on the Company's website for 90 days.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Third Quarter 2014 Financial Highlights</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenue for the third quarter of 2014 was </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the third quarter of 2013, an increase of 25%. Net revenue for the nine months ended September 30, 2014 was </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;">. The third quarter of 2013 was the first quarter that the company experienced net revenue. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating loss for the three months ended September 30, 2014 was </font><font style="font-family:inherit;font-size:10pt;">$13.2 million</font><font style="font-family:inherit;font-size:10pt;">, including $1.3 million in stock-based compensation charges, compared to </font><font style="font-family:inherit;font-size:10pt;">$6.9 million</font><font style="font-family:inherit;font-size:10pt;">, including $0.5 million in stock-based compensation charges, for the three months ended September 30, 2013. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><a name="s9862C997253A9F42B53F3EF7A60662BA"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Galena also incurs non-cash income and expense related to changes in the fair value estimates of the Company&#8217;s warrant liabilities. Non-cash income related to the change in warrant values for the three months ended September 30, 2014 was </font><font style="font-family:inherit;font-size:10pt;">$6.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to non-cash expense of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended September 30, 2013.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss for the three months ended September 30, 2014 was </font><font style="font-family:inherit;font-size:10pt;">$6.2 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$0.05</font><font style="font-family:inherit;font-size:10pt;">&#32;per basic and diluted share, compared to a net loss of </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$0.11</font><font style="font-family:inherit;font-size:10pt;">&#32;per basic and diluted share, for the three months ended September 30, 2013.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September 30, 2014, Galena had cash and cash equivalents of $24.6 million, compared with $47.8 million as of December 31, 2013. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Highlights</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Announced NeuVax&#8482; (nelipepimut-S) Phase 3 PRESENT Trial enrollment status.  </font><font style="font-family:inherit;font-size:10pt;">Galena</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">provided the current enrollment status for the Company&#8217;s Phase 3 PRESENT (</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">P</font><font style="font-family:inherit;font-size:10pt;">revention of </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">R</font><font style="font-family:inherit;font-size:10pt;">ecurrence in </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">E</font><font style="font-family:inherit;font-size:10pt;">arly-</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">S</font><font style="font-family:inherit;font-size:10pt;">tage, Node-Positive Breast Cancer with Low-to-Intermediate HER2 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">E</font><font style="font-family:inherit;font-size:10pt;">xpression with </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NeuVax</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">T</font><font style="font-family:inherit;font-size:10pt;">reatment) clinical trial.  As of September 22, 2014, 533 of the 700 patients required by the clinical trial protocol had been treated.   The Company expects to treat 700 patients by the end of January 2015 with the intention to over-enroll the study, targeting the end of Q1, 2015 to close enrollment.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significantly Expanded the NeuVax Intellectual Property Position with Notice of Allowances for Three Important Patents</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Patent will cover the use of NeuVax to prevent recurrence of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">any</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;HER2/neu expressing tumor having a fluorescence in situ hybridization (FISH) rating of less than about 2.0 as a stand-alone therapy or in combination with an adjuvant and/or other agents.</font><font style="font-family:inherit;font-size:10pt;">&#32;Currently there are no approved HER2-directed therapies for patients who express lower levels of HER2, or less than 2.0 by the FISH testing scale.  Importantly, this NeuVax patent provides Galena with coverage for any tumor expressing low-to-intermediate levels of HER2.&#160; The patent, which has now issued, will expire in 2028, not including any patent term extensions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Patent To Cover the Use of NeuVax in Combination With Herceptin&#174; (trastuzumab; Genentech/Roche) for treating patients having any HER2/neu expressing cancer.</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;The allowed claims of this patent will cover all HER2/neu expressing cancer types and patient populations.  Once issued, the patent will expire in 2026, not including any patent term extensions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Improvement patent in Japan</font><font style="font-family:inherit;font-size:10pt;">&#32;will cover the use of NeuVax alone or in combination with other agents to prevent recurrence of any breast cancer tumor expressing low-to-intermediate (Immunohistochemistry (IHC) 1+ or 2+ or FISH less than about 2.0) levels of HER2.  Once issued, the patent will expire in 2027, not including any patent term extensions.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Initiated the Phase 2 Clinical Trial for GALE-401 (Anagrelide Controlled Release).</font><font style="font-family:inherit;font-size:10pt;">&#32;The study will treat patients with elevated platelet counts in myeloproliferative neoplasms (MPNs) including essential thrombocythemia (ET).&#160;The Phase 2 trial is an open-label, single-arm, multicenter study of GALE-401 in approximately 20 patients with MPN-related thrombocytosis. The goals of the study are to confirm the platelet-lowering activity of GALE-401 in patients with MPNs, to assess safety and tolerability, and to measure blood levels of the drug. The primary efficacy endpoint will be the proportion of subjects who achieve a complete or partial platelet response for at least four weeks during the first six months of treatment.  Based on discussions with the U.S. Food and Drug Administration (FDA) and pending a successful development program, Galena would pursue approval via the 505(b)(2) regulatory pathway.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><a name="s9862C997253A9F42B53F3EF7A60662BA"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Appointed</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Mark W. Schwartz, PhD as President and Chief Executive Officer and member of the Board of Directors.</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;Dr. Schwartz was previously Galena's Executive Vice President and Chief Operating Officer where he worked across all of the company's programs, oversaw the initiation of the commercialization efforts, and also managed intellectual property efforts, acquisitions, and partnerships. Dr. Schwartz brings more than 30 years of experience in the biotechnology and life science industry and joined the Company following Galena's acquisition of Apthera, Inc. where he served as the company's President and CEO. Prior to Apthera, Dr. Schwartz served as President and CEO of Bayhill Therapeutics where he&#160;completed&#160;a successful partnership with Genentech around one of its compounds.  Previously, he served as President and CEO of Calyx Therapeutics. Earlier in his career, Dr. Schwartz held a range of positions in R&amp;D, marketing, sales, business development and executive management at Trega BioSciences, Incyte Genomics, Synteni, Tripos, Applied Biosystems and DuPont Diagnostics.  Dr. Schwartz is currently on the advisory&#160;board for BayBio, a Director of Targazyme Pharmaceuticals, and is on the faculty of&#160;San Jose State University in the Masters of Biotechnology Program.&#160;He is also a&#160;former Board member of the&#160;Biotechnology&#160;Industry Association. Dr. Schwartz received his Bachelor of Arts in Chemistry from Grinnell College and his Ph.D. in Chemistry from Arizona State University.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Licensed the U.S. Rights for Zuplenz&#174; (ondansetron) Oral Soluble Film.</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;Zuplenz is approved by the FDA in adult patients for the prevention of highly and moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). &#160;Zuplenz is also approved in pediatric patients for moderately emetogenic CINV.  Zuplenz is a rapidly dissolving, oral soluble film that dissolves on the tongue in less than thirty seconds and eliminates the burden of swallowing pills during periods of emesis and in cases of oral irritation, potentially increasing patient adherence.  Galena expects to launch Zuplenz in the first quarter 2015.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><a name="s9862C997253A9F42B53F3EF7A60662BA"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">GALENA BIOPHARMA, INC.</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(Amounts in thousands, except share and per share data)</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td width="45%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="11%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,620</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,124</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Costs and expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenue (excluding amortization of certain acquired intangible assets)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">925</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,243</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,633</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,082</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,990</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Selling, general, and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,698</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,369</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of certain acquired intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">70</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">259</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,063</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,208</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,893</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,840</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21,490</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-operating income (expense):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of warrants potentially settleable in cash</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,735</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,614</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,135</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(925</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(495</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other income (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">597</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">693</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">881</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total non-operating income (expense), net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,035</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,235</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,190</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,749</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,173</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,128</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,650</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,239</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,173</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,287</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,650</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,177</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted net loss per share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.05</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.11</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.24</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average common shares outstanding: basic and diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">119,038,656</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87,319,450</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">117,767,791</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,678,612</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><a name="s9862C997253A9F42B53F3EF7A60662BA"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">GALENA BIOPHARMA, INC.</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(Amounts in thousands)</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td width="59%"></td><td width="1%"></td><td width="18%"></td><td width="1%"></td><td width="1%"></td><td width="1%"></td><td width="18%"></td><td width="1%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Unaudited)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2013</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">ASSETS</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,787</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted cash</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,683</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">450</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">386</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,789</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,521</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,455</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equipment and furnishings, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">589</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">665</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,864</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,864</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Abstral rights, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,714</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zuplenz rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,663</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">GALE-401 rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,155</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,898</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,898</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Deposits and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,492</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87,976</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,292</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,667</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of warrants potentially settleable in cash</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,765</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,965</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,163</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,149</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,586</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,447</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations, net of current maturities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Deferred tax liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,053</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,053</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent purchase price consideration, net of current portion</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, net of current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,097</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,743</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,633</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">82,090</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total stockholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,859</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,886</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,492</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">87,976</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><a name="s9862C997253A9F42B53F3EF7A60662BA"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">About Galena Biopharma</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care.&#160;&#160;Galena&#8217;s development portfolio ranges from mid- to late-stage clinical assets, including a robust immunotherapy program led by NeuVax&#8482; (nelipepimut-S) currently in an international, Phase 3 clinical trial.  The Company&#8217;s commercial drugs include Abstral&#174; (fentanyl) Sublingual Tablets and Zuplenz&#174; (ondansetron) Oral Soluble Film. Collectively, Galena&#8217;s clinical and commercial strategy focuses on identifying and advancing therapeutic opportunities to&#160;improve cancer care,&#160;from direct treatment of the disease to the reduction of its debilitating side-effects.&#160;For more information visit www.galenabiopharma.com.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements include, but are not limited to, statements about our 2014 revenue from the sale of Abstral&#174;, our planned launch of Zuplenz&#174;, the issuance of patents, and the progress of development of Galena&#8217;s product candidates, including patient enrollment in our clinical trials. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those identified under &#8220;Risk Factors&#8221; in Galena&#8217;s Annual Report on Form 10-K for the year ended December 31, 2013 and most recent Quarterly Reports on Form 10-Q filed with the SEC.  Actual results may differ materially from those contemplated by these forward-looking statements. Galena does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this press release.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NeuVax&#8482; is a trademark of Galena Biopharma, Inc.  All other trademarks are the property of their respective owners.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contact:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remy Bernarda</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">VP, Marketing &amp; Communications</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(503) 405-8258</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">rbernarda@galenabiopharma.com</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>earningsreleasegraphic.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 earningsreleasegraphic.jpg
M_]C_X``02D9)1@`!`@$`E@"6``#_[@`.061O8F4`9``````!_^$6PD5X:68`
M`$U-`"H````(``<!$@`#`````0`!```!&@`%`````0```&(!&P`%`````0``
M`&H!*``#`````0`"```!,0`"````'@```'(!,@`"````%````)"':0`$````
M`0```*0```#$`)8````!````E@````$``$%D;V)E(%!H;W1O<VAO<"!#4S(@
M36%C:6YT;W-H`#(P,3$Z,#DZ,#(@,#DZ-#8Z,#````*@`@`$`````0```?2@
M`P`$`````0```6P`````````!@$#``,````!``8```$:``4````!```!$@$;
M``4````!```!&@$H``,````!``(```(!``0````!```!(@("``0````!```5
MEP````````!(`````0```$@````!_]C_X``02D9)1@`!`@``2`!(``#_[0`,
M061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+
M$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`'0`H`,!(@`"$0$#$0'_
MW0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!
M`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$
M(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F
M1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!
M46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD23
M5*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/54DDDE*22224I))))2DDDR2EUC
MYGUFP<;JU72*Z[<O)<0<KT&[FXM;A[+\ZR0RACO\_P!+]+_H_4K]>^M5.%C9
MC>FUCJ6;A`'*QF/+356X'?D/VM<^QF.[;Z[,?]+3O_2>DO+LGK6=G-]*U[68
MSG>I]FH&RDN/N=:]LN?DW/=[W9&79D7_`/"*S@Y8SUEH&#-S`QQL>H^#Z9U/
MZ\],QBZK`_7KAIO:8I!_X[_"_P#6?^W%7Z#USJ69D-ORW[AEY+<2AC1MK9MJ
MR,_(VL_>]*EOOLWO7`8]G"ZCHU@KZU]5\(2'/&9GW-/!]2NW&Q7_`/;-5BLY
M>7QX\)$1<C^D=_2./_N6AR_,YL_,CB-0@+X(_+KZ!?[WS/HB222S764DDDDI
M22222E))))*?_]#U5))))2DDDDE*4+KZ<>IUU]C:JJQ+['D-:T>+GN]K5-"R
M<:C*HLQLFMMM%K2RRMXEKFGEK@D/%3S>7]?,%^0W"Z)4[J678=E9;(KW:_1=
M].[;&_V?H/3_`.U"Y?KWUPS/?CTY0OS7$MMR:=*,<:[J.FC_``N5[MEO4G[_
M`$6?H<7_`$M=O%Z1;]5?K*[!L;7D=,ZW59B8=]XW,WN&^G$R]-_N>WT'M_[5
MU6,M_G*;?2S[O^:EI+<GH]N!8##WX5Q!!&CFC%OVX[-JT<6.&\(<<:!XM#(W
MWXO^C!S\V0Q_G9\$I$B$:/MBO^Z_ON)T_(OP\BO)Q;#3?2=U=C>0>_/TVO\`
M\(U_\XKG4^FTY=%G5NEU"KTQOZET]G%7[V=A-_.Z>]W\_3_V@?\`]UOH6/V?
M]67R<7JUF,?S:<ZAW_2RL7]"W_,5[`Z1U.K(9?TG)QLVVGWMLPLBNPMT_.KL
M-;_H_3KV*<R@=;X)#]\<`_NGB:D?=@34?=Q2^88SQG^]'^L\Q18XB&ZN.C0.
MY/T5U+<O'P/KC=U3(L<>F?5^NGIS7`2YSS5]F;137N#GO999F95VSZ%-"+B_
M5=]W7,+.Q<5V&QM[+<_I[V%C:RPF_P!?!]3:VS!R;*_2]#_M'=9_W&_F>:ZY
MG-NR/L=5K;F8UEEN3;60679M[O4ZAE-AK/T3'_J>)N_[3T?\,F2E[DA#P(EX
M<38P0&*$\N]UP>/"^TX^11E4,R,>QMM-K0ZNQAEK@>[2B+R3ZI_6?+Z'=L,W
M=/L,W8_=I/-V//T;/WV?0N_K_I%ZKB9>-FXU>5BV"VBT;F/;P1_WUS?SV?F*
MAGP2Q'O$[2;F#F(9@:TD/FBF2224+.I))))2DDDDE/\`_]'U5))))2DDDDE*
M22224T^J]+Q>JX-F%E;@Q\%MC#MLK>T[JKZ+/\'=2_WUN7GGURZ;=@=2%ENT
M_;*Q:Y[`6L-H`;E[&N+OI6?I_P#KZ]/69U[IC<_"<YE-%V90'/Q?M+/4K#R-
MKMS"6M]S?W_979^E_P`&I^6S'',7\IT/U:_-\N,V.OT@>*)?)<7I?4^I;C@8
MS[V-G=:(;4V!N=OR;2RAG_;BL-^KO3*CNZGG-N>/\!T]HL.HD;L_(#<9GN^G
MZ-62GS^J]2R[#7U"VQSJG;#0_P!K:W,]A9]F9LIJ<R-O\VJWKK4$2?FE7A#_
M`+]Q_>]O3'#7][)_WCV/U9ZL,1SF8U3ZL!C\:DUONLO>;<FZG"I)MR7.:S;O
MNN]/%IQ_H+E;?K'F66VU=6PL'J=C;'5ONNQQ7?['.8=N3B>AL^C_`*-'?E_8
M>E]-O(+79/5&9.^=#5@FMO\`[<Y5G_;:/D?4SZQ=1Z[U%V/B>CCNS+W,R+SZ
M=9:ZQ]C',;[[[&;7?3KIV*N1CCDD348]"3KZ/F]7]YT,9S2P1LF60ZG_``_E
MT0TV_5;))+L/+Z<Z/:,>YN17/BYN8&6_YEBZ#ZOY%?2[O\G=5HR*+?==B937
MXI)_X)]GJT_:/[?Z3\_^19Z7_BUQJ0']2RW7NT)JI'IL\VN>[?:_^SZ"ZG!Z
M1TSIS8P\9E)XW@2\C^5:[=8[_/4>7F<7"8@RG?0_)_C3]:,?*YS,3D(8R/TH
M_P`Y]D/1_C-L&0#$3V3I)*@Z*DDDDE*22224_P#_TO54DDDE*22224I))))2
ME%[&/8YCVAS'`AS2)!!Y:X*222GS'KOU9ZO91F93J;'W]*?Z?VAT..9B`;L;
M(W-]]N=@T;:,ISV?K-;/YVW(K])<AZX#=T^V)GR7OJ\T^M7U']'K>+;@UD=+
MZGDUU7LK'\P^QX]:&_F8]S/4?7^93=^B_P`)0K_+<U^A/3]W_O6GS'*"1XX[
M_I?Q7Z)T/]H_6/IV':QWV7H.%1=F,=Q]IO+NH-J_M6WLL_\`05>E+,Z%T]V)
M3D7W`_:NH9%F7?NU(WF,>C_T%Q&48_\`UM::J9LAG+RT_P"^/^,VH0$104DD
MDHURDDDDE*22224I))))3__3]527&]6^NO66_67(^KG0.D#J.5A5-NR'V7LI
M$.%3_P!'ZFUNUGVBG_";_P#@OSTOV_\`XRO_`)UZO_8VG_THDI[))<_T'J/U
MPS,MS>M=)IZ9BL82'B]MSWN_-8QM+G;/Y;WKH$E*27&_77Z_V?5[-IZ=T_#'
M4,QU3\G)9+AZ53`7;W>FQ_YK+;;/]%55_P`*NEZ+U;%ZSTK&ZIB']#E,#P#R
MT_1LJ=_+JL:^IZ2FZDA9-IIQ[;@-QK8YX!TG:-RQ/J1]9KOK/T4]2OH;C/%S
MZMC'%PAH8[=[@/WTE/0))(>1?5CT69%SMM5+'66.\&M&Y[O\T)*2)+@\'_&+
M]8>J4'+Z5]5KLK"+W,JO^TM9N#3$[/0=_P!%]GO_`,(CGZZ?7,<_4Z_Y933_
M`.ZR2GM4E6Z;?F9&#3?G8XP\FUH=9C-?ZOID\5NMV4[GM;_.>S^<_P!)_.+G
M?KA]>1]5NI=/HNQ3D8F6VQU[V'](P,+??77]%^UKMSO<DIZM)5\#/P^I8=6=
M@W-R,6]NZJUG!'']ES7>Q['>^M_L>L?ZW?6:_P"KXZ:::&W_`&_+9BNWN+=H
M=^>W:"DIZ!))4NL]5Q>C=+R>J99BC%87N`Y<?HUU,G\^VQS*F?RTE-U)<;]2
M_K_;]8<ZWIW4</\`9V7Z+,G%82[]+4X;M[?4:S\U]=M>W^=J?_P2[))3_]34
MZ)_^6/KW_A%G_4].74?6/.^LN+70/J_TUG4+'DFYUMK*V,:(VB'V5/>^S=^;
M_HUSO4_JW];L#ZY9GUE^KHP\D=0H;2^K*+QLVMH:[2MU>[=]E8YK_4_ZU^>C
M_:_\;?\`W"Z1]]O_`+T)*1=,^N?UH/UMPOJYUSIN/A/S*WW379ZC@QK+GL<"
MQ]E?NLQG,77=6ZGB=(Z;D=2S';<?%8;'\28^C6S<6M]2U_Z.IO\`I%R/2?JW
M]:\WZXXWUG^L8Q,<X..ZBJG$+SO+A:QNX6&S;[<JWW^K_HOT2O?73H'6/K)E
M=/Z6S;3T)M@OZE:'Q99M)VX[*Q[OHCZ?^ENJL_[3I*>9^J_6.B],?D_6CZWY
M#:>I?60/./CN9986X0(8T&IC+7-Q[]C&4^M_.X^/5Z7^&4/\77UCZ7T[ZRYO
MU;P<K[3T;-L-W2[G-<S;80'.QB+VLM]U?Z+?9].[&_1,_6EZC7334QM=3&UL
M8T,8UH``:W1C&M'T6-7-?7WZJY'7^GT7=-<*>K].M%V#=N+(,M]2OU!]#Z++
MF/\`]+36DIZ#/_H&3_Q3_P#J2N-_Q.?^)!W_`(;M_P"IJ75XXZCD]&#<^IE/
M4+*"RZMCIK%A:6.V.]WZ-[O<U<)]6>C?XS?JWTW]G8.+TVRDV.MF][W/W.#0
MX35;4S\S]U)3Z4L_ZP?\@]2_\*7_`/GMZYO[7_C;_P"X72/\ZW_WH769V+]M
MP,C#<[9]IJ?4YX$QO::]P'\G<DI\^^I&3]9Z/J+T\?5W#HR[7WY!O=DOVL8T
M/.UK6A];W/L<[Z7YGI_\(MWI^9_C*MSL>O/P.G8^&YX^TVM>]SA6/=9Z;1<[
M](]OLK_X3Z:Y_H.-_C0^K/3QT?"Z/B9>/18\LR#<WW[G;]PW9-#]O[N^FI:/
M[:_QN?\`SOX?_;S/_>U)3W:X;ZV@._Q@?59CA+7C)8YIX+7,V/8[^2]IVN78
M]/\`M_V*G]HFHYI8#D>@'"H//TFU>HZQ^QGT=SG>]8'7N@=1SOK=T'JN.UAQ
M.G>K]I<YT.&\0W:S\Y)3CY_2^I_4*^[K/U>8[+^K]CO4ZETB233^]FX;O=[&
M-_GOW*_YWU**_4PZWUVZWT[KW3/JYU'IMOK8[^J5-=V<Q\2ZFYG^#M;^[_US
M^;7I"\]^L'^+-W[3Q^H?5US<>AV73D9O3B[9236X_K&./H,=6RRW]#_PC_0_
MT22GT)>;_7OJ-'7?K!5]7++O1Z-TEOV_KV1.@:T#;0('J.?LL94ST/5_3Y?\
MSOQ5Z#G/RZ\.]^#6V[+:QQHK>=K7/C]&+'?FLW?37/\`U%^J]_0NG7V]3<V[
MJ_4KCD9]H.X%TN=4S=#=VS>^W_CKK4E/$_77ZV?5>[(Z7UWZLYK1U;I+FULH
M]&ZIK\?7]!K54STZY?7Z7J5?H,B_^0O4.C]5Q>L]+QNIXAFC*8'M!B6GZ-E3
M]O\`A*K`ZJS^6K5M-5U;ZK6-LJL:6/8X`M<UPVN8]I^DUS5R?U)^KO6OJSF]
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MZ)5;E6.NN;9?4;'QN+:K[L>O?L:QN_TJF;_8GSQ\-^H'A/#+S_E%;"?%6E`C
MB#K)+G/K7EY-.9TJBJ[*JIR++A>W"`=<X,J-E>QI9;]%_P!)1Z`_J3NL/:'=
M1?TW[,38>HL:PC(]1OI"C]'5;_,>MZG^#_FTO:/!QV-K_'A5[@XN&GI4ED_6
MK)R,3ZN=0R<6PTWU4.=78WEI'<3*S_K+UWJM/0\VRGIV;@VLKEN4YV*6UF1[
MSZ67D6?YE-B$<9E5$>H\.I_E^\DR`OP%O3))+EOK'UT-Z@>F8O4J>FW8E7VA
M]ESV-:^]W]!P;/4W?J[_`'WY^QGJ^C]F]-_Z="$#,T/-,I`"R]2DJ71^J4=7
MZ9C]1Q]&9#-Q8>6N'LMI=_*IM:^IRROK7E9-.5TJBJ[)JJR+;FWMP@'7.#:G
MV5AC7,L^C8WWHQ@3+@V(N_\`!1*0$>+?^UZ))<M]6LS)RNKV_9<C.R>F5TOK
MR3G-8TLRV65AM+1Z=-[+&4^MZS-NS^:6UU^^W&Z#U+(I<:[:<2^RM[>6N;6]
M['-G\YK@E+&1(1O>OQ5&5QMOI+FV]:ZD&#H1=OZ\2&,R6U_HSCN$_MIU9AGI
ML9^CLH_\L_U3^8NJN6E]6\B[*^K_`$W)O>;+KL6I]CW?2<YS&N<YT?O)2QF(
ML]_Y22)6Z22P?K1UFK$.+TW[8W`MSG$V91<UIIQZ_?D6UFT/9Z]OLQ<;V_SE
MWJ_X!&^J_61U7I[A9=7?EX=AQ\JRH@L>YGT,JK9[?2RZME[/^VO\$E[<N#CZ
M(XAQ</5__];KL_\`YI?M/+];[7]L]1OVO[+]OV^IZ=?I[_L'Z#U/L_HK7Z%^
MR?V97^QX^Q2_;]/=OWN]?U?7_3^MZWJ>KZWZ7>OF5)33^0?SG3Y_YO;]'_N5
MD?F/R]=OF?IO-_97[3Z=]K_IVZW]G_3^EZ9^T_0_1_T?_3*^OE5)1RVCOMU_
MO2^3^JN&YVWZ>7Z3[TW_`)CR?L_VS9O?M^R_M'T=V]WJ?9_LGZML];?_`$?]
M$NBZ)^R_V71^R(^P0[T8W?O.]7?ZWZ7U?6]3U?5_2^K_`#B^8TE+E^7_`"N_
M^4^7_P!&68]_T-OT'Z;S?V5^TNG?:_Z=NM_9_P!/Z7IN^T_0_1_T?=_/*^OE
M5)12VCOMU_O2^3^JO&YVWZ>7Z3].=;_9G[)ROVM_R?Z9^U3N^A^=_,_I?^VT
MNN?LO]DY/[7_`.3MGZS.[Z$C_0_I?\Q?,:2,?T?F^;]'_!^3^N@]=MNO_=?U
M7ZJ5'I?[,_7/V?\`2^U6?;)W;OM'M]7U/6]_T/2]+_!?9_1]#]!Z:^8TD!L=
M^G]W_"3U#]-=+_9/K9_[-C?]I/V[9NV_:=E?J_2_1>IL]+U_0_PO\[^G]12S
M?V7^T>G?:_Z;OM_9_P!+Z?I/^T?0_1_T;U/YY?,:2/Z1^;8_WOD_Z/\`ZC1T
MZ;_3=^EJ_P!B?\X+O0_Y7]%OVKTO4CT_\!]L]/\`5?5_[C_:?UCTOYG]$K75
M/L/[,R_VC_0?0L^U_2_F=CO7_FOTG\UN_F_>OE])(_-'YMH_WO\``_[A(V.V
MY?J9GHRS;&[9[/WMGMX_.V_00.D?L_\`9>)^S/Z!Z+/LOTOYK:/1_G?TOT/]
M)[U\P)(=#ON/+JI^G*/V;^U\OTI_:/I4_:-V^?2FW[-Z?J?HO2W_`&G^C_X7
MU/5_2)J_V9^V[_2G]I_9Z_M&W?M]'?;]F]6/U;U-_K^EN_6-GJ?X)?,B2/?Y
MOE'\O[B/LW_E_A/_V0#_[31R4&AO=&]S:&]P(#,N,``X0DE-!`0```````<<
M`@```@`"`#A"24T$)0``````$$8,\HDFN%;:L)P!H;"GD'<X0DE-`^H`````
M&`<\/WAM;"!V97)S:6]N/2(Q+C`B(&5N8V]D:6YG/2)55$8M."(_/@H\(41/
M0U194$4@<&QI<W0@4%5"3$E#("(M+R]!<'!L92\O1%1$(%!,25-4(#$N,"\O
M14XB(")H='1P.B\O=W=W+F%P<&QE+F-O;2]$5$1S+U!R;W!E<G1Y3&ES="TQ
M+C`N9'1D(CX*/'!L:7-T('9E<G-I;VX](C$N,"(^"CQD:6-T/@H)/&ME>3YC
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M+VME>3X*"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"3PO9&EC=#X*"0D\
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M:6YT+G1I8VME="YS=&%T949L86<\+VME>3X*"0D)"3QI;G1E9V5R/C`\+VEN
M=&5G97(^"@D)"3PO9&EC=#X*"0D\+V%R<F%Y/@H)/"]D:6-T/@H)/&ME>3YC
M;VTN87!P;&4N<')I;G0N4&%G949O<FUA="Y0359E<G1I8V%L4F5S/"]K97D^
M"@D\9&EC=#X*"0D\:V5Y/F-O;2YA<'!L92YP<FEN="YT:6-K970N8W)E871O
M<CPO:V5Y/@H)"3QS=')I;F<^8V]M+F%P<&QE+FIO8G1I8VME=#PO<W1R:6YG
M/@H)"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME="YI=&5M07)R87D\+VME
M>3X*"0D\87)R87D^"@D)"3QD:6-T/@H)"0D)/&ME>3YC;VTN87!P;&4N<')I
M;G0N4&%G949O<FUA="Y0359E<G1I8V%L4F5S/"]K97D^"@D)"0D\<F5A;#XW
M,CPO<F5A;#X*"0D)"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME="YS=&%T
M949L86<\+VME>3X*"0D)"3QI;G1E9V5R/C`\+VEN=&5G97(^"@D)"3PO9&EC
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M=&EC:V5T+G-T871E1FQA9SPO:V5Y/@H)"0D)"3QI;G1E9V5R/C`\+VEN=&5G
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M;G0N=&EC:V5T+G-T871E1FQA9SPO:V5Y/@H)"0D)"3QI;G1E9V5R/C`\+VEN
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M9V5296-T/"]K97D^"@D)"0D)/&%R<F%Y/@H)"0D)"0D\<F5A;#XP+C`\+W)E
M86P^"@D)"0D)"3QR96%L/C`N,#PO<F5A;#X*"0D)"0D)/')E86P^-S@S/"]R
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M"3QS=')I;F<^,#`N,C`\+W-T<FEN9SX*"0D\:V5Y/F-O;2YA<'!L92YP<FEN
M="YT:6-K970N='EP93PO:V5Y/@H)"3QS=')I;F<^8V]M+F%P<&QE+G!R:6YT
M+E!A<&5R26YF;U1I8VME=#PO<W1R:6YG/@H)/"]D:6-T/@H)/&ME>3YC;VTN
M87!P;&4N<')I;G0N=&EC:V5T+D%0259E<G-I;VX\+VME>3X*"3QS=')I;F<^
M,#`N,C`\+W-T<FEN9SX*"3QK97D^8V]M+F%P<&QE+G!R:6YT+G1I8VME="YT
M>7!E/"]K97D^"@D\<W1R:6YG/F-O;2YA<'!L92YP<FEN="Y086=E1F]R;6%T
M5&EC:V5T/"]S=')I;F<^"CPO9&EC=#X*/"]P;&ES=#X*`#A"24T#Z0``````
M>``#````2`!(``````,/`B__[O_N`S@"00-G!7L#X``"````2`!(``````+8
M`B@``0```&0````!``,#`P````%__P`!``$```````````````!H"``9`9``
M`````"```````````````````````````````````#A"24T#[0``````$`"6
M`````0`"`)8````!``(X0DE-!"8```````X`````````````/X```#A"24T$
M#0``````!````'@X0DE-!!D```````0````>.$))30/S```````)````````
M```!`#A"24T$"@```````0``.$))32<0```````*``$``````````CA"24T#
M]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R
M`````0!:````!@```````0`U`````0`M````!@```````3A"24T#^```````
M<```_____________________________P/H`````/__________________
M__________\#Z`````#_____________________________`^@`````____
M_________________________P/H```X0DE-!`````````(``3A"24T$`@``
M````!``````X0DE-!#````````(!`3A"24T$+0``````!@`!````#CA"24T$
M"```````&@````$```)````"0`````(``````0``(,`!.$))300>```````$
M`````#A"24T$&@`````#6P````8``````````````6P```'T````$P!!`&D`
M;0`@`&P`;P!G`&\`(``Q`#4`,`!$`%``20`M`%(`1P!"`````0``````````
M```````````````!``````````````'T```!;``````````````````````!
M`````````````````````````!`````!````````;G5L;`````(````&8F]U
M;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``````````
M3&5F=&QO;F<``````````$)T;VUL;VYG```!;`````!29VAT;&]N9P```?0`
M```&<VQI8V5S5FQ,<P````%/8FIC`````0``````!7-L:6-E````$@````=S
M;&EC94E$;&]N9P`````````'9W)O=7!)1&QO;F<`````````!F]R:6=I;F5N
M=6T````,15-L:6-E3W)I9VEN````#6%U=&]'96YE<F%T960`````5'EP965N
M=6T````*15-L:6-E5'EP90````!);6<@````!F)O=6YD<T]B:F,````!````
M````4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L;VYG````````
M``!"=&]M;&]N9P```6P`````4F=H=&QO;F<```'T`````W5R;%1%6%0````!
M````````;G5L;%1%6%0````!````````37-G951%6%0````!```````&86QT
M5&%G5$585`````$```````YC96QL5&5X=$ES2%1-3&)O;VP!````"&-E;&Q4
M97AT5$585`````$```````EH;W)Z06QI9VYE;G5M````#T53;&EC94AO<GI!
M;&EG;@````=D969A=6QT````"79E<G1!;&EG;F5N=6T````/15-L:6-E5F5R
M=$%L:6=N````!V1E9F%U;'0````+8F=#;VQO<E1Y<&5E;G5M````$453;&EC
M94)'0V]L;W)4>7!E`````$YO;F4````)=&]P3W5T<V5T;&]N9P`````````*
M;&5F=$]U='-E=&QO;F<`````````#&)O='1O;4]U='-E=&QO;F<`````````
M"W)I9VAT3W5T<V5T;&]N9P``````.$))300H```````,`````3_P````````
M.$))3004```````$````#CA"24T$#``````5LP````$```"@````=````>``
M`-F````5EP`8``'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B95]#30`!
M_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3
M%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-
M#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,_\``$0@`=`"@`P$B``(1`0,1`?_=``0`"O_$`3\`
M``$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`````````
M`0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:``P#`0`"$0,1`#\`]522224I))))2DDDDE*223)*76/F?6;!QNK5=(KK
MMR\EQ!RO0;N;BUN'LOSK)#*&._S_`$OTO^C]2OU[ZU4X6-F-Z;6.I9N$`<K&
M8\M-5;@=^0_:US[&8[MOKLQ_TM._])Z2\NR>M9V<WTK7M9C.=ZGV:@;*2X^Y
MUKVRY^3<]WO=D9=F1?\`\(K.#EC/66@8,W,#'&QZCX/IG4_KSTS&+JL#]>N&
MF]IBD'_CO\+_`-9_[<5?H/7.I9F0V_+?N&7DMQ*&-&VMFVK(S\C:S][TJ6^^
MS>]<!CV<+J.C6"OK7U7PA(<\9F?<T\'U*[<;%?\`]LU6*SEY?'CPD1%R/Z1W
M](X_^Y:'+\SFS\R.(U"`O@C\NOH%_O?,^B)))+-=922222E))))*4DDDDI__
MT/54DDDE*22224I0NOIQZG77V-JJK$OL>0UK1XN>[VM4T+)QJ,JBS&R:VVT6
MM++*WB6N:>6N"0\5/-Y?U\P7Y#<+HE3NI9=AV5ELBO=K]%WT[ML;_9^@]/\`
M[4+E^O?7#,]^/3E"_-<2VW)ITHQQKNHZ:/\`"Y7NV6]2?O\`19^AQ?\`2UV\
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MO@D/WQP#^Z>)J1]V!-1]W%+YAC/&?[T?ZSS%%CB(;JXZ-`[D_174MR\?`^N-
MW5,BQQZ9]7ZZ>G-<!+G/-7V9M%->X.>]EEF9E7;/H4T(N+]5WW=<PL[%Q78;
M&WLMS^GO86-K+";_`%\'U-K;,')LK]+T/^T=UG_<;^9YKKF<V[(^QU6MN9C6
M66Y-M9!9=FWN]3J&4V&L_1,?^IXF[_M/1_PR9*7N2$/`B7AQ-C!`8H3R[W7!
MX\+[3CY%&50S(Q[&VTVM#J[&&6N![M*(O)/JG]9\OH=VPS=T^PS=C]VD\W8\
M_1L_?9]"[^O^D7JN)EXV;C5Y6+8+:+1N8]O!'_?7-_/9^8J&?!+$>\3M)N8.
M8AF!K20^:*9)))0LZDDDDE*22224_P#_T?54DDDE*22224I))))33ZKTO%ZK
M@V865N#'P6V,.VRM[3NJOHL_P=U+_?6Y>>?7+IMV!U(66[3]LK%KGL!:PV@!
MN7L:XN^E9^G_`.OKT]9G7NF-S\)SF4T79E`<_%^TL]2L/(VNW,):WW-_?]E=
MGZ7_``:GY;,<<Q?RG0_5K\WRXS8Z_2!XHE\EQ>E]3ZEN.!C/O8V=UHAM38&Y
MV_)M+*&?]N*PWZN],J.[J><VYX_P'3VBPZB1NS\@-QF>[Z?HU9*?/ZKU++L-
M?4+;'.J=L-#_`&MK<SV%GV9FRFIS(V_S:K>NM01)^:5>$/\`OW'][V],<-?W
MLG_>/8_5GJPQ'.9C5/JP&/QJ36^ZR]YMR;J<*DFW)<YK-N^Z[T\6G'^@N5M^
ML>99;;5U;"P>IV-L=6^Z['%=_L<YAVY.)Z&SZ/\`HT=^7]AZ7TV\@M=D]49D
M[YT-6":V_P#MSE6?]MH^1]3/K%U'KO478^)Z..[,O<S(O/IUEKK'V,<QOOOL
M9M=].NG8JY&..21-1CT).OH^;U?WG0QG-+!&R99#J?\`#^71#3;]5LDDNP\O
MISH]HQ[FY%<^+FY@9;_F6+H/J_D5]+N_R=U6C(HM]UV)E-?BDG_@GV>K3]H_
MM_I/S_Y%GI?^+7&I`?U++=>[0FJD>FSS:Y[M]K_[/H+J<'I'3.G-C#QF4GC>
M!+R/Y5KMUCO\]1Y>9Q<)B#*=]#\G^-/UHQ\KG,Q.0AC(_2C_`#GV0]'^,VP9
M`,1/9.DDJ#HJ22224I))))3_`/_2]522224I))))2DDDDE*47L8]CF/:',<"
M'-(D$'EK@I))*?,>N_5GJ]E&9E.IL??TI_I_:'0XYF(!NQLC<WWVYV#1MHRG
M/9^LUL_G;<BOTER'K@-W3[8F?)>^KS3ZU?4?T>MXMN#61TOJ>375>RL?S#['
MCUH;^9CW,]1]?YE-WZ+_``E"O\MS7Z$]/W?^]:?,<H)'CCO^E_%?HG0_VC]8
M^G8=K'?9>@X5%V8QW'VF\NZ@VK^U;>RS_P!!5Z4LSH73W8E.1?<#]JZAD69=
M^[4C>8QZ/_07$91C_P#6UIJIFR&<O+3_`+X_XS:A`1%!2222C7*22224I)))
M)2DDDDE/_]/U5)<;U;ZZ]9;]9<CZN=`Z0.HY6%4V[(?9>RD0X5/_`$?J;6[6
M?:*?\)O_`."_/2_;_P#C*_\`G7J_]C:?_2B2GLDES_0>H_7#,RW-ZUTFGIF*
MQA(>+VW/>[\UC&TN=L_EO>N@24I)<;]=?K_9]7LVGIW3\,=0S'5/R<EDN'I5
M,!=O=Z;'_FLMML_T557_``JZ7HO5L7K/2L;JF(?T.4P/`/+3]&RIW\NJQKZG
MI*;J2%DVFG'MN`W&MCG@'2=HW+$^I'UFN^L_13U*^AN,\7/JV,<7"&ACMWN`
M_?24]`DDAY%]6/19D7.VU4L=98[P:T;GN_S0DI(DN#P?\8OUAZI0<OI7U6NR
ML(O<RJ_[2UFX-,3L]!W_`$7V>_\`PB.?KI]<QS]3K_EE-/\`[K)*>U25;IM^
M9D8--^=CC#R;6AUF,U_J^F3Q6ZW93N>UO\Y[/YS_`$G\XN=^N'UY'U6ZET^B
M[%.1B9;;'7O8?TC`PM]]=?T7[6NW.]R2GJTE7P,_#ZEAU9V#<W(Q;V[JK6<$
M<?V7-=['L=[ZW^QZQ_K=]9K_`*OCIIIH;?\`;\MF*[>XMVAWY[=H*2GH$DE2
MZSU7%Z-TO)ZIEF*,5A>X#EQ^C74R?S[;',J9_+24W4EQOU+^O]OUASK>G=1P
M_P!G9?HLR<5A+OTM3ANWM]1K/S7UVU[?YVI__!+LDE/_U-3HG_Y8^O?^$6?]
M3TY=1]8\[ZRXM=`^K_36=0L>2;G6VLK8QHC:(?94][[-WYO^C7.]3^K?UNP/
MKEF?67ZNC#R1U"AM+ZLHO&S:VAKM*W5[MWV5CFO]3_K7YZ/]K_QM_P#<+I'W
MV_\`O0DI%TSZY_6@_6W"^KG7.FX^$_,K?=-=GJ.#&LN>QP+'V5^ZS&<Q==U;
MJ>)TCIN1U+,=MQ\5AL?Q)CZ-;-Q:WU+7_HZF_P"D7(])^K?UKS?KCC?6?ZQC
M$QS@X[J*J<0O.\N%K&[A8;-OMRK??ZO^B_1*]]=.@=8^LF5T_I;-M/0FV"_J
M5H?%EFTG;CLK'N^B/I_Z6ZJS_M.DIYGZK]8Z+TQ^3]:/K?D-IZE]9`\X^.YE
MEA;A`AC0:F,M<W'OV,93ZW\[CX]7I?X90_Q=?6/I?3OK+F_5O!ROM/1LVPW=
M+N<US-MA`<[&(O:RWW5_HM]GT[L;]$S]:7J-=--3&UU,;6QC0QC6@`!K=&,:
MT?18U<U]??JKD=?Z?1=TUPIZOTZT78-VXL@RWU*_4'T/HLN8_P#TM-:2GH,_
M^@9/_%/_`.I*XW_$Y_XD'?\`ANW_`*FI=7CCJ.3T8-SZF4]0LH++JV.FL6%I
M8[8[W?HWN]S5PGU9Z-_C-^K?3?V=@XO3;*38ZV;WO<_<X-#A-5M3/S/W4E/I
M2S_K!_R#U+_PI?\`^>WKF_M?^-O_`+A=(_SK?_>A=9G8OVW`R,-SMGVFI]3G
M@3&]IKW`?R=R2GS[ZD9/UGH^HO3Q]7<.C+M??D&]V2_:QC0\[6M:'UO<^QSO
MI?F>G_PBW>GYG^,JW.QZ\_`Z=CX;GC[3:U[W.%8]UGIM%SOTCV^RO_A/IKG^
M@XW^-#ZL]/'1\+H^)EX]%CRS(-S??N=OW#=DT/V_N[Z:EH_MK_&Y_P#._A_]
MO,_][4E/=KAOK:`[_&!]5F.$M>,ECFG@M<S8]COY+VG:Y=CT_P"W_8J?VB:C
MFE@.1Z`<*@\_2;5ZCK'[&?1W.=[U@=>Z!U'.^MW0>JX[6'$Z=ZOVESG0X;Q#
M=K/SDE./G]+ZG]0K[NL_5YCLOZOV.]3J72))-/[V;AN]WL8W^>_<K_G?4HK]
M3#K?7;K?3NO=,^KG4>FV^MCOZI4UW9S'Q+J;F?X.UO[O_7/YM>D+SWZP?XLW
M?M/'ZA]77-QZ'9=.1F].+ME)-;C^L8X^@QU;++?T/_"/]#_1)*?0EYO]>^HT
M==^L%7U<LN]'HW26_;^O9$Z!K0-M`@>HY^RQE3/0]7]/E_S._%7H.<_+KP[W
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MG2J*KLJJG(LN%[<(!US@RHV5[&EEOT7_`$E'H#^I.ZP]H=U%_3?LQ-AZBQK"
M,CU&^D*/T=5O\QZWJ?X/^;2]H\''8VO\>%7N#BX:>E263]:LG(Q/JYU#)Q;#
M3?50YU=C>6D=Q,K/^LO7>JT]#S;*>G9N#:RN6Y3G8I;69'O/I9>19_F4V(1Q
MF541ZCPZG^7[R3("_`6],DDN6^L?70WJ!Z9B]2IZ;=B5?:'V7/8UK[W?T'!L
M]3=^KO\`??G[&>KZ/V;TW_IT(0,S0\TRD`++U*2I='ZI1U?IF/U''T9D,W%A
MY:X>RVEW\JFUKZG+*^M>5DTY72J*KLFJK(MN;>W"`=<X-J?96&-<RSZ-C?>C
M&!,N#8B[_P`%$I`1XM_[7HDERWU:S,G*ZO;]ER,[)Z972^O).<UC2S+996&T
MM'ITWLL93ZWK,V[/YI;77[[<;H/4LBEQKMIQ+[*WMY:YM;WL<V?SFN"4L9$A
M&]Z_%497&V^DN;;UKJ08.A%V_KQ(8S);7^C..X3^VG5F&>FQGZ.RC_RS_5/Y
MBZJY:7U;R+LKZO\`3<F]YLNNQ:GV/=])SG,:YSG1^\E+&8BSW_E)(E;I)+!^
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M?I/O3?\`F/)^S_;-F]^W[+^T?1W;W>I]G^R?JVSUM_\`1_T2Z+HG[+_9='[(
MC[!#O1C=^\[U=_K?I?5];U/5]7]+ZO\`.+YC24N7Y?\`*[_Y3Y?_`$99CW_0
MV_0?IO-_97[2Z=]K_IVZW]G_`$_I>F[[3]#]'_1]W\\KZ^54E%+:.^W7^]+Y
M/ZJ\;G;?IY?I/TYUO]F?LG*_:W_)_IG[5.[Z'YW\S^E_[;2ZY^R_V3D_M?\`
MY.V?K,[OH2/]#^E_S%\QI(Q_1^;YOT?\'Y/ZZ#UVVZ_]U_5?JI4>E_LS]<_9
M_P!+[59]LG=N^T>WU?4];W_0]+TO\%]G]'T/T'IKYC20&QWZ?W?\)/4/TUTO
M]D^MG_LV-_VD_;MF[;]IV5^K]+]%ZFSTO7]#_"_SOZ?U%+-_9?[1Z=]K_IN^
MW]G_`$OI^D_[1]#]'_1O4_GE\QI(_I'YMC_>^3_H_P#J-'3IO]-WZ6K_`&)_
MS@N]#_E?T6_:O2]2/3_P'VST_P!5]7_N/]I_6/2_F?T2M=4^P_LS+_:/]!]"
MS[7]+^9V.]?^:_2?S6[^;]Z^7TDC\T?FVC_>_P`#_N$C8[;E^IF>C+-L;MGL
M_>V>WC\[;]!`Z1^S_P!EXG[,_H'HL^R_2_FMH]'^=_2_0_TGO7S`DAT.^X\N
MJGZ<H_9O[7R_2G]H^E3]HW;Y]*;?LWI^I^B]+?\`:?Z/_A?4]7](FK_9G[;O
M]*?VG]GK^T;=^WT=]OV;U8_5O4W^OZ6[]8V>I_@E\R)(]_F^4?R_N(^S?^7^
M$__9`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'``
M(`!#`%,`,@````$`.$))300&```````'``@````!`0#_X3K6:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60]
M(E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@T*/'@Z>&UP;65T82!X;6QN
M<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB,RXQ+C$M,3$R(CX-"@D\
M<F1F.E)$1B!X;6QN<SIR9&8](FAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O
M,C(M<F1F+7-Y;G1A>"UN<R,B/@T*"0D\<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(B!X;6QN<SIE>&EF/2)H='1P.B\O;G,N861O8F4N8V]M+V5X:68O
M,2XP+R(^#0H)"0D\97AI9CI#;VQO<E-P86-E/C$\+V5X:68Z0V]L;W)3<&%C
M93X-"@D)"3QE>&EF.E!I>&5L6$1I;65N<VEO;CXU,#`\+V5X:68Z4&EX96Q8
M1&EM96YS:6]N/@T*"0D)/&5X:68Z4&EX96Q91&EM96YS:6]N/C,V-#PO97AI
M9CI0:7AE;%E$:6UE;G-I;VX^#0H)"0D\97AI9CI.871I=F5$:6=E<W0^,S8X
M-C0L-#`Y-C`L-#`Y-C$L,S<Q,C$L,S<Q,C(L-#`Y-C(L-#`Y-C,L,S<U,3`L
M-#`Y-C0L,S8X-C<L,S8X-C@L,S,T,S0L,S,T,S<L,S0X-3`L,S0X-3(L,S0X
M-34L,S0X-38L,S<S-S<L,S<S-S@L,S<S-SDL,S<S.#`L,S<S.#$L,S<S.#(L
M,S<S.#,L,S<S.#0L,S<S.#4L,S<S.#8L,S<S.38L-#$T.#,L-#$T.#0L-#$T
M.#8L-#$T.#<L-#$T.#@L-#$T.3(L-#$T.3,L-#$T.34L-#$W,C@L-#$W,CDL
M-#$W,S`L-#$Y.#4L-#$Y.#8L-#$Y.#<L-#$Y.#@L-#$Y.#DL-#$Y.3`L-#$Y
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M9F8](FAT='`Z+R]N<RYA9&]B92YC;VTO=&EF9B\Q+C`O(CX-"@D)"3QT:69F
M.D]R:65N=&%T:6]N/C$\+W1I9F8Z3W)I96YT871I;VX^#0H)"0D\=&EF9CI8
M4F5S;VQU=&EO;CXQ-3`P,#`P+S$P,#`P/"]T:69F.EA297-O;'5T:6]N/@T*
M"0D)/'1I9F8Z65)E<V]L=71I;VX^,34P,#`P,"\Q,#`P,#PO=&EF9CI94F5S
M;VQU=&EO;CX-"@D)"3QT:69F.E)E<V]L=71I;VY5;FET/C(\+W1I9F8Z4F5S
M;VQU=&EO;E5N:70^#0H)"0D\=&EF9CI.871I=F5$:6=E<W0^,C4V+#(U-RPR
M-3@L,C4Y+#(V,BPR-S0L,C<W+#(X-"PU,S`L-3,Q+#(X,BPR.#,L,CDV+#,P
M,2PS,3@L,S$Y+#4R.2PU,S(L,S`V+#(W,"PR-S$L,C<R+#,P-2PS,34L,S,T
M,S([0S-$.#`S-S8S-#$X,C-%,C4U,C)#.3)&0C!"1C0Y044\+W1I9F8Z3F%T
M:79E1&EG97-T/@T*"0D\+W)D9CI$97-C<FEP=&EO;CX-"@D)/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&%P/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C`O(CX-"@D)"3QX87`Z0W)E871E1&%T93XR,#$Q+3`Y
M+3`R5#`Y.C0V*S$R.C`P/"]X87`Z0W)E871E1&%T93X-"@D)"3QX87`Z36]D
M:69Y1&%T93XR,#$Q+3`Y+3`R5#`Y.C0V*S$R.C`P/"]X87`Z36]D:69Y1&%T
M93X-"@D)"3QX87`Z365T861A=&%$871E/C(P,3$M,#DM,#)4,#DZ-#8K,3(Z
M,#`\+WAA<#I-971A9&%T841A=&4^#0H)"0D\>&%P.D-R96%T;W)4;V]L/D%D
M;V)E(%!H;W1O<VAO<"!#4S(@36%C:6YT;W-H/"]X87`Z0W)E871O<E1O;VP^
M#0H)"3PO<F1F.D1E<V-R:7!T:6]N/@T*"0D\<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(B!X;6QN<SIX87!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87`O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT='`Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@T*"0D)/'AA<$U-.D1E<FEV
M961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX-"@D)"0D\<W12968Z
M:6YS=&%N8V5)1#YA9&]B93ID;V-I9#IP:&]T;W-H;W`Z.#-F-S1F,68M83=E
M-RTQ,64P+6)A-#$M.6%A8C-D8C,P8S(S/"]S=%)E9CII;G-T86YC94E$/@T*
M"0D)"3QS=%)E9CID;V-U;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#HX
M,V8W-&8Q9BUA-V4W+3$Q93`M8F$T,2TY86%B,V1B,S!C,C,\+W-T4F5F.F1O
M8W5M96YT240^#0H)"0D\+WAA<$U-.D1E<FEV961&<F]M/@T*"0D)/'AA<$U-
M.D1O8W5M96YT240^=75I9#HY0CDU,$8Y,40U044Q,44P03%$-CA&-C0T,3`T
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M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIP:&]T;W-H;W`](FAT
M='`Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@T*"0D)/'!H;W1O
M<VAO<#I#;VQO<DUO9&4^,SPO<&AO=&]S:&]P.D-O;&]R36]D93X-"@D)"3QP
M:&]T;W-H;W`Z24-#4')O9FEL93YS4D="($E%0S8Q.38V+3(N,3PO<&AO=&]S
M:&]P.DE#0U!R;V9I;&4^#0H)"0D\<&AO=&]S:&]P.DAI<W1O<GDO/@T*"0D\
M+W)D9CI$97-C<FEP=&EO;CX-"@D\+W)D9CI21$8^#0H\+W@Z>&UP;65T83X-
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`\/WAP86-K970@96YD/2=W)S\^_^(,6$E#0U]04D]&24Q%``$!```,2$QI
M;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````245#
M('-21T(``````````````````/;6``$`````TRU(4"`@````````````````
M```````````````````````````````````````````````18W!R=````5``
M```S9&5S8P```80```!L=W1P=````?`````48FMP=````@0````4<EA96@``
M`A@````49UA96@```BP````48EA96@```D`````49&UN9````E0```!P9&UD
M9````L0```"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@````4
M;65A<P``!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``!#P`
M``@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#-C$Y
M-C8M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````````
M`````````````````````````````````````````````````````%A96B``
M``````#S40`!`````1;,6%E:(`````````````````````!865H@````````
M;Z(``#CU```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@```/
MA```ML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````
M`````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````````
M````````````````````````````````````9&5S8P`````````N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````````
M```````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="`````````````````````````````&1E<V,`````````+%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````
M`````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ``````````````````````````````````!V:65W```````3I/X`%%\N
M`!#/%``#[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE87,`
M`````````0````````````````````````*/`````G-I9R``````0U)4(&-U
M<G8````````$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*`$\`
M5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`O`#!
M`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X`3X!
M10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!X0'I
M`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L`K8"
MP0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#K@.Z
M`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33!.$$
M\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(
M!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_!]('
MY0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)CPFD
M";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`"Y@+
ML`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-PPW>
M#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F$$,0
M81!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#
M$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%>`6
M`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48^AD@
M&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2''L<
MHQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!
M(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D
M321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH/RAQ
M**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M
M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z
M,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXV
MZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG
M/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J0:Q!
M[D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?`
M2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.
M)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/
M5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;
ME5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B26*<
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MEHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4()2*
ME/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>
M0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@
MJ%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R
M2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;
MO16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''
MO\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!
MTT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>
MHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;
MZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV
M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___]L`0P`!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("
M`@(#`P,#`P,#`P,#_]L`0P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@!;`'T
M`P$1``(1`0,1`?_$`!\````&`@,!``````````````<(!@4$"0,*`@$`"__$
M`+40``(!`P0!`P,"`P,#`@8)=0$"`P01!1(&(0<3(@`(,11!,B,5"5%"%F$D
M,Q=2<8$88I$E0Z&Q\"8T<@H9P=$U)^%3-H+QDJ)$5'-%1C='8RA55E<:LL+2
MXO)D@W23A&6CL\/3XRDX9O-U*CDZ2$E*6%E:9VAI:G9W>'EZA8:'B(F*E)66
MEYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ]/7V]_CY
M^O_$`!\!```&`P$!`0````````````8%!`,'`@@!"0`*"__$`+41``(!`P($
M!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B%C,)L23!
MT4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756-X2%H[/#
MT^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>WQ]?G]TA8
M:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_=``0`/__:
M``P#`0`"$0,1`#\`W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=8IIX::&:HJ)8H(*>)YIYII$BBAAB4O
M)+++(52..-%)9F(``N?>U5G94127)H`,DGT`]>JNZ1H\DCA8U!))-``,DDG`
M`&2>JL_DU_-N^,W1$62PFRLE_IS[`I#44PP>QJZ'^ZV/K(2Z,N<WRT=3BD6.
M12&3'KD)KBS*GU&0O('W;.?N<6AN]UM_W1LC`'Q+A3XS*<_IV]0_#@9#&OF"
M>'6'_NU]]7VE]N5N=NV&\_K#S,I*B*T<?3HX)'ZUW1HZ`BA$(F8$48+QZ/[U
MGOG)YKJWJ_=W8ZX':NZ=];;VC79#$4]5)3XZEW/NO&4V0CVSBVR<QJZJKAEJ
M#`B$F65XR0/P(6YBVZTL.8M]VS9I)9]NM;F9$=@"S1Q.5$C:10!@-6,`'K)K
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MXC#IJ&&4_/R8?B4T9<5`J.D5GN-AN'C_`$5TDIB<J^DUTL/(]&5]D?2WK%-/
M#3PS5$\L4,$$4DTTTTB10Q11(7DEEE<A(XXT4EF)``%S[VJL[*B*2Y-`!DDG
M@`.JNZ1H\DCA8U!))-``,DDG``&2>JGOE'_."^,O0K9+;.P:\=\]C4IGICB-
MD9"`;-Q-;'Y(]&?WWHJL8QBE7UQ8Y*^86*MXSS[R"Y!^[CSSS?X-[N\7[IV5
MJ'7,I\9A@_IP8;(X&0QCS&KAUB/[M??)]K_;E;G;]CG_`']S(M1X=LX^G1A4
M?JW5&3!%"(5E8<&T\>M=3Y+?S"_DQ\JIZN@WMO)]M;"FE=J?K/8QJ<#M(0%G
M:*/,:*B3*;HFC5N6R$\T=Q=(XQQ[S?\`;_V9Y$]OEBGVO:Q/O`&;J>DDU?/1
MC3$/^::J:8)/'KEM[O?>8]U?=YY[3>][-IRXQ-+&U+16]*F@EHQ><T\YG<`Y
M14X=`3T1U_+VMW1U/UG3QECOGL/:&V9E07,=#D\W1T^1FTGC13XYI78G@*O/
M'L=<W[VG+G*O,F_.?]P[*:4?-DC8J/S:@_/J)/;GE>3G7G_DWE-%+?O'<[>!
MODDLJJ[<#A5)8UP`#7'6VK\T.SJ7;7R7_EE]#4#QP2=D_)#=>[*BB@=59=M=
M.])[[J88VCL7^V7/[FQQ'T4M#;_6Y/\`+%B]SLG/V]25)ALD6I\WGGCJ?MTJ
M_P"WKZ1;MX;>YV2P1=*LYTJ,`".,T'V"H_9U9E[`?1SU[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7__T=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW39FLUA]N8C*
M;@W!E<=@\%A,?69;,YG+UM/CL5B<7CX)*JNR.2R%7)#2T5#1TT322RR,J1HI
M9B`#[O%%+/)'##&SS.0%4`DDG```R23@`=:9E569B`H%23P`ZT;/YP'\Z_<G
MRSR^6^)_PYR.>HNAJNN?;F[-[[>ILC'O'Y"U_E^W?;^UZ.CB_C-%UG--Z5BC
M05F>',BI2D0RY>^U_M+;\MPQ<S<V(G[W"ZDC<C1;#CJ<GM,O_&8_+NR(+YSY
M\N-SF?8.62[(25>1`2SG@5CIG3ZMY^6.+Q_*:_E!?S'=I]I[*^4$F^*CX.[:
MP@@JJB;=-"N7W]OK9_DCJLEMG-]3R5E'C(-JY:FBM*NXIZ:2#TSQ4_D1'#?N
M9[H<B7FW77+R6(WBX?`T'3'&_`,LM"2X/#PP0>!:AIU;DGDGF7;;J/=[F^^B
MA&63XF=>)#K72!\R=0XXZV!/EI_.G^*/QN_B6TMBY9?D/VG1":F?`=>9&E_N
M=B,A&&1DW+V"%K<-3F.8>NGQJY*I0@JZ1GD1QR)]W_G/FWP;O<HOW7LS4.N9
M3XK*?]]PX;AP+F-3Q!/0:]SOO2^WO("W%EM4W[YY@6H\*W8>"C"O]K<49!0B
MA$0E8'#!>/6M/\G?YEWRF^7E168[?&]6VCUW4R/]MU9U\]7@-HBG+/XX\Y(M
M1)F-VS*A]39"HFAU7,<48-O>:G(/L_R/R$L<VV[8)]W`S<STDEKYE,!8A_S3
M533XBW'KFE[M_>#]S/=%I[7=MX-KL!)I9VVJ*`C.)*$O,:'/BLXKE57AT3RA
MF`50+`"U@/H+?2UOQ[F"-NL9;J,DDGCTJ*:74!_ON?S_`$]JU/#HBGCH3U:Y
M_)XZ]._?FSLO+34WW&/ZSVON_?M62I:.*HCQG]V,/(Q(*JZ9;<D4BWMS'<<C
MW`WWF=]&T>T^Z6RR4FO[B&W'J1J\5Q^:1,#]O65WW'N53S#]X#8KYXM5MM-I
M<WC8P"(_IX_S$MQ&PK7X?7(.'\BNTQV5_P`*.?A7U-356O'="=-[SJ*JG\CM
M%%NC?/7>_MX9$^-'*I42;>@Q(-P#8#5Q;WA_L>V_0^Q7-FYLGZEY=Q@?Z2.2
M-!^6HOUV,OKWQO<79-O#=L-I*Q'])Q_F`ZV7O<"=2%U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7__2W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW3%N?<V#V;M[-[KW-D(
ML5M[;F+K<SF<E,D\R46-Q\#U-74&"EBGJIS'%&2L<2/)(UE52Q`+L$$US/%;
M6Z:IG8*H]230?+]N.JLP16=C10*GJ@/Y2=$?.K^;7D)=DY#*Y7X+_P`O*AJH
MZJNBW=0LOR"^1-)02_<IG]Q[!^ZI!L'8P\(FH,5GJBGF_14UU'*XC@@F;EW>
MN4/;9%O$A7=^=R*#2?\`%K8G&E9,^))Y,\8(_"C#)(-WC;-VYFK:/<M9[%^*
MG]M+\C_OM/D>X^8\NBLS?)O^3A_)RHZ[:OQ;V10_*#Y/XZFEQN5WK09/';OS
M=-E(U,<T>Y^YZRCJ=N;2I1/<2X[;%-(ZVT20*1J]C*TY/]V?=R2.[YCO&V[E
MMB"%8%%*_P#"[<$,YIP:4@>88\.HPYD]S?;;VJ@EL]JA6\WM01HB(9M7_#9C
M4+GB%U$>:CJEOY9?S8/F!\TJBOQ.^]]ML3K"LD80=0=9R5NW-GO2EB8X-R5:
MU+Y[><@4C7_$:B2FU"Z01?3WD7R/[2\F\DB*>QL!<;L!_N1-1Y*_T!33'_M`
M&I@L>L)O<[WKYZY_%Q9W-^;78VJ/IH*HA&?[0UU2XXAR5KE57HDF*J0H0+95
M`%@.`!_2W^'N7(V\^L:;^`DL3D]")C:KZ6)_%A]?]]]?:^)N@?>P<:CI>T%1
M<+_C]/\`C?LPC;%>@G=PTKTKJ*;@#_8BW^`_P^GM8C5'0>N8\D];+?\`(+ZZ
M/V7R#[<J(.)ZK:/7&(J2@OII(JS<^XH4?Z@%JS&E@."0+_3WA/\`?`WRLG)O
M+D<G!9KEQ]I6*,T_*7KIK_=T<K!(?<CG.6/+-;V4;4SC7/.`:5S6W)`-#05&
M!U4S\%NV6^1G_"CK=';,%4];C,GV)\DXMOSD^4?W3V3UON;8.V?&25TPMAL-
M`P('&OZ<W]DW.&VC8?8>SVUDI((;4M_IY)5D?\ZD]9C[!=ONGNIN-T&K'&)5
M'^E5=`_GGK>:]X@]3GU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__3W^/?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]UBGGAIH9JB>:*"&")YIIIY$BAABC4L\LLCLJ1QHJDEB0`![V
M`20`*D]>ZHW^;O\`/R^&GQ3;,;-Z[R9^3?<6/:>D;:W6>3I#L;`Y*(LGBW=V
M:R5F"IVIY@/)3XQ,G5J059(SR)<Y0]F.:^9O"NKV+]W[6:'7*#K8?T(L,?D6
MTCT)Z!&_\_<O[%JB-Q]1>?P1D&G^F;X5_:3\NM0SYH_S=?FO\WI,GA-^]BR=
M>]4ULLOAZ<ZHEKMK[/>C9B8J?<^0CJ7W)O=D'ZOXA4M3,URE/&.!E1R;[7<H
M<GF*>UL!<;FO^C34=Z^904TQ_P"U%?4GK'#GCW`YIYA@GM8KDVFWL#V1$@D>
M6I_B;Y@4'5:N.F\6B,`*$L`J@*%'X``L`!_A[F)&!`(X'K%/<[5TDD62NNOG
MT(.,J_T\\BW]!]/];^OM4C?RZ!=[;_%C'0CXJJN%YY_K_O?^W]K(V\N@;?P9
M;'0BXNJ!`Y/%K6/U_P!]?VNB?@>@;?0$$XZ$+&U-[<_6WY'U]F$3<!T$+V#C
MCI:T4_Z?]A_7_?<^UT;9KT&;F+CUMJ_$?.P?#[^33OWO:M9:#)GK/N?NR.1K
M(\F:R--DL/L2.[E;O7+BL6D8N;F46^OOG3[SSGG3WZ&RQDM!#+;6@_TJ@/+_
M`+RSR5^SKM3]T?8AR3]W/:-RE0+<7INK]_GJ8QQ'_;0PQ'\^M8?_`(3T1U%7
M_-+ZAJ:EVFJ4Z\[MKJN9S=I:B;8E?'/,Q;EFDJ*HL?R2;_U]RC[Y:4]NK]%%
M%^H@`^P.*?R'0F]JV>;FR>=S5S;R$_:67_/U]$GW@WUDAU[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7_]3?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO==7']1_M_?NO=`SW]\@NI/C%U=N3N/NO>
M.-V7L3;%.)*O(5K&2LR5=,&%!@=OXR'56YW<66E7QTM'3(\TK7-@BLRG.P<O
M[OS/NMMLVR6;3W\IP!P4#BSMP5%XLQH!]I`Z)>8.8-HY7VF[WO?+U8-NA6K,
M>)/DJCBSL<*HJ2>J@_AI_-V^-W\R?<O;7Q:[?Z\H^O4[`&X]O==[0WCEHZ[&
M=R=993'O15NWLG5P_:PXOL5J,S32XZ"5UD@D!I)I)(9#[F#GCV;YD]N++:N:
M-JOC<I`$:=XU(-O,#4,!DM#6@#D5!'>`&'4,^W'OWRQ[C[ON?+=S:_1W;.PM
MED8$7$5.%<!9N),8)!4]C-I/6KG_`#:?Y3>]?Y=_8)W=LBGR^[OBAOK,20=?
M;TEC:JK^O\I5O)-!UEV#41)IBR%/&"N*R3A(LM3QV.FI21#.7MA[FVG/%D+2
M]98N985_43@)0.,L8_X^OX#G*D'HHY[Y%DV"5]QV]6?:'.?,Q$^3>JGR;\CU
M3H#^/H?Q_MOI_L?Q[ED&G47S1"537C3KNY1ED7_8_P"M?ZG\6]FMK+4:3QZB
MSF?:]#&51PX_9Y?YNE5BZHW7D_CZ_GZ>S)#\^HNOH!0XZ$;%U9!7U?T/U]JX
MVIT#KZW!!QT(V+J^5YX_I_O?M;&V0>@9?6^#CH1<;5?IY^MC];6/_%/9A&WE
MT#KV#CCH1\)#596LH<901M/79*KI<=10Q@L\U973QTM+$JBY+2SS*`.>3[5F
M>.&*2>5@(D4LQ]`!4G\AT&_H9;JZAM8(B\\CA54<22:`#YDX'6SS_/8W32?&
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MPPQHI+,Q`4"Y]V1'E=(XD+2,:``5))X``9)/D!U266*".2::14A1269B`%`R
M22<``9).`.JU.Z_YH?1^QMS4W5O2V/S'R9[HS%9_!\%LSJS17X-\W*SI%1Y'
M>,:56/81%2\WV$=>845C+X@I83QRI]WWF[=]O?F+FN:+8.5(DUR3W?;)X8I5
ME@)#9X#Q#'J)&G5@'%'G[[WGMYR]N\?)W(5O/S;S[,_A16NW]\1E-0%>Z`9#
M2AU>`LY0`Z]`!(C=K?,&H^"_1><^1'SS[$V[2;LW4D-+L/X^=84="\<&7AAF
MJJ;8^RY:V:;/[VW1)]PIS6;J:F/$44:`HD,2AYR+^JVT<[\P6O*WMAM,YVZW
M)\6^N6;Q)0:`S2*`(X(A3]&%4,K5.MF8Z4D'9N8>;N2^6MQYU]Y]^M5W*Y"^
M'MUFBB"TI4K!%(Q>:ZN6K^O,TG@C2!$B(I>31I^<O\P7O+^8%VF^^>T<@V%V
M5@JFKCZRZDP];42;1Z_Q50WCU1JXA&;W77P(OW^6GC$U0PT1K#3K'"N:GM_[
M>['R!M@L]MCUW\@'C3L!KE;_`)]0'X4!H.)JQ).$?NI[G[[[B[F9[R0Q;1&3
MX-N"="#^(_Q.1\3$5/``*`H*QMW(9'$9''Y?$5];BLMB:VDR>+RF-JIZ')8S
M(T$\=50Y#'UM,\531UM'4QK)%+&RO&ZA@01[D%HHIXI(9XE>%U*LK`%64BA!
M!P01@@X/4)/<SV<\5U:S-'<QL&5E)5E8&H((H000"",@Y'6Z%_+:_F+]8?S#
M>H\K\)?FWC]M[E[,SVV*G;!&YJ:"/`]_[6BI1>3ZQ1X_M#$)"*B5:<PRSR1+
M74965)%BPD]V/:G<O;S<TYWY(\1-E60.0A):T<G]I@8F@)KIKH?!!/0OV']]
M[#W$L5Y*YRFC'-:II5GH%O(P,GT\<`=ZBFL#6@KJ"ZUG\US^55V#_+K[*&:P
M8R^]?C!OS+SQ=8]C3QFIK=MUTWDJ8^M^Q)X8Q#2[FH*=6^QK6$<.9IHS(@6=
M)X4EKVT]R;+GFP^GN-,7,4*_JQC`<#'BQCS4_B7BAQ\)!)CSQR3-RY<M>V:%
M]FD;!\XR?P-\OX6\^''JH\?3_8$6/Y_K[EB*0JPSGJ(=XL%N+=J+BAZF44QC
MD`)/!'^Q!^O'L\B<,H8=0?NMDT$LD3#[.E_C*K])]JT/[>@1?0?$.A'Q=6#H
ML>./:R-N@;?6Y[NA(Q=5<"Y_I:__`!7VNB?AT"[Z"A-!U87_`"X^N1W#\U/C
MCLJ:G-7CV[&Q6Z<S"5UHV&V''4;TR*3`@KXIHL%XVN+?N`?GV"O=??#R_P"V
M_.&XK)IF^C:-#Z/-2%:?,%Z_ET-_8GE1>:_>7D#:9(M=N-P2:0>1CMJW#@_(
MK$5/K6G1P?\`A4IW&,SW-\8NA:.L66GV/L#=G:6;I8WN(LMOO,P;9P8J%MQ+
M%BMH53I_M%1?\^\6ONY[68]LYAWIU[I94A4_)!K:GRJX'VCKK%[PWXIM&VJ<
M]TA_XZ/\O^H]%(_X3;TZS?S**:9E8FEZ"[7DC(U64RUNSH&+`<$%7MS^?8G]
M_6IR&J_Q7L7\@YZ(_:)`=_O7(RML:?FPZ^@5[PHZR+Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[K__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]TWY3+8K!XZMS&;R>/P^(QL$E5D,IE:VFQ^.H*:(7EJ*VNJY(::E@C'ZG=E
M4?D^W8()[J:.WM87DN'-%5069B>`"BI)^0Z8NKJVLK>:[O+A(;6-2S.[!$4#
MB69B``/4FG5.7R;_`)U?QQZD.2VUTJC]^;ZIFEIA686I;&=:XVJ34A>JW;)#
M++GQ#)SHQ<,\,@!'W,9Y]Y(<A?=EYQYE,-[S-(-IVDYHXUW+#Y1`@1U'G*RL
M..@]89>[/WVO;OD=;K;N3(CO^_K4`QG19HWJT]"9:<0(%9&R/%4YZI,W+\D?
MF[_,B['H>J\=E\MEXMR5.NCZMV.9ML]=X3&12@397<PCG<U&'Q*3!IZW+U%2
M5N`GK9(SEQM7)7M-[&[%-S%/;11O`O==STEN7<\$BQAWIA(56OG@$]<[]_\`
M<[[P?WIN:8>3;*\GE@NG[;"TK!9Q1@Y>?N[HXZU:6Y>32:`&I5>K*MY;I^(O
M\B;HQ-Z[]JL=W!\P.PL%40[6VYCI(H-P[@J0H2:AV]',DT^P^I\3766OR\\8
MJ,@R:0LLHCI8L6=_YFYW^\?S%^[K!7L.0[:6ND_"H\GF(Q+<,/AC!TQUQ0:I
M&Z,^UGLY[>?=3Y6?>]R=-Q]Q+F&DEQ3O8FE8+16S%;AOCD-'EIJDH`D2::/R
MG^7/>'S6[AS'=/>^Z9<[N&N\E'@,'2&:FVGL/;?G::DVILO"O--'BL/2:KNQ
M+U-7->:HDDE8M[R:Y2Y1V3DS:H=HV2V"1#+N<O*_F\C4R3Y#@HPH`Z@;G[G?
M>^>-VEW+=ISX8)$<0)T1+_"H_P`)XL<GH&<?^/S[%J?SZBJ\\^EQC@>/I_C_
M`+[\>U*4Z"]X>/0E[:RF4P64Q>;PF2K\/FL/74>4Q&7Q=7/09/%Y*@FCJ:'(
M8^NI7BJ*.MHZF-9(I(V5T=00;^WW@@N89+>XB62WD4JRL`592*$$'!!!H0>(
MZ#AO+FPN8;RRG>*[B<,CJ2K*RFJLK"A!!%00:@Y'6XO\`OGOU)_,@Z;S'PG^
M;&(V]N#L;<.V)MO3QYZ*&EPO>."I8?*F4QKQ^$83M#!&!*ITIFBF::$5U$4=
M)(X<'?=?VHW7VUW5.>N1FD79%EU$+4M:.3P/$M`U:`M6E?#>H(+=)?8#[PFV
M>Y]BO(O/#Q+S<(RJEJ!+Y`,D<`+@`5=!373Q(Z494U<OYI/\L#LG^7-VN(0<
MIO/X[[[R56>HNTY:?7(H_<J3L'?$D$:4]!OC#4H.B2T<.5ID^XA`83PPR[[;
M^XMASWMPKIBWV%1XT5>/EXD=>*$\1Q0X.*$GG._),_+D[SP!GV>0]K<2A/X'
M_P`C>?V]58EBA5A_9/)_P_(]R]:2U)4GK''FK;"*RJF1_@_XOI4XRJL5Y_P_
MK_OK>S13U%%]!75CH1<956T\C\?[?VJ1J=`V^@K7'0D8JK_3ZOP#P?S^?:Z-
MN'0,O[?XL=;%7_">KK=MU_*/LGLVH@+T75O5$]#1SE24AW!V!F*7&THU\@2-
M@\-D1;ZD-[QQ^]%O7TG).T[*C?J7MZ"1ZI"A8_\`&VCZRJ^Y/RQ]9[C;_P`Q
MR+^EM^W%1\I+AU537_FFDPZIH_G2]PGNG^9?\GLU#5"JQ6R-SXOJ#"F-]<$=
M'UEA*+;V16`BZ^.3<R9"0VX+NQ_/MWVCVO\`=7M_L$96DDR-.WVRL6'_`!G2
M.LH/<N^^KYKO$5JI"BQ_F!4_S/1Y?^$RFS<]F/GAO_>=)B*RHVYLKX_;GHLY
MFTA8X[%Y+=FZ=IT^!H*FJ++''79:+$5CPQ^IWCII6L`A/L'_`'A+J&/E#;K1
MI0)Y;U2J^9"(^H@>@+"I^8]>A'[/P2'<]UN-!\)856OE4M6GVXKUOFW!^G/O
M#7K(#KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO_]??X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=)O=V\=I;!V[D]W;YW/M_9VU<+3/5Y?<FZ,QC\%@L931B[3
MU^5R=12T5+$/ZNXN>!S[?M;6ZOIX[6RMWFNG-%1%+,3Z``$G\ATU//!:Q27%
MS,D<""K,Q"J!ZDF@`^9ZU]/EO_PHI^./6$F2VA\6<%+\B-YP>6F_OK5O6[:Z
M?QE4ME$L&0EACW'O58GO=:&&FI)0+I6^\A^2ONY\Q;T8KSFFY&W6!SX8H]PP
M^RNB.OJQ9AYQ]8S^XWWFN6N5DGLN5;7]Z;L`1KJ4MD/S;XI:>B!5/E(.M<#Y
M!?S`?D_\O\F]5W7VAE,K@!5&IQW7N!_W[?76'^@B%'M;'2)35D\"J`M37M65
MG]93?WF'R7[?<G\CQ*NP;/&EU2C3/WSOZUD;(!_A32OHO7.CW2]S_<#W'F?^
ML^^RO8!JI;Q_IVZ<*:8EHI(IAWUR>KGH0_AO\5>X_F1V+3=?]48?_(Z)J:HW
MEOG)Q3Q[1V)AI9`K9#.5T:'RULR!OM*"'55UC@A%"+)(AKSO[B\O>WFS/NV^
M7/ZA!$4*T,LST^%%]!^)SVH.)J0"`_;GV5YN]W.8XMCY;LZ6X(,]RX(@MXZY
M=V`-2<Z(UJ\APHH&9;V_D[\N/BA_(TZ7?I#HO'8CMKYC;TP=-65\>3>&7(0S
M31.:'?/;];CY!-M[:U-),[X?;E.Z5%7';3I1Y:TX7I%SK]X+F$;YS%.]KRC!
M(1&BU\-!YQP`X>0@#Q)F''Y!8QU@Y-Y']O\`[MO*8VCENT6?F.>,&:=P/'N7
M%:/*17PX5+'PX@:*#^)RSMI4=W=V]J_(OLO=/<7=6],MO[L7>-:*S-;@RTH.
MF-+K1XG%4,02BPF`Q,!$5%0TR1TU-"`J*.2<JN7MEVS8+"UVG:+18;&(4"CS
M]68\68G+,:DGCUC_`,[[WN.^7EUN.YW)DN&./X5`R%4<`HX`#_#T'=#]5X_(
M_P"*>Q0O'J&;HUU=+3'_`(_'(]O)T&KOSZ7..'T/^^_I_P`3[4IPZ"UX>/2\
MQPY'^P_WW^P]K$&>@I>'!Z$_;.5R>"RF+S>%R-=A\SAZVDR>(RV+JIJ#)8O)
M4,R5-#D,?74SQ5%)64=1&KQRQLKHZ@@W]J7@@NH9K>YA62W="K*P!5E84*L#
M@@C!!P1T&C=W5A<PWME</%=Q.'1T)5E93565@00P(!!!J#D9ZVY_A9\R.E?Y
MG?16;^%/S2PN$S?8N8VTV)J$RG@H:7MJ@QT`DI=W;5JX_$^`[3VXT*U<J4VB
M42Q_>4O[?FB@P4]UO:O>O:O>DY\Y':0<O^+JHM2;5F/]FXSJMWKI5C@5$;YT
ML_4C[NGWB]I]V=L3D#GJ2->=DBT@O0)?HHRZ<`+E0-4D8^,`RQ"@=(M3_P#F
M9?RT>UOY<_;QV_F_O]X](;TK:V;ISMY:,I2YVBC+3MM+=?@04F(["P5,;5%/
MZ8ZV%?NJ?T%TBF7VW]Q-NYXVT2QE8MXA`\>&O`_QI7)C8\#^$]I\B5ON5R'/
ML,K21H9-JD/8_$J?X&QQ]#YC[.JVZ&8QR:6X`-UY_'U_WKW+\3AE!'6*V[V3
M032(5ID]+_%U)](O]/I_C_L?]8>U2G/'H#WT(R:="/BJFX47_P`1[61M^SH&
M7\%"33K<D_D.XC'])_!'Y&_)O<:104.4W/N_<4U1-IC\FT>E=ER3R.9FM:#^
M+5.37@VU*?S[PF^\E?2;WS[RURS;DEH;=%I_PRYD_P"@5CZZ(?<ZV!=G]O-_
MYBF4!KV^-#ZQ6\8`J?\`3O*/RZT<MS[CSW9F^-Q[NK(:S+[I['WEF=R3TU/'
M)59#)[@WIGJG)_9TL":Y:BLK,CE!%%&MV=V"CZ^\E;2WAVVPMK4$);6\*K4X
M`5%`J?0`"IZ27\DVY[O=3(I:::=B*<26;`'\J=;C6?KJ/^0U_*2QVW\7445!
M\X?E3(\]15Q+3S9+!]@YW"P-ELDBRQN)\'T)M&HCHZ8,'@ES<J/8K5./>+EE
M`_O7[I-+*K'E#;O+R,2L=(^37#@D\"$J.*CJ9^8-TA]I_;QY(V4[W**)P[IW
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MT>RL''1[4PN^]FK/'!7`PM4U4)BJU<QS63.7V2W#DVZV))>7]JAMMXB4+<K\
M4M?X];5<QOQ%#0&JTQG%;WJVKF6XG,5]N$LFRR&L(7M0'^!E7!9?(GB.J4L3
MDWB<(Q(M;\_CWD'%*&`*G!ZPMWG:'@D>.1*,.K>OY9/\O;M+^8-V'78_!9*'
M9O4.Q*S%?Z5NR9_MZNIP\626:HH=O;9PSS+-EMUYJFI)#"7"T=+&K33N;)#*
M`?<CW2VOVYVQ)9HC/O,ZMX$(J`Q%`7=OPQK45IW-@*.)!U[:>QVZ^Z>[NB2B
MVY?MW7ZB<T+`&I"1I^*1J$"M%7+,<!6V;/G3V)V9_*X^+."Z'_EP_$+L[=><
MS6&JJC(]R[?V!DM^[9Z]>57H<AO7>E7BJ6MR>]NU<H:<RT\533B@I4"/)^PD
M5(^(G+8@]T^:I]_]QN:X$17`$#2"-G'$11`D+'"M<D'437BQ+]=#K?8;#VLY
M3@V#D#EES&H.5742U*&:=AW22&@\J4`50J!5&A'O[.[WS^]MR;@[3R6Z<EV+
MN3+UN9W;E=^MDQN[,9RNE:2MR&:?-I%DI:R64\ZU`4`*H50`,RMOAL8;2W@V
MM(EL(U"H(Z:%4<`-.*=8_;Q)N4UQ<7&["7ZQR2QD!!)_,>7D!@=)1_T'_7'^
M]<_[;V>6WQKU%7,)_2EK2M>G&A^J^S,=1C=<#TM<=_9_V_\`O?M]/+TZ#-Y^
M+I<8X<+]?]\?:E.'07O//I?8X6(_UQ_Q'M7'7H)WAP>E_CA]#^+#_>?Z>U\?
M'/02O#Q]:]"?M?+Y;;N5Q&?P&3K\+G,)7T>5PV8Q57/09/%9.@G2IH<ACZVF
M>.HI*REG17CD1@RL`1[4RVUO>6TUG=P++:R(5='`965A1E8'!!!H0<$=!U;^
M\VV]@W#;[J2"^AD#QR(Q5T=2&5E92"K*0"""""`0:];5_P`4/E9T?_-(Z)SO
MPN^:>"PN5[#RV"^S62H$&+7L5<73L]#OG8]<J@[8[6VTZ_=.E-I)96J*=6@:
M>GBP,]U/:G?/:/>H^?>0WD_JZ)*D"K&U9CF.4?CMW^%6:M*A'.K2[]8_NX?>
M3V;WGVD>W?N"T2<\K%I!:BI?HHS)'P"W2`:I(UH&H98@%#I%J/?S)?Y</;?\
MNCN5MH;J^[W7U/NRIKZSISMV&B\.-WAA8'$LF$SBPAJ?#;^P$,B+7T)8+*+5
M-/J@D&B</;3W#VSGS:Q/`1%ND2@3PDY1OXE]8V_"?+X6R.B3W<]N;SE2Z,Z*
MTFU2,?"D_P"?']&'EZC(].B'XRJY4W^O^OS_`,:]RFK=8WWL'Q=")C*P(NLG
MA5+'G\*+G\W^GM4C>70/O;8L=(&2:=;EOR5KY/AG_P`)U\/M,:L1NSLWI_9&
MR]*$P5!W#\A,]'N3=4<GJ60U$.V\YD58?4"+D6!]X*VS_P!=/O!7UX3KM8+U
MV]1HM%\-/R+(I_/KJ+RC8?U*]BMCL@GAW'[M5B/,271,K`\<@RD>E1Y#JH/_
M`(3Y_!G&=U=ZYSY@]M4=)2=%_%&49C#U>=6.#`YSMVGQS9:@JJFHJC'3'$]7
M87_<S5N3HBK7H2WI#@2%[X\XR;5M$/*NV,3N^Y88+EEA)H0*9K*W8!YJ&]1T
M7>UO+:W5W)S#>+2UM\1UX&2F6SY(/YD>G1!OYK/SGR/SX^6V\NS<=65?^B/9
MAFZ]Z.Q$QDCC@V%B*R;5N>2E8D0Y3?N4\F4G)]:0R00$D0+[D7VIY-CY*Y:M
M+"1!^])_U;AO^&$?!7TC':/GJ/GU#/O)S2_-&[W#1/\`[K+:J1#U'F_VL<_Z
M4#H@&W<CD,1D,?E\17UN*RV*K:3)8O*8VKGH,CC,E0S1U-#D,?74LD5515U'
M4Q+)%+&RO&ZAE((O[E1XHYXI89HU>%U(96`((.""#@@C!!Q3K'*2XGM)XKFU
MF:.XC8,K*2&4@U!!&00<@CAQZWA?Y/W\ZR@[_I]L_&7Y:9ZBP_><4=+A>O>U
M*]H:##]QB)%AI<-N.3]JDQ'9Q50J.-%-FSR@CJSXYL+?=_V3EY?-SS/RE`TF
MQ&K2P#+6_F63S:'Y9:,<:IE<V/9CWYMN:?IN5N;IUBYC`"Q3&BI<^0#>2S'\
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MOD:?D:$9`Z*]YVBRWS;[C;;^(-!(/S4^3+Z$>77S1?EE\5^VOAAWKO#H/N/%
M?8[HVM4_<8G-4D4PP&^=IUDLO\!WMM:JE4&IPF;IXB2O,M)4K+3S!98G'OH7
MR?S;MO-.T6N\;9)6WD%&4_%&X^)&'JI_(BA&#UA#[B\@7.TWD]I<)W@$QO3$
MB>1^W^(>75HW\@+Y@?[+M\X,!UUN/*&BZ\^2]#!U5FDJ)?'14>^%J)*_K',2
M!W2)97SCS8D.?HN6)/`]@SWXY6',G(\VXVT==PVUO'4CB8Z4F7[--'/SCITD
M]@N8GY4Y\_<]TVFQW-?!8'`$H),+?,EJQC_FH3UNV?(OYK='?%3<6S,%W97;
MHVS1[\H\E58#=5'M7)9[;#38>JI*?)XVMJL-][D:7(TB5T,S)]JR>&4,')!`
MQ)Y)]K>;/<.RW2\Y5BMYY+-U$D1E6.6C@E64/I0JVEE!UUU`@CK)GW-]]N0/
M:#<]BV[GR>\M(-QC=H;A8'F@K&RJZ,T6J1776C$>&5T,#JK@!M5]M_RV/E_1
M?PG<^X_C!W&*V+PIANR*#9E1FRD@50E/B]^4%)G8)>+#Q(K"W'M7=<C>[?)#
MF5]BW>S"G+PB0I^;PEDI^=.G-C]Z/9/GM4AVOGS9KIWI2*66..0UX`0W'AR5
MQPT5Z*EVQ_(*_EA]R029'`]397JFLKD>6'-=*[\S6#HB\@9DGAP>2GW+M$QA
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ML?>9N3^:N77==\Y?N[4@TK+$Z`\>!90#P)J*BG3'C&5]+*RL"?JI##_;BX_/
ML21\>HQO@RU#`@]"#CAR/Z<?6WUO_P`:]KXJ9Z"-YY]+['CA/]]^/9@GX>@G
M=_BZ$C:^9RVW<MB=P8#)UV%SN#R-'EL-F,94RT>1Q>3Q\\=30U]#50LLM/54
MM1&KHZD$,/;\UK;7MK/9WD"RVDJ%'1@"KHPHRL#@@@T(].B2'<+[:;^TW/;;
MJ2#<+>19(Y$8JZ.A#*RL*%65@"""""*CK:'^//R%Z&_FQ?'W/_#GYAX/$U'9
ME9A;K,HIL7/NRIQ-,_\`#NS.MZWQD;<['VXY,]130#3;7)&DE')44\7/_P!T
M/:[F#V5Y@AY[Y%ED/+)D^;&W+',$XXO`_!'/R5B'"N_8/[N/WD.7O?W8']N?
M<00ISXD-"#14OT1<SPX`2Y0=TL2TX&6(>'K2+3W^?_\`+^[A_EW=VU/6W844
MVX-BY^6NR74G:U'1/38+L';4$JW1U7R0XG=^$26./*8XN6AD*RQ%Z>6*0S_[
M>>X&T\_;.M]9$1[A&`)X2:M&WJ/,HV2C>?`T8$=1[[K>V>X\A[JR,IDV68DP
MRTP1_`_D'7S'GQ&#T"WQ]V'6=P=S=1=48^.2:L[)[*V/L>-(P6<IN;<F-Q-3
M(``3:&EJG<G\!2?8PWS=$V;9-WW:1@%MK:27_>$+#]M.HFV'86W_`)GV/950
MGZJ[BBQY!W"D_*E:D^0SUM?_`/"C%]T=AP?`OX#=,8R3*[Q[7['K,OA=J4I*
MQO'MO%T.P=EM5!5M!BZ"7<U=43S&R04]%)(W"W&&'L8UO92<Y\[;O+IMK:"C
M.?5V,CT_I'2H`XDL.NF'N);RW=IL7+&W)1[B8``<%2,#/V#]F.@>_FQ=I[*_
MEB?R^.G/Y6/0&8C'8/9NSC5]S;GQS+39>78]7623[^W#DGA5)X,IW/O(5%'"
MKMJCPE/4P_H$1]F?MGMMW[A\\;I[B;W$?H;>7]%3E?$`_34>1$*48^KE3Z](
M>=]PM^4N5K;EO;"!<2QZ,<0GXW/S<X_,]:@[<+8`6XM;@`?0`#\<>\MK7X@?
M/K#GF,$1S?8.'Y=/&._L_P"P]FH\^HFO//H0L0\D+PRPR212PRQ30S1.T4L4
MT3K)%-%*A62*6.10RLI#*P!!!'M0`K*58`J<$'S'SZ"EU))%(LL3E9%-01@@
MCS!ZW$?Y0W\Y\[I3;'Q>^8>Z$3<Q^UP?5G>>?JUCBW(WH@QNS>R\C4,L<&XB
M-,5#F96"5YTQ516ITS5&(/O)[&&U6ZYLY)M*VHJUQ:H,IYM+`HXIYO$,KED[
M>U<T?8G[QR[A+:<E>X%Z%OC1+:\<T$GDL4['@YX)*3WX5^^C/M(7]XF]9K=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U_]+?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5Q_-
M1_EK;%_F)]&2X%%QNVN^-@4^1R_2?9$\)4X[+2Q"2KV9N::%&J*O8V[3`D55
M'ZFHYQ'5P@O$4DD+VZY^O>1-Y6X&J3:)B%GB]5\G7TD3B#YBJG!P&.:^6;3F
MC;)+*X`6X`)C>F4;_H$\&'F.OG(;UV7V9T)VEG=E;RP^:Z[[:ZIW9]CEL36J
MU+E]M;KV[6Q5=)4PRH=$RQ5$,-51U41:&HA:.:)FC=6/0#:]SV[>]LAN+>5)
M]JNHJ@C(9'%"#_,,#D&H.1U@WS7RQN&R[J91&8MUM9`V/5352#\Z`@CK?![0
MW#C?YI7\HC9'R$V_2P5O:6T-K0;_`*_'T(26KQW8?7<%1@>X=L)'$`\:9.BI
MZZHIX`+R#[1K'CWBU[;W\OM#[XR[#=2E=EO)#;$G`,4Q#6TG^U?0I;R!?J1_
MO'<HQ>]WW=I-\L(->_[=$NX0A<MKA4K=Q"F3JB,I"?BD2+&!UJNU[(PN0&%K
M@D`\6OQ<?X^^B,IQUQ:M59?D>E!M'O'N3JN=:OK3MGL?84T3!D_NEO3<."@N
M!;UTN/R$-+*E@+AD8<?3V%MYY;Y=WQ&3>=BL[H'_`'[#&Y_:RDCJ2N5^=.<N
M6'C;EWFC<+$KP\"XEB'"F0C*#C&>CB[#_G._S`^MO%!)V[C>P\?`5)H>R=F[
M?SSR*I!TR9C&TN$W`^H`@EJLGGZ_3W$>]?=^]K=T+,FQ-:2GSMY73]B$O'_Q
MCK)/EC[V'O9LRJD_,B7\(_#<PQ/Z<754E/YR>9Z/'UY_PI)WWBV@@[A^-&UM
MP1^A:G)];[UR>VJDVX>6/#;FQ^XZ=VT_1/OHQ?\`(O[B;>?NK;:Q=MBYJFC]
M%GB60?9J0QD?;H/60W+?WV-P;PTYFY)A?AJ>VE>/[2(Y%EKY8\0?:.CT[%_X
M4"?R^^QZ-,-VAC>S.LA7*(:^EWSU]#N_;5G!#K-5[/JMT-/3CZ$R4:7'X]QA
MN?W=/<;:9&GVN6UNM.08I3&_[)!'0_8YZG#9/O2>U6_1+#N9NK(N*,L\/B)P
MR*Q&0D>65'V=+U]L_P`CGYG2228NK^)6;W#DE%I=L[@Q?3^^7EE.KR&BQU;L
MC<,]4&;D2P2&_P"H>T$6[>_?(ND,^[QVR>4B&YB^RK"5`/L(^71M=\K?=U]Q
MQ)6SV2>YD&3$ZVTQ\ZGPVAD)SY@\<]!1V!_PGZ^+&ZJ=LGTYVOV=UVU3&9J1
M*NLPG96V3J`,1A2L@Q.9>#CZ_P`2<V/UX]B_9OO2\Y[<PBWW8[.[4'-`\$G[
M073_`*ICJ*^9ON0^W6[AI>7N8-PVZ4C`;P[F(<*=I$<A\^,QX]$/["_D)?*7
M:?FJ>N-_]6=IT<98P4<U7E=B9^9%U:!]KEZ;(X-9&``YR*J"?K;GW,6Q_>JY
M&O-$>];5?6+GBP59HQ^:%7_ZI]8T\V_</]S+$22\L[[MNY1BM%+/;2GC@+(K
M1>G&<9/H*]$<WY\$/F%U']P^]_CUV3345(SB;+X'"-O'"*D9YF;+;0?-T4<)
M`O=V7CW->P^[/MOO^A=MYRL3*W!))!"_V:)M#$_8#UBSSA]WSWIY2\5]Y]N=
MS$"DUDAB-S&*&E3);^*@!XBK#&>@0P>4W%LK<.-S&(KLOM;=>V\E39+&5]+)
M58C-X7+4,RS4M73O^Q5T=733("#P1^1]1[D6:VL=VL)[6ZBBN-NGC*NIH\;H
MPH01D%2#U"%O>[OR[NUON-A//:;Q:3*Z.I:.2*1"&5@11E92`1P(ZV1.D^Z.
M@_YNOQ^S7P[^7F'QZ=N)B6KL1F:-*;'9',9'#TDHHNSNMJPQE,'OO;ZL9<A0
MH##-"9"(Y*.2>"+GY[F^VG,/L9S'%SWR+([\JO)0J:MX&L_V$_\`'"YQ'(<@
MT5B)`K/V2^[M]X?EO[QG+,GMM[BQQ)S['`:X"K>JBG_&+?R2XC`U2Q#%`9(Q
MX?B1Q5&?`;^5QW'\5_YR75G6/;6,ESFRNML-V#WAL+LS'T$L>U^Q-M[:Q4F`
MVQE*1W\L6-W!C-S;IH/XEC7=IJ*I4%2\+PS2"#GKW2VGFCV=W/<-LD"7UR\5
MM+"3WQ.YU.*>:,B/H:E&'H05![R+[0;ERG[SV$5ZIDVJWBEN89:=LB@%$J?)
MT=T++D@CS4AC?KV;L?:/6?R\^2/\S[Y.0/A.MOB=T+B>I.@URT2+))3RXNIW
MGVKOW`TTDO[V7W5N#=L&TL*U@\\L=4@%I(V]X\;?=W5_RUL?(&P'7?[E>&:X
MT^M1'#&Q]$5#,_H"I\CUEG<Q6]O?76_7W;%;PE5)X!?B=A\SA?R^SK0$^5?R
M1WY\NOD'V?\`(?L>9O[Q]D;AFR,&+$SSTFUMLTBK0[4V?C6<MIQVV,!!!2I:
MWD='E/JD8G-SECE^SY6V+;MCL5_2@2A/`NYR[GYLU3\A0<!UBSS+ODW,&[W>
MXR_"QH@_A0?"!_A/S/1>V_3_`(^G_6^OU]BVVXCJ(N8L)-4>G3OC[V']+?[[
M_>#[-QU$EYY]+_&?0<_6W_$^U"9Z"5]Y]"+C+$68`@VX/(-_Q_L?:Q.@=>X-
M1QZVG?Y3G\XB?:L.V/C5\N-RS5>UT%#@>K>Z<S.TU5MI-4=)CMH=CY"9C)4X
M",%8Z',2EI*(`153-!IE@Q5]YO8<7XN^;>1[2E[E[BU44$GFTD"CA)YM$,/\
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M[-KR`B3[TPL>M\#4OZY+M0R,8Y(6@FKVA]RWY1OUV7=YB>6[A^)SX$AQX@]$
M/^B#_;C(-8[Y_P"2HN:+$W%JBC=XE.D_[\7^!O\`GT^1QP/56_\`PF:^53[5
M[.[F^$&^YI:?&]ATE?V7U]A<S%+"U'OG:M.F$[+VJ]!5JAIZO+[<A@JIH'0,
MKXJ8,-18>Y)^\)R]]38;/SG8YE@(BD9?-&.J%P1_"U0"/XQT`O9R^-I)O/*5
MZE$),BHPQ7X94(/K@D>E>BO?/;H&7XR?*/M7JR&GDAVW!F3N?8LDBV2?9&Z]
M67P*0O\`ID&*6:2@<C_=M(_Y]Y9>UO.*\\\B;!O[N#>&+PY_E/%V25]-5!(!
M_"XZY"^^OMN?:_W7YJY6BB*[6)_&M:\#;3CQ(@/7PP3$3YO&WV=$5R,OU!_Q
M_P"->QO*>H^LTZ0]?+PQ^OU_U_\`#VB<UKT*+6/*CI#Y"3EO\+GZ_P"V]HG/
M0HM$^'I$5\M[_P"Q_/T]I'/0GM$X=(O(F-[ZT5[?34H:WU_J#S?VG8\>A+9A
MUII8C[,=+?8'R/\`D#TS50U?4G>/;?6\U.ZO$FS.PMU8"D#*=0U8^@RD6.E6
M_P!5>)E/((M[#VZ<M\O;PK+NNQVEP#_OR)&/[2*_L/4D;%SES9LAC.U<PW<"
MKP"R.%XURM:'/D1GSXGJQ#J?^??_`#.>KEIZ:H[NPO:F+IBEZ#MG86V]PU$R
M+8:),]AJ?;>XW+`?J:K=C]>3<^XNWKV-]N;\L\6TR6LA\X9&4#_:L67^74\<
MK^^'/T2HE[<P7<(X^(@#<>&I-)_;7`ZLPZI_X5.]DT!IX.\OB?M#<L(")49;
MJC?V6VM5M8`-,F"W=C=RTLCZKL4_B$:F]KCZ^XOW3[N%BQ8[-S-(A\A-&&'^
M](5/YZ>IJVGWH\94_>>R::@5,;\/]JP_EJ_/H[^%_GQ_RDOD7!#COD+U/N?9
MM;6`1U4W:W2F%W]C*4L!<Q[DV9)NW)1@,Q_<$$)`%S:_L.P>U_O#R@_B\K<P
M.%7@+:Z>(G[48QJ?L->G]XO_`&:Y[C,7-_+-A=ZAGZNSCE(QY.4=E/E4$'H8
MME=?_P`EKO?/XG>?QQ^3&P>L-_8K(4V6V[DNL>]$V'N?%9F"9'HJNAV?V/4R
MS4L\<Y_S24,8<$J5TFWLUE]TO?O9+*XVKFO93N>T2H4DCN[,2HZ$496D@"$@
MCS+DCCQZBZ7[J?W>]SW.UYAY+EN=CY@@D$D-QMM\Z/'(IJKI'.9T4@D85%%.
MW`QU>U@<;/38G!)ELH-S9C&XN"CFW//0X^CK,K,U/3I69/PXZ*.BHFRTD"RR
M1TP2`FVE0H4#&B[EBFNKN2VM_`MGD+"(,S*@J2J58EF"@T!8EO4DYZRTV^WN
M+:QLK>]O3=7D<2J\S*J-*P4!I"B`(I<C450!0310!0=4O_SM?AG\U_G%U'L/
MJ3XR9GK.FZ]Q6<FWAV;M7=6ZLKM?<V_,]BM";,Q=%6+@J_`';^%>6>LDCJJJ
M#S5W@8V$"DRE[2\U<I\G[K=[IS!#<->LFB)T176-6^-B-0;4V`"`:+7UZ#'.
M^R[SO^UC;]JN(TC+5D#$@N!P4$`T%<GUP.M,'N;^5C_,+Z$-7-V'\3^V&Q5!
MJ,^X]CX>'L[;@C4,WF.5Z]JMR1P1:4)O,L1`'('O+#:O<GD;>M(LN9+82-P6
M0F)OV2!:_E7J`;[D3FJP+&;:7=!^*.CC_C))_:/LZ(5DJ2MQ%9/C,O15N(R5
M.VB?&Y6DJ<9D8)%;2R34-=%!51,I!!#(#Q[D2RDCF5)(9%>,\"I!!_,5'4,<
MU6UQ;"X2Y@>.0`892I_G^?[.IN._'LZ7CU#EYY]+[&'A?^0?I[4)Y=!.^'Q=
M"-BR/3_KK_MO:V/)Z!M]7/0E8RQ"BP(O8@_0@V_K]>#[7Q^70*OJ@L?/K8G_
M`)6'\V')]'/M_P"/WR1S59F.EIIH\;LOL'(2U%?F.J'F*QTV+S$K>:IR77@D
M-E_5/B`;IKIAXXL:_>KV&BYHCNN:^3K=8^9%&J6!:*ET!Q9>`6>GY2^='-6R
MY^[?]ZF;DJ>RY#]Q+MI.46;1;W3%F>S)X(_$O:UX4[H/PUC&E-N'&9/'YG'4
M&6Q5?193%Y2DI\AC,ECJF&LH,CCZR)*BCKJ&KIY):>JI*JGD5XY$9D=&!!(/
MO`J:&:VFEM[B%H[B-BK*P*LK*:%6!`((."#D''74ZVN;>]MH+RSN$EM)45T=
M&#(Z,`RLK"H96!!#`D$&H/4_VWT_U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7__4W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW6K;_`#;O@%NSXY=Z;._FY_#;;DO][>H][X?L?Y&=
M8;>I'5MP8K%S*NY>RL+CZ-?WOXOMYZBBW531K>>FF-?8LE4SY"^V7.UOOFS7
M?MES5-_BEU"T=K*Q^!C\$3$^C4,1\B-'`KU&?-G+<EINEISGLL?^/V[`S(O^
MBQ\'('FVGCZCY]"#_.<Z]VM\BOC%T!\\>IWBS.!3`[<7)Y6CT3&MZQ[1IJ3,
M;2R=7)"&`.W]RU:TKJ3>-\FX-M)]CW[LO,=QR[S3S)[<;LVAIF9XU/E<0565
M1_S4C&JOF(AZ]8D_?F]OH]_Y4Y:]T-JBU36!$%PPI4VTYU0N32M(YB4`KQN#
MZ=:M.1E_6?Z7'^]_[?WFO(>/7-&SC^'I$9"7@C_??['VA<XIT)[-,CI#5\GZ
MO\?]]_L/:-SC''H4VB<.D57R?7_??U]I7/IT)K1.'2.KI.2/\?\`>/\`C?M.
MQS3H1VJ<#TD*R3EN?];VT>/0AMDX8Z@K8+SQ<EC^+`7^IO\`T'LKG;N.>I,V
M2WI%&*4J?Y5_R=#KT9\8?D1\F\XFW>@.F.PNU\CY5CGFVEMVLJ\)C=3:?)F=
MSSK3;;PT*$^IZJKB`]A3>^9M@Y>B,^];M!;I3@S#4?\`2H*LWY#J7]BY7WO=
MU5;#;9'4GXB"%`^;''5_/QV_X31=U9G'0;T^8W>.Q?CUM"FC%7EMM[1J<?O3
M>%-2J%=XLMNG)3XW8&W"5.DR1R954-^/ZPKO/OY8-,+#D_8Y[^]8T4L&52?Z
M,:@R/]E%ZDVT]KK;;[:3<N:][BMK*,:G.I451ZO*Y"J/G_/H^VV<%_)!_E[&
M)^J>J*3Y7=R82XAWCN.*F[/J8LG"0@G7=^[*:+KS;^F52RRX''RR1GZ`FWM1
M8>W?O_[EZ9-[O?W'L<G%6)B.GY01DS,?E,R`^O4+\X_>O^[I[5I-:\M5W_?D
MP!:`/'J\M=Y+2+3_`$H!,1_#U=!\,OEYE?D'T/F>_P#M#";4ZFV?4=BU&T-F
M44.2JZB&+#Q5N"VUC),MF:\4T-;E,QO'*M00""GIXS(J(J$FYA/W9]N[#D#F
MRUY1V6_GO[Q+))9W957]1M;D(BU*JL2JYU,QR36@ZFC[N_NWOOO-R+>\^;[L
MEMMME+N4L-K%&[N?`C6-=4DCZ0[F9I$[4C%$';4]5`?SI_YHOS#_`)>GRJZ>
MPO2F4V%E.K]_=,?WER6R-_;+AS5#4;HQ&],YB<I64N>Q=;A=RT+38N2B5HDJ
MVA4H&$=V:XF]IO;KECGGEW=9=V69-P@NM(DC>A",BD`J0RG.K-*^5>AGSWS?
MN?*MYMIM(XY+:5&U*X/$'B&!!X'[.BY]/?\`"I\DTU)\@/B;(FIHUJ\_TUOU
M)TC6_P"Y+#M/>]%3.;?A#ES_`(M[/MS^[B]6;9.9`?19XR/^-H3_`,<Z(K7W
MCL0@;<MID3U*,&'[#0_SZ/E0_P`W3^2G\R*-,+WK2;-QE97Q)"^.^2W1].Q@
MDD"ATBW9#BMU8:DTN;"5<A#P+W`]A%O:SW@Y5?QME$[*#6MI.?\`CFI&/V:3
MT:'W(]L-\7Z?<MPMJL/AN8Z?+BZD#[:_GU[)_P`G3^33\MJ%\YT#EMO[?J:Z
M(S4^3^-O=]%E:&&213XY9=JY+);SP=,NH7\2TD!M]+#VHM_=WW?Y2<0[U'(Z
MJ<K=VY!_WL"-C]NH]$NX>T?M)SG$9MO@A5V'QV<R^>?A!>/_`(R/E3CT2#M+
M_A,/G:`SU71'REQN310[TV"[=V1/C918_MPR;HV;6UL;DC@O_"4%_P``>Y#V
M;[T,/:F_<K,/5H)*_P#&)`/V>)U#O,7W2$G#/R[S91J82XC\_G)&3_U:ZKH[
M)_DG_P`Q3J/SS'I:G[,Q4!8C*=3;JPN[&EC0,Q:/`U4V&W4S$+PHH&8DV%S[
ME_9/?CVTW;2K;X;24_AN$:/_`(V`T?\`QOK'?FG[LWNUM`:2#8DOH17NMI%D
M/F<1DK*>'`1Y)`%>B2;DZR[)ZQKVQ'9/7V]]@9**4Q246]-JYS;,X='TL%3,
M4-'Y+,I%UN#^#[F#:MXVG=XEFVK<[>YB]8I$D'_&2>L9>9N6N8=@G:#>]DN[
M2:I%)HGC-148#J"?RZ<L4054@@_3D$$<_P"\'V(XNHOOQ0L#U>'_`"T?YGVX
M?C#4X[J'N2KRVZ.@*R=(,54KKR&:ZFJ:JH+25N'B:]1D-G2O*TE7CE)>G-YJ
M4:C)#-C[[T^P]IS[#-S%RS'';\WHM6'PI=@#"N>"S8`20X;"R&E&3*S[MGWK
M[[VIN(.3^>)9KOV_D<"-A5Y;$LV7C'%X*DM)"*D9>$:]22[=^V]R8'=^!Q&Z
M-KYG&[AV[GZ"GRN%S>'JX:[&93'5<:RTU915=.\D4\$L;`@@_P"!Y'OG9>V5
MYMMW<[?N%L\-]"Y1XW!5D8&A#`Y!'78?:]TVW>]NLMXV>^BN=KN8UDBEC8/'
M(C"JLK+4$$>8Z?/:;I?U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U__U=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U@J*:"KAFIJF&*IIZB&2GGIZB-)H)X9D:.6&:&0-'+%+&Q5E8$,I(/'
MOP)4AE)#`U%.O>5.BC8GX8=7X#XV]I?%/#FMCZ:WZ>P8=K;4JTAGH^KL1O\`
MFGS;;:VB5"2+M[:N\:ZIR.'AD);'I)'31MX8(@!A:<Z;I:\T[-S>*?OBT>)F
M8$CQC%1:O_2DC`20_BR2*L>@IS/RAMG-/*?,')]\O^ZV_MI8C@'P_$!TLH]8
MWI(G\+`4X=?/[[7V-N+JOL#>W66[Z9J/=&P-U9W:.?IF5E"Y/`9&HQM3)$&`
M9J>H>#RQ-]&B=6'!]]4]KW:TWS:MMWBP?5974"2H?Z+J&%?F*T/H0>N$&[\O
MW_+&_P"\<O;G%HW"RN9()!GXXW*&E>(J,'S%#T"F1E_5_OO^-^W)#GCTMLX_
MAZ1&0DM?G_?'VD<YZ%%HG#I%5TA.HW_K_P`;^O\`7VE8UZ$UJG`=8MJ['WSV
M;N2DV?UQLS=6_P#=F1D2&@VULO`97<^<JG=]">+&8:DK:PJ6;]10*/J2![+;
M_<;#;+>2\W*]B@M5&7D944?FQ`Z&NQ;'NV]7$5IM.W37%RQPL:,QSC@H./4^
M7GU<_P#&?_A.O\Z>\S09KMM-K?&/9U28YI&WW4KN3L&6E9@'^TV%MJJE6BJ=
M'T3)Y"@<'ZI[@SF?[PG)FS>)!LXEW&[&/TQHB!^<C"I'S16'SZR6Y0^[GS1?
MF*XYAN(["VXZ:B24_P"U!TK_`+9J_+JW/;?\M+^2_P#R\8Z?(_)3?<?R+[6Q
M<?G_`+O;ZR*[FE:O@<,@H>E=C7Q=#'(Z$*,Z]5%?]4OY$<VV_>^GNHQ7E79W
MLMG<T\5!X24/K<RT+4X_I=WHO0]WWF'[O7LA#IYHYCMY=YC%?!K]3<DCR^GB
M#>%4X!E")7BV.N^T_P"=PNVL(-@_#OHC:75>T<=%)1X?+[HQF+A%%`"4CFPG
M7FTS0[;Q!6-%*B>IJUO^J/BWN1^6/NI6\DJ[A[@\SRWEVQ!:*`D*3Z//)61\
M\=*(?1NL5_<+^\#W.03;?[6<GQVMN`0MS>T>3C0,EO$1%&:9&N28>JXS4)W'
M\H.]_D%D/XCW#VINS?(61I:;%Y#(FFVWCV=M=L9MC&K1[?Q]B?K%3*QL+D^\
MF^5^1^4.3(?!Y9Y?MK2HH75:RM_II6K(WYL>L$^>_='W']R[D7'._-M[?@&J
MQN^F%#6M4@0)"A^:1J?7AT"/WNE2;BR@FP_P'TX_K[%WB&O'J.?IJD"F3UL(
M?/7?C?"_^5[\!^IJ:H_A>Y.Q>^_C!49^E.F.5Z;$[VQW?&_S.'X*4V>HJ:"2
MY``D`/''OG%"QY^]XO<K?G[[:&"]"'RHL9M(:?;&*]=^/:S91[;>QOM3RX$"
M7306C2+Z2W+?53@Y/PR2,/RQ3`Z*=_PJGVFJYOX8]@1#4*W&=Q;/EE5;KIII
MMC9ZD42#@ZQ53$#^BD^U/W<+FJ\U67H87_ZN*?\``.A%[QPUL]FN`O"1U/Y@
M=:CHX_WW^^_K[RA7B.H`GS`_70XE7_6'^]_X<>SFVRK5ZASF0?JC[/\`/TO-
MLY"OPM=3Y/#5]=ALG3D/!D<165.,R$#CZ-#6T,L%5$P_JK@^U;PPSH8YXE>,
M\0P!!_(U'0$EOKVSD$UI=21RKP*L01]A!ZLGZ4_F;_/?IE**GV5\I.TI<70E
M!#@]Z9>+L7"+&NA1`*#?5-N`10E%"VC:,@#@CV#-T]JO;W?-;7W*MJ)6XM&O
M@M]M8BE3]M>CJP][_=+ES0NW\WW31*<+,1.M,8I,)*#'E3Y4ZMIZ=_X42_*K
M`K34?;'5W4W:=*K()LAB8\UUWN"9+MK)EH:C/8'R$,+:<?&O'TY]QMNOW7N3
M[TLVS[Q>6;GR;3,G["$?_C9Z'^U??2YWVOMW[EVPOXP>*:[=R,UJP,B>E*1#
MAYUZLOV%_/@^'G:^.3!=X=/[]V7%5*JU=/E<!M[M3:.I@%D\II7BRDD5R?KB
MR=(^GN-[_P"['[@[1+]5RSOUM<.,@J[VTORI6JC_`)R#/4H;;]]3VEWJ$V7.
M/+E[:1D=P:.*[@\JUH1(?/\`T$U'[.A#7KS^29\MW+X%^B,/N/*6D0[;S%=T
M7NCSN;D1X1Y=H15522O*M237_I8\I5W+[R_M^`9XMTELH\=Z+?1T^;@2D#YZ
MQ_+I1+M/W+_=HZ+>XV*&_F-0(Y6VR8FN:1$VX8]O#PVQ\CD.=]_R&NE<]!)E
M>E.\]Z;7BJ8S+04FZ:'!]@X-R1=%BR>*?;.06G;\.7J&`_K[$FR_>TYGVYUM
M^9^5+:<J:,8F>WD'VJXE6ORHHZ`7-/\`=^<C;S&]WR3SY>VFL503I%=Q<!2C
M1&W8*<FM7.>A4^'OQK^=_P`$\]#LM*C9'R#^..:ROFRNW]O[EDPF[=D3UTVB
MIW1L_&;RCQ-#%RPFK\8E9+%5A6:(I4$NY3[E<]>S_N[8MNC)=[+SS%'1))(M
M<-P%&(IF@+L?X8Y2BLF`U4&D'?LK[6_>+^[QN:;$CV',WM;<3@R0PW'A7-H7
M-'GMTNA"@\GE@65UEH=&B0F1KK1>W/O%?K/7KOW[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U__];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6G)_/_`/C:>N/D'M+Y#8+'K!MC
MO7!_PS<LT$86&#LK9-+3451+-H`2)]P;4:BE2_,LM'4.;FY]YY_=DYO_`'KR
MI>\K74M;O;9*Q@G)MYB6`'KHDU@^@9!UR^^^9[?#9>>-MYXL;>ECN\6F4@8%
MU`%4D^0\2'PB/-F21N->M=ZJ\M1/%2T\<M14U,JPTU-3H\U3432-ICAIX(@T
MLTKL;*J@L3]![R/E=5#.[`*!4DX``]3_`)>L4]OMI9G2.&,M(2``!4DG`'VG
MRZL#^//\H#YY?)PT.2P?4-7UCLNN\4@WSW/+/L+%-22GBKH,%5TE3O/,1:`2
MK4^-:)_^.@'/N(.:O>KV_P"6/%BFWE;J^6H\*VI*U?0L"(U^89P1Z=9(\C?=
MY]R^:Q#.-E-CMS4_5NJQ"GJJ$&5OD5C*GU\^KK>M/Y!_PE^-&WZ3L?YW?(1=
MZ)1Z*BJP]1GZ7ISJYJF$B63'K)_$I-\;J8BRA8:ZC>8&WV_-O<"[A[[\_P#.
M5VVU>WO+#QLV`50W,]#C4>WPH_S5@/XNLF]O]@?:WVYV]-[]S>;(GC7)\61;
M6W)!KI4%_%D/`45U+<-&:=";N#^;!\!_A]MZKZZ^"WQ[PN<--&U(N5VQMJCZ
MMV'530MICK,CFZK&OOK>$@<:FDFI09@`14<W!CM/W>?<CG6XCW3W%YE-LC$$
MHSFXGIY@*&\&+Y4<T_@Z!/-7WR/:CD*UFV;VLY5-_*@(#J@M+6H-*DE3<2GS
M.J--0I23->JFOD#_`#5?F-\A?O<;E>RINNMGUAE0[,ZH6HV?CWII#8TV0S4-
M54;KR\14`,D]>86/^ZQ]/>17*'L;[;\G^%-;[(+S<EI^M=4F:OJJ$")#Z%8P
MW](]88>X?WH?>7W#\>VN.8VVW9WK_B]C6W0CT>0,9Y`1@J\K(?X1U7L^3>66
M6>622::9WEGFE=I)II78M)+-*Y,DLCL269B22>3[F(,%554`*!0`>0'`#Y=8
MX2022NTDK%G8U).22<D_F<]>%?\`XGWOQ/GGIHVGRZY"O']?]N1[WK/KUKZ3
MY=#;\;=A2]S_`"!Z7ZKC22:/??9FT-OUXC_4F&J<Q2R9VH^HLM-A8JB1B?H$
M)]AGG/?QRWRES)OVH![6RED6O\80Z!^;Z1^?0V]M>3CSES_R=RMX9,5]N-O$
M].(C>11*U:CX8]38-<='(_X5`=V"K^1GQLZ/P]6B8_ICK+(]EU]%3L%CH=P;
M[W%3T6*1HU-DEH\!L%'CN/3'4\?7WAI]WG:3^XN8MXF4F2[G$0)XE44EOVM)
M0_,==M/=/<!#N7+FW1-IBAI(0/P]P5?V!33HXG_"DB@_OS\$?AMVU&JNE-V5
MM^0S+Z[0]B]19/)+:2P/CEEPR?ZY4?X>PK["2?1\Z<S;:?.W<?\`.*8#_G[H
M^]U(UN.5K:Z4]JS(1\]2D?X,]:6Z_P"P^E[_`.M8V]Y;CB.L;9O[%QUV#=T_
M']>?\3?CV<6O`^G40\R@:@?/_9/2MQ9Y7_&W/_$>UZ>74;7W!NA'Q)_3^/I_
MM_\`D7M7'T#+\?%T)^'/J7_7_/LPAXTZ`^X\#T*.(-M/^Q'LRA/#'0%W$?%T
M)&-T%5UA2`+G5:W^/)_K[-(<<.@7>Z@3I)K\NCV_%W;GS2W%DJ9?BY#WF)4F
M4'(;`R>X\+MBG<2!1_$LP:R@VG3QA^&%3*%(!N+7]@?GF^]J;*U<^X3;1I(^
M&Y2*24BGX$TM,33AI6O\NI)]K=I^\#N=]&OL_'S#J#?'9R3PP`@@4EE#);J*
M@`B5P#0UP#ULX?$?K'^9?@IL-7_)#OOKRJVQ%-#)7[*J]H8W>N]JBC1E,E%-
MO+`C:6/QE5,MU\_FRX2U]+'W@7[E\P>PMXMU%R'R;?+?D$+.)F@@!/!A!)XS
M.!_#IAKZCKK)[)\H_>PVU["X]U_<C:Y-I5@7M6MH[JZ*#BAN81;)&Q_WX9+N
ME/A).+/Q<CD6_P`/>/\`UEQUW[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z__U]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=%:^7GQ&ZL^:?5,74/;9SM/M^FW7M_=]%E-KU='C
M]PXW)X&>57&.KZVAR,%,F5Q594T4Y,+'PU#%;.%8##DCG?>>0-Z;?-D\,W+0
M/$5D!*,KT^(*RDZ6"N,\5'D2"`O<;VYY>]S]@3ESF19?HUN8YE:,JLBLE0=)
M96`UHSQMVGM8D=P!%5%?WU_)U_EBSU^!ZOVGM;>7<.W9*G%Y&+86)7L[LV#,
M8YF@JJ7/]E[EJI,9MNL2I5HZBG3(P/"X8?;@C3[F>WY4]]/=Y8[K=[R6WV.4
M!E,S>!`5;(*01C4XIE6*$$4[^L?[[GW[MGL'XMELEE!<<Q0U1EMD%S<ADP5>
MYD;1&=6&02J0:_IX/5:WR(_GZ?)?LG[[#=';:VUT+MR<SPPYBT.^.PY*9QI1
MFRV7HX=N8J8I<_Y/CGEC8^F8VO[F7E/[LO)FT>%<<R7<VZ78H2O]C!7_`$J$
MNW^VDH?->L;.?/OG^X6_">SY-L(-FL34"3%Q<D'`.N11&F,]L.H'@^*]4S[^
M[:["[6W!4;K[.WUNSL#<M4[M+F]X9[)9_(?N-K:.&;(U$XI8-1XCB"1J.`H'
MO(?:MKVC8[1+'9MM@M;->"1(J+]I"@5/S-2>L0]_WGF#FF_EW3F+>+F]W!ZU
MDFD>1LFM`7)(7T48'`"G2,&2_P!J/^O<V]F?B"G'HB-E\NN8R5OHUO\`;_[#
M_8^]^(,9ZH;+^CUR_B?^UG_;D^_"0?Q=:^B_H]<QDOIZ_P#>;>]^)3@>J_1?
MT>L@R7YUC^OUM_Q'XM[WXOSZH;+^CU<O_(NZU/8WS<IMWU4`J,9TUUWNG>;2
M,+Q)F\XL&RL(AY'[HBS]7,GUYI[VX]X]_>8Y@.V>V\FW))2;<+J*&G]!"9G_
M`"K&H/\`INLM_N7<G#=_>&'>I8:V^TV4\X/D)'`MT'VTF=AQ^#JFK^;[W-_I
M]_F*?+'>%/5K6XC#[]J>K=NRH_D@.$ZLQE+L1#3D%E\%3E,153BW!,Q/Y]E_
MM;M/[EY$Y;MBM)7A\9O]-,3)_)2!^769_N!N!ON;=R;56*)EC'V(`#^TU_R]
M;)7\TIAVM_PGW^-^_4O4RX/;'Q"W;+4.I,B/_=W'[/KY"SEF!,F<=22;G\^X
M`]N?]UOO7O-FV`\MXG_&BX_X[U,O.0-Y[?/*%_T"%_L^$GK2=`_WW^PX_P!?
MGWE\#0CK&&05C>OIU[^TG^Q_VVK_`'F_LVM#@]1-S.N01PJ>E9C"+I_QO_#V
M8IY=1E?5[NA%Q3`:22`!R;FUO]<GZ>U2>O0.OQ6H''HX?0'QE^0GR)R46-Z2
MZ=W[V,^L+-D<#@:H[>HO4L9?);IK12;;QJJS<F>JC]E>]<X<L<K1>-S!OEM:
MKY!W&LXKVQBKM_M5/3.S>W?.W.TYMN5^6KN\?^)$/AC-.^5J1IG'>Z_RZO@^
M/?\`PG\[ZW$*/*?(#LS:74V,8K)/MO:,9[`W@4TAC!-6K)C-JXV4L;:XZC(!
M;?I/N#>8_O4<M;<KP\K[-/?W`X/*?`BKZ@4:1A\BL?V]9`<J_<9YNWATN.=N
M8[7;;4G,4(-S,13@2"D*&OF'E&.&<7;]"_REOA;T4M%6CKENU-STA@E_O+VW
M51[K<5,`OY:7;@IZ/:-(#+ZA:A9U-O6;#WCWS3]X#W+YG$D*[S]!8M4>':`Q
M8/D9:F8_\Y`/EUE;R/\`=+]E.2C#<-RT-UW-"I\:_(G[EX$0:5MQG(/A%@:=
MV!U9#CL9C<114V-Q-!18O&T<2P4F/QU+!14-+"@LD-/24T<5/!$H^BJH`]PS
M-/-<RO/<3-).QJS,2S$^I)J2?F>LC[:VMK*"*UL[=(K:-:*B*%50.`55```\
M@!3J=[:Z>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__
MT-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=='Z'_6]^Z]UJZ?SP_Y;3RTN;^;/16W[55'$*OY![+PU&`:N
MCB58QVWBZ*E3U55%&JIGT1;R0A:XB\=4[Y?_`'>_=IHVM^0.8KHZ":6<K'@?
M^4=B?(_Z#Z']/S0#`S[U/L/'>I=>YW*EF!<J*W\*`#4/^4I0!Q'^C^HI+BDK
M'577*'@ZR1_O?'!N/K[S'\4^O7/DV(SVYZYC)_T8_P"^^G]/?O%^?538_P!'
MKG_$^?U<_P"^_P`/=O%^75?H?EUS&3_VK_87_P`?][]^\7RZJ;'^CUS&3/\`
MJA_QKW[Q>J?0CTZYC)_[4/\`;_[[GWOQ/V=:-C\NN8R0_J.?]@/^*>]^)7JA
MLOEUM%_R1XZ#H3X5_-7YF[ABBIZ;&4N>CQU74'2LV'Z8V+D=U5<41)-TK\_N
M/P?IYDA`N?QAG]Y"]??N<^2>3+=JD*&8#^*YE$8K]B1U^QNND/W+N7$V3DSG
M3G&XBHUS<+$I/G';1F0D9I0M,0>%2G6E3E<QD-Q97*;AS$K3Y?<.3R.>RT\A
M+//D\U6SY+(3.6N2TE75.QO]2?>0$$*6\,-O$*11JJK]B@`?R'2R]N'N[JYN
MI#621V8_[8D^?6['D8!VQ_PE[I6]-55[;^-^.JO2%=HI^INV86D'HU:7AH]M
M-?\`M6^OY]XB1G]V?>$-,*^X$?\`.:(_Y7ZR5E!O?;4ZS4FP!QZJ`?\`)0]:
M1WZ;L2`!R238#CZD_0>\P!D@=8P."8VQY?X>A_Z)^*OR2^3N7CP_Q_Z1[([6
MG658ZBOVMMNNGVYC@[A0^6W75)2;8Q,8/U:IK(@![2[ES7RYRS$9M]WJWMEI
MP9QK/^E05<_DIZ",W)7-'-,W@[)LL\QU'NTZ4&?-VHO\^M@;XR?\)H/DOO$8
M_,_);M39/1^'D9)*G:NT$_TF[]\10,89ZNGGQ>R\5,Q.G7'69((024-K&&N8
M?O*\O6.N'EO:9KV8<'D_1CK\A1I&'VJGV]#;8ONN;S?E9N9][BM8JYCB'BR4
M]"U51?M#/]G6P+\<OY(_\O\`^/2X[(2=63=S[NH/MY3NGNS(#>2FL@`8U%-M
M%(,?L:E4R^I0<=(ZV`UDBY@KF+WR]P^8/$C7=_HK1JC1;#P\'R,E3*<?TP/E
MU.7+?L![8<N>')^X5OKQ:?J71\6I&:^'00\<_P!G48SCJU_$8;$;?QU)A\#B
ML;A,101+!0XO$4-+C<=1PI^F&EH:**&FIXE_"HH`]Q+/--<RO/<S/),QJ68E
MF)]234D]3)!!!:Q)!;0I'`HH%4!5`]````/LZ<O;73O7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__1W^/?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW03]U=H["Z<Z^RN^^TG--UW25>&PN[\K-01Y'#X'$;IR]'MI\YNF
M&5M$&T,?/E4.4J&62.EHS)-*OB21E,-JL+W<KZ*UV[_<XAF0`T9F12]$/\9T
M]@P2U`,D=,7+P)!(;A08#AJBHHV#4?PYSY4XXZTD_P"<3_+>K/AEV8.X.I\5
M-4?&'MG+RR8(T0>JI>K-X5ZR5\^PJZ=3((MOY)?)48"=S9J=7I22\"M+GK[*
M>ZJ\Z[5^YMYG`YJLT[ZX,\8P)1ZL,"4?Q4;@U%YF?>$]D3R+O#<Q<OVI_JC>
M2$@+D6TIR8CZ(<M$?X04.4U-2J,B?]5_M[<>YU\0^O6-/T?RZY?Q+_:O]A_3
M_D?O>OY]:^B^77,9+^K?\4_WU_?M9]1U4V?RZY#(_P"U#_B?]M_K>]^)U7Z/
MY=<QD1>Y*_[?WO6>JFS/H>N1R84%R>`"QY^@`Y]^UGTZT+(DA0,GK:@^5%0W
MP^_X3G[#V"RG%[O^1.*V-AJV!F\=;)5=T;FG[1W(K(;2$P;'HY:63ZV4`?0C
MWA+:S?US^\-N=_JUVEC))I/EIMD$*_MD[OSZZG<F;8.1O8'8[$H4NI[,.P/'
M7=L92#\U5POY4].M,;WD_P!11Q(SUOY?RA.E<C\@OY(6(Z%W\F7V;A>V]M=^
M;'PN>DH8:JK7:&\]W[JBQ6\<3CZJ2&*KIX:C(234JR,J3>`&^A@?>$WN?NL>
MS^[=QO-D5EEMI;>0K6@UHB50GRX`&G"OKUE5R;:O<<D[=9W*,GB0,N>.EM5#
M^8-0.AD^,_\`(0_EW?'<8W*9GK2N^0&]*%:=SN?O+()NG'K6P69JFAV+208W
M8]+&[BX6:AJ76W^</U]EF_\`O-SUOOB1Q[B+*T:O9;C0:'R+YD/Y,/LZ=VOD
M'EC:A&4VY9IE_%+WFOV'M_EU<;@-N[?VKB:/`[7P>'VW@L=$(,?A<!C*+#XF
MA@7A8:/&XZ&GHZ:)0.%1%`]Q=-/-<R--<3-),QJ68EB?M)J3^?0P1$C4)&H5
M!P`%`/RZ>/;75NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_]+?X]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=(CLK
MK[;/;'7F^NL-Z4$63VEV'M#<6R=RX^9$DCJ\'N;$U>'R<)21634U)6/I)'I:
MQ_'M58WD^W7UGN%JY6Y@D5U/HRD,/YCJDL:3120R"L;*01\B*'K69_EQ?([`
M=@MWI_(X_F%/%NK=/6M?N[J/JG<FZ*IEJ^SM@[4J)GPNVES%46GBW]M+!T])
MF-MUP8S5&.2,HWFHP9L@>=-FN]J?8_>3D0F*&8)-,J#$4KX8E1QCD8LDJ\`Q
M(/:^(ML9-OY@@WWVWYMA$ND,@U?Z+#Q0@\1(@TLK#((#`U6O6NK_`#`?A5V+
M\!?D!F^H=XFJS.TLC]SN#J;L)J4P4._=C251BI:MB@^WI]R81V6DR](IO!5*
M'4&":%WRK]O.?-NY_P"7X-VM*)>+1)XJYBEI4CU*-\4;>:X/<&`Y[>Z/MAN'
MMSS)-M<X,FV25>WFIB2.O`^0=>#KY'([64DD`R`L.?\`8W/L=!NHU-H?3KF*
M_P#H>/\`7/O>KY]5^D]1GKF*_P#VHV_)O_MK#W[5U4VGRZY_Q#_:O]Z_Q_Q]
M[U=5^D_H]";TML7(]R=P=5=28A)I\CV9V+LW8M-'""7']Y]P4&(FE&D$A::F
MJGD8VX5"?Q[*M]W6/9=EW7=I7`2VMI)#7^@A;^=*?GT?<K<N2<P<R;'LD:$O
M=74<>.(#N%)_(&I/D!UL2_\`"H'LO'X+_9-_BUMUUIL5M/;FZ.S:_&PN`D-%
M3P8_KK8\<L*V113TM!E1'P+"]N#[Q*^[S827,O-?,EQF2218@?5B3))^VJ5Z
MZ3>[5Q%:;9LNS0#2M:@>B(NE1_DZUT/A=\7MT_,SY.]1_'+:HJ87[`W+"FZ,
MS3QE_P"Z^P,.O\5WUN>4@%8_X5MZGE\&JPDK)(8_U.`9WYNYCM^5.7=SWVXH
M3#'V*?QRMB-?S8BOHH)\NHJY4V1]_P![LK``^%JU2'T1<FOV\!]O7U*NOMB;
M6ZOV-M#K?8^(IL!LW8FV\+M':V%I$5*?&8';^.I\7BZ1`H&HQ4E,H9CZG:[&
MY)/OG3>7EQN%W<WUW*7NII&=V/$LQJ3^T]9>1Q1PQQPQ*!&J@`>@&`.EA[3=
M7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]/?X]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=='Z'
M_6]^Z]UI#_\`"DCX^Y_H[Y:]*_-'K6IR6U:CM7&8_'5VZ<!.]!D=O]T=/M25
M.WMP4E;3:'HLGD=HO1F%_K(^(D)OZA[RX]A-Z@WCEK=^4=P19$MV+!&R&@FJ
M&4@\0'K7TUCJ#/=*QN-MW/:N9K%RDIHI8<0Z94_FM0?6G5B72/8O3_\`PH(^
M`>;Z<[6JL#L[YC=*T=+53YF"FC2KV_O=*)Z';O;>W:*.U34==]BB`TN>Q\),
M=/.98;*\=#*07?0;O[$\\P[OM@>7E:[)&FN'BK5H6/`2Q<8V/$4.07'1CN&W
M;+[R\ES[7N`6/=(\AJ5,,P':Z^9C?\2^8J,,%(TV.Y>J^Q?C]VEO?IGMG;M5
MM3L/KW.U6`W)AJK4RI4P$/35^.J=*ID<+F**2.JHJJ.\=32S)(ILUAFCLN][
M;S!M=EO&U3B6PG0,K#^8(\F4U#`Y!!'7/OF/E3<^5MXO-DW:W*7D+4/HP\F4
M^:L,@^AZ#3[_`/Q/^W]FM1T1?2_+K(*__:N?]?WZH]>J?2?+'78K_P#:CQ_O
M?OVH>O6C:_T>KG/Y!_4S=O\`\R7JO)U5(U5ANF]M[U[<R3E-<,%9B<3_`':V
MR\I/I61=R;III8_SJAN/T^X9]^MZ_=7MSN4"24FO)(X!ZD%M;_\`&$(/V]3Q
M]W3EP;C[BVM\\1,-C!),3Y:J>&E<4KJ<,!@]M1PZ#S^>WW(.XOYFG?"4U2:C
M$=3T^TNF<4HDUQP2[.PL57N.-/PK#=N;KPX_#+8_3V4^S&U?NOV_VAF6DMRS
MSGYZVHO_`!A5ZG7W1OQ=<SR0!JK!&J?*I[C_`(?]5.K\?^$TWPF'773.\?FG
MO;$&+=_>9FV=U5]Y"%GQ?4.W,F?XIFZ36-4?]_=W41(86+T6+IW4Z)3>%_?_
M`)N.X;O:\J6<E;2R[YJ<#,PPI_YIH?\`>F8<1U(WM9R_^[MJEW>=*7-U\-?*
M,</]Z.?L`ZVBO>//4J=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__
MU-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW1'/YA'P9V+_,(^/57T'OC<61V4J;OVIO;;N]
M\+C*'+YG;&:VY7.*B?'T.1DAI9FR^WZZMQ[AWT*E47*L4"D6\E<WWO)&^)O5
ME`LI\)XVC8D*ZL.!(SA@K8_AIY]$N_[':<P[;)MEZ2(F8,&'%2IJ"*_F/L)Z
M!;X0?R?OAU\#=RTW8O5.%WON3MR+"U^`G[-WYO/)Y'+RXS+Q1)EJ&#`8=L+L
MZEH*YH48Q_P^1D9%8/J4,#7F[W.YJYS@-END\2;;K#"*-`%!'`ZCJ<D>NKI+
ML?*>R<O$OMML1.10NS$L1\_+^717/YWW\JN#YK]6MWATM@H$^4O4>"J&Q]'1
MQQP3=Q;%H?+6U?7]>PTBHW+C+R3X"=SJ\[/2,?'4*T0L]FO<]^2MT_=&ZS$\
MM73C57/@2'`E'HIP)!Z4;BN0)[M^V=KSWM1NK2)5YBME)B;`\0><;FE37\!\
MF^1Z^?Q/3U=+//2U<,]'5T<\])64=7#)2U='64LSP55'5TLZ+-355-41M')&
MX5XW4J0""/>=RW<;HKJ0R,`01D$'(((P01GK!>;ENYADDAD73*A(8&H((P01
M3B#UB_<'Y_WG_C7NWCITP=AG&*5_U?9UW>6_YN/\18#_`%_>_J$]>JG8KBF$
MSUMW_P#"8_8..V1UU\T?EKNF(TV(P=)A=@TF3D4)''A-E8/(]C;Z>.9[*$45
MF-+\V!B%_I[Q/^\CN;W^Y<I\LVS5<ZI2/Z4C"*.O[&I]O66_W<-@&V;+O^]S
MI26:41@^B1C4U/M+"OE@>G6O3T)U!OW^9'\ZL7L;'2UAS?R+[CW3O?>N>1'G
M?;.RLMG\CO#?6YIV/*C";;DE$&HV>I,,8Y<#W,.\[K:<@\E-=N!X=E:)'&O#
M5(%"1K^;<?E4]%EE82\W\XRQ@G1+<,[GTC5LG\P*#\NOIY[`V+M?K#8VS^N-
MDXJGP>S]B;:PFT=KX>E55@QN!V]C:;%8JCC"JH/AHZ5`6(NS7)Y)]\^+R[N-
MPN[J^NY"]U-(SNQXEF))/YD]94111P11PQ*%B10H`X``4`_(=*[VFZ<Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_U=_CW[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]UX_0V^OX]^Z]UIN?\*"/Y4_\`=^JW!\^_CUMLC#9&?[SY-['P
MU)=,77SLD2]TXBBIELM%72%8]R1HH\<I7(&X>K=<J/9#W,9T@Y)WR?O&+21C
MQ'^^&)]/]"/VI_".H*]T?;^*[\;F;;+<?4`5G0#X@/\`1!_2'!O49\CUJ47'
M'TMP?IP?\;\\^\G_`!#U`)VR'`T@?MZ]<"YX%A?F]@.;_P!/Q[V)#TW^[(\4
M7^?6Y?L=C\*?^$TFX,^CR8?>OR%V5FZV)@OAJ9\M\CMW)MG&^IM+LT/6<L;K
M]?1%_3WB3?D\X>_T,)&JTLYU'V+:IJ/_`%5!'Y]90[9`G*OM<-';(;9F/^GF
M/^9A^SI=_P#":3X2#KOIK=_S2WIB/#NON[R[*ZH%7!IGQ74>W,G;+YNE\JZH
M_P"_6[*'AEL6H\7"P)67VC]_^;OWAO%KRK9RUM;/OFH<&9AA3_S30_M<^G3O
MM=R^=MVE]UN$I=W61ZB,</\`>CD_EUM(>\>>I1Z][]U[KWOW7NO>_=>Z][]U
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M'GP<\C7J\<IB+--2RELY/:?W$CYTVGZ+<)`.8K5`)!P\5!@3*/7RD`X-G@PZ
MQK]PN33L5T=SL(S^ZIFX#_0W/X?]*3\/IPZI\VCM+*;^W=M/8>$B>;-;YW1M
MW9N)BC!,DF3W3F*/!T2JHN;_`'%>ON4[RZCL+2[OI32*&-W/V(I8_P"#H`;?
M9O?7]E9*.Z655_:0.MX_^;_TAE>X<9_++_E4]4U,E%2;_P![T>0W5/1QD#;/
M3OQ]V+0;>R6Z:J-!98,?C<Y4RP`FSUD$:<LR^\.O;'=X]IDY^]Q=Q4&2&$B.
MOXI[F0L%'VE17Y$^G637-FW-N46Q<MP?[CR3*9/E#",_MP.MASK[8FUNKMB[
M/ZWV/B:?!;.V'MK";1VOAZ5%C@QN"V]CJ?%XRD0(JAC%24JZF(N[78\D^X3O
M+NXW"[NKZ[D+W4TC.['B68DD_M/0WBB2&..&)0L:```<``*`=+#VFZOU[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__7W^/?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T!_R/\`CQU;\JNE]]=$=QX"+<.Q-^XB
M7&Y"+TQY'$UR?OXC<F`K2COB]Q;>R*1U5%4H"8YHQ<,A96-MCWO<.7=UL]XV
MN8I>0M4>A'FK#S5A4,/,'I)?65MN-I/97D0>WD4JP/H?\HXCY]:2'PV_EB=I
M?'G^=ITG\=>U:"3+;=ZSS><^0>U=]+021X'L7K;K^@K\CLS=5&/7!%5-O`XZ
MBR-)J8T615XC=/&SY;<U^XFW;[[1[KO>WN%N;A5MGCKW1RR$"13YTT:F4_B6
MA]:0=L7)5SM'/UK;R@M8Q!ID>F&484?Z8,0#^WK<XP/0$DWRZW]\H=WC&UV2
MI^I=H=&]/0Q,9JG;.RXLMD=\=CY.H62%8Z7+;SWAD:2G?QLS?8X6"[?N,HQ2
MFWFG+=GL%MJ6,W+SS>C/01Q`>H1`QS^*0^E>IQ6V_P`=DNWH6T!%]0.+?M-/
MR4=&G]D'2OKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MK__0W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW3#4[6
MVU6;BQ&[JO`8BIW5@,;E\/A-QSX^EESF)Q.?EQL^<QF.RCQ&MI*#+SX>D>IA
M1Q',]-$6!*+9U9YT@DMDF86[LK,M3I)6NDD<"1J-#Y5/J>JE5+!RHU@$`^8K
M2M#\Z"OV=/WMKJW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=?_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=?_2W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7_T]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U_]3?X]^Z]U1O\R_^%%W\J+X0;\S75/9/?]7V#VEMBMJ,
M;NG8?1>T\IV?D-KY.D;QU>)W!N*@:AV'B\W0S@Q5%!)EQ74TJE)H492![KW1
M`S_PLG_E*_\`/*?,`_X_Z']B\_\`L7_?NO=>_P"@RC^4K_SRGS`_]$_L7_[;
M_OW7NO?]!E'\I7_GE/F!_P"B?V+_`/;?]^Z]U[_H,H_E*_\`/*?,#_T3^Q?_
M`+;_`+]U[KW_`$&4?RE?^>4^8'_HG]B__;?]^Z]U[_H,H_E*_P#/*?,#_P!$
M_L7_`.V_[]U[J[;^6_\`S*>E_P":'U!N/OCX^[`[OVIU=@MWS[(QNY>Y-EX7
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MWMN?%[2PYHL7E,UM^BFA3*9:(S,U5&4B#,`Q`4^Z]U2)U)_PK=_E;]T=K=9=
M.[0VQ\KHMV=L=A;,ZTVQ+F.I]ET>(BW%OO<>-VOA9,K5T_:U;44N-3)96(SR
M)#*Z1!F5&("GW7NMH+W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=!/W'WQTE\>-HS[^[Z[=ZUZ8V33LT<NZ^T=[;<V+@/,D9E--%D]RY'&TD]6
M8P2(HV:1A]%/OW7NJU*_^?[_`":\;5S451_,(Z$DF@8H[T&2W%E:1B/S#7XO
M;U90U"_[5'(P_P`??NO=0_\`H(+_`),G_>P3I#_;[R_^Q3W[KW7O^@@O^3)_
MWL$Z0_V^\O\`[%/?NO=>_P"@@O\`DR?][!.D/]OO+_[%/?NO=>_Z""_Y,G_>
MP3I#_;[R_P#L4]^Z]U[_`*""_P"3)_WL$Z0_V^\O_L4]^Z]U8]\=?DIT=\M.
MJ\-W?\=.P\3VIU/N.NS..P&^<#2Y>FPF9JMO9.HPN:7&29G'8R>MAQV7HYJ:
M26.-HO/#(@8LC`>Z]T./OW7NO>_=>Z][]U[K6#I_^%;_`/*;B[;/4FYV^2.Q
MJJDW[4[`SN]MT=3X(;&VS646<FP-=GLW68+L#.;A3;=#50M+--3XVHG2`%_"
M2"OOW7NME[:VZML[YVU@=Y;+W#A=V[1W3B*#/[9W/MO*46:P&X,'E::.MQF8
MPV7QTU109/&9"DF26&>&1XY(V#*2#[]U[I^]^Z]U[W[KW7O?NO=>]^Z]T1S^
M85_,#Z+_`):'QVJ_DY\B*'?V1ZYH]Y;7V-+3=;;?QNY=RG,[MDK8\6ZXW*Y[
M;E']BAH)/+(:D,O%E8GW[KW58'PM_P"%-W\NCYW_`"<ZK^)O2FWODI1=H=OU
M^X<=M2IWSUKM/![5BGVSL[<6^,B<OE<;V3G:VDC;#;8J1&4I)M4Y12%4EE]U
M[K8B]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:Y7RX_X5'?RP_AO\B^TOC)V
M`_?>]M^]/9\;3WMF.JNO-L;FV72[JIZ.FJ,WMZBS>5["VY4UN2VQ6U#4&1`I
M52#(4\T(9C&3[]U[H8/Y=_\`PH@_EZ_S,>_9/C5T-4=Q;5[3GV=G=Z8#&]O[
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M1?S)O^\DOA#_`.A?WO\`_:#]^Z]U/H/^$3O\Q*4R_P`3^3_PNHU`7PFBSW>&
M1,C$G6)%FZ6QHB"BUB"][_0>_=>Z<O\`H"8^?G_>5OP^_P#.KNC_`.U7[]U[
MKW_0$Q\_/^\K?A]_YU=T?_:K]^Z]T^;7_P"$2OS7DW+MZ/>GRV^+5'LY\YBD
MW75[73MG);EI=MM70#-U&WL=E>N\5BZ_.0XTR-2PU-53023A5DE126'NO=?0
MY^.OQ^ZK^*O1O5_QUZ2VU3[2ZLZAVAB]F;.PD)5Y8\=C8CYLADZH)&^2SV;K
MY)J[(UD@\M;75$T\A+R,3[KW0T>_=>Z][]U[KWOW7NO>_=>ZK#_G`_S#]L_R
MQO@AW!\F*^;'5/8,=`-A]$[7R#1LN[>ZMW4M93;-HGI'YK,5@!3U&;RD8L3B
ML74A3K*`^Z]U\9"DI.UOD=W'!144&Y^UN[>\^QTAIZ>!)LSO#L3L[L?<FE$1
M%!GR6X-T[GS'^O+//_C[]U[I\ZK[+[=^)??VR^T]CUF5Z][KZ![,QVX\.]5!
M-2Y+;>^-AYY7FQF8Q\AB=XXLA024E?1R^B:$RP2@JS`^Z]U]KC^7;\VNN_YB
M'PZZ2^6?6[4]+0]F[5@DW7MB*I%34[#['P['$]@;$KV)\WFVUN>EJ(89)%0U
M='X*E1XYT)]U[HZ_OW7NO>_=>Z][]U[KWOW7NM</_A5]_P!N2?DA_P"']\=_
M_?Y;&]^Z]U\P'^7O_P!E\?"#_P`6^^-7_OY]E^_=>Z^YU[]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KQ(`))L!R2>``/J2??NO=?%?_`)S'\P;M;^8G
M\].].T]Z[MS&3ZWVGV#O#K_H'94F0FDVWL+J7:V?K<-MJ#"XI6%#2Y3<U'0)
ME,O4HIEK,C52,SF-8E3W7NFSXN?R6OYH'S/ZLQG=WQO^(>_^P>I\[4Y"EV_O
MJ?,;%V9A-QR8FOJ,5DY=N2;\W7MBHSU#0Y2CFII*FDCFIEJ(9(O)KC=5]U[H
MQO\`T#4?SN/^\%=V?^C1Z(_^VE[]U[KW_0-1_.X_[P5W9_Z-'HC_`.VE[]U[
MIKK?^$WO\[*AF$,GP+[`G8QB371;]Z6K80&)&DS4W9<D8D%N5O<>_=>ZB?\`
M0.5_.O\`^\!>R_\`T,>GO_MC^_=>Z,;\1_\`A+]_--[@^2'4?7OR$^->\OC[
MT=G=VT)[7[=S>YNM,A%M'8>.U9'<<N*Q^#WCG,A7[GRF/I7HL5$*:2(Y"HA,
MQ2!99%]U[KZN/4'4O7G0O5G7W2W4VV,=LSK3JW:."V-LC:^*B$5%AMN;=Q\.
M-QM(G]N>;P0!III"TU1,SRR,TCLQ]U[H1_?NO=>]^Z]U[W[KW7P:?D1_V4!W
MG_XF+LW_`-[7-^_=>ZV`?Y$/_"ASMG^6#NC#=#][S[B[:^#&X\P%R.UTFDRF
M\NAJS)U)>MWGU,*N914X)ZB9JC+;:9XZ:K)>HI&@JVE^[]U[KZHO2_=75'R*
MZNV7W5T?OW;?9W5?8>%I\_L[>VU*],AALSC:C4A*.`D])74=1&\%725"15=%
M51203QQS1NB^Z]T*'OW7NO>_=>Z][]U[K5T_X5^?]N=-Q?\`BQO1O_N7N3W[
MKW6C/_PFB_[?@_`[_P`.GN#_`.!Q[B]^Z]U]B/W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=5+?SK_YD&%_E@?`3M7OVGK,>W;^XH#U=\=\!6&"5LSW%N^@KTPF3>@F
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M[KWOW7NO_]:[?_A6'53T_P#),^1$4,A2.M[$^/%+5*`I\L"=U[,K5C)925`J
M:2-[K8^FU[$@^Z]U\Q;^7%_V\+^"/_BY'QD_]_5LGW[KW7W*O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\H_P#X52?S
M._\`9W_G94_'KK3<1R/QX^&%5GNNL0^/JQ+A]Z=U3U$5-VWO93!(U/74^&R&
M.BV[CI#Y$$6+J*B!@E<X/NO='V_X1W_RN_\`2CV_NW^9=VYMT3;$Z/K,EUW\
M<J7*4NJFS_<>2QHBWGOZFBJ(C'44G6VU\F*&CE`9#ELLTD;+/C3;W7NBZ?\`
M"N/^6)_LKGR\Q7S?ZOV^:/I/YC9&OFWU'CJ41XS9_P`D,92?>;KBF\7[=-%V
MOAHOX_!J]=1E(<PW"J@]^Z]TZ?\`"1C^:'_LLGRKR_P0[5W#]GTK\N\K33];
MS9*J\>-V;\D*"A2AP<</E(BI8.W<%2)A);7>;+4F(1;`R$^Z]U]/'W[KW7O?
MNO=>]^Z]U[W[KW6N'_PJ^_[<D_)#_P`/[X[_`/O\MC>_=>Z^8#_+W_[+X^$'
M_BWWQJ_]_/LOW[KW7W.O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=-V
M8)7$Y1E)!&.K2"#8@BFE(((Y!!]^Z]U\"G+R22Y;*2RN\DLF1K9)))&+R22/
M4RL[N[$L[NQN2>2??NO=?9W_`)#$4<7\G7^7DL4<<2GXX[4E*QHL:F2:JR<T
MTA5``9)II&=V^K,Q)N23[]U[JW#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U\&GY$?]E`=Y_P#B8NS?_>US?OW7NMGW^:S_`,)_=Y4?
MQ)^/O\T;X.[1EW5U5VM\7>CNX_DITAM.A>HRW5FXMR]2;2W'NWM/K[$4L1J<
MOUIF:VKGK\Q0Q(U1@)WEJ8U;&LZX[W7NJX?Y,?\`/#^0_P#*0[26EQ[9/M3X
MI[WS5-4]O?'^ORC1TS-)XJ:IWYUA55;O2;2['HJ-`"X"T68AB2GKE.BFJ*7W
M7NOK-_$'YA_'KYU]$[/^1GQE[!QG876F\:;T5%,139W;&<@CB;+;-WM@)'-?
MM;>&`EF"5=#4J&`9)8FEIY89I/=>Z,Y[]U[KWOW7NM73_A7Y_P!N=-Q?^+&]
M&_\`N7N3W[KW6C/_`,)HO^WX/P._\.GN#_X''N+W[KW7V(_?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U\E/_A3Q_,]_P"'`/GSF.LNN=PG*?&WX@S[@ZGZY:@JO-AM
MW]@??00]N]EP>*1Z:LARN?Q,6(QTZ,\4V*P\%1$5^ZD!]U[JVS_A'+_*Z&[-
MY[R_F@=N[<63;^P*C.=5?%RFRE*&BR.^:NCDQW:':-"DZ#7#M/#5IV_CJA=<
M;UM?D@-,U$I'NO=5_P#_``K"_EACX<_-F/Y7]8[>&/Z"^:%?FMUUT>.I1%BM
MF_(*C*UO9FWV6!/%10;Y6I3<E$'*F>IJ<E'$HCI./=>Z,9_PD`_FA_Z"?D-N
M3^77VQN(TW5GR;RDNZND*C)U16@VK\@L;BXX*[;E.\SK#24W;FUL7'3HM_7F
M<710Q)Y*UR?=>Z^EI[]U[KWOW7NO>_=>Z][]U[K_U[K_`/A61_VY0[]_\27\
M>O\`W\.U??NO=?,>_EQ?]O"_@C_XN1\9/_?U;)]^Z]U]RKW[KW7O?NO==,RH
MK,S!54%F9B`JJ!<LQ-@``.3[]U[K7XWS_P`*A_Y*W7^]-V;$S7RJR]?F-F;C
MS6ULM6;8Z2[LW3MRIR>!R-1BZ^;!;FP6PJ[![AQ+U5*_V]=13S4E5%IEAD>-
ME8^Z]TEO^@K;^2'_`-Y/[S_])T^0'_VN??NO=>_Z"MOY(?\`WD_O/_TG3Y`?
M_:Y]^Z]U8+\!OYN?P2_F:9GLK`?#KM7-]C93J3&;:S&^H,OUIV+L%,50;MJ\
MQ18*6"??.V<!#DFJZC!5(9*=I6C"`N`&6_NO=66>_=>Z][]U[KWOW7NJ*_\`
MA0K_`#-H?Y9W\OO>^YMFYN/'_(SOG^(],_'JGAF5<GB=PYK&2'=G9D$8)E2F
MZOVO-)6Q3:7B&9GQL$@TU%_?NO=?)K^)OQF[5^;/R:Z@^,O4E'+F>RN[]^8[
M:V-JJL5%338N*NEDK=Q[QW!,FNH7!;3P-/5Y;)3<NE)22ORP`/NO=?;6^'_Q
M:ZP^%'QFZ9^+73N/%#L'IG9&+VEC)Y(8H:_/Y&%6J]Q[OS?@`BEW#O+<=55Y
M2O=?2]75R%0%L![KW0/_`,S'X+;%_F._"ONWXG;W^RHJC?NVY*WKW=593F=M
MA=K;>U97KS>D!C5JE(L3N"&-*U(2LE5C)ZJFOIF:_NO=?%/WYLCM3XT=U;IZ
M_P!W46;ZX[FZ,[&R6W<W2QS38_/;.[`Z_P!P24LTM%6T[1RPUF)S>,\M-4PM
M9M*2QL05;W[KW7V*_P"2'_,GPW\T'X"]8=YUU=0#NG:,:=5_(S`4O@A?%]M[
M4H*)<CG8J"(C[3"]@XFII<]0JH\4*5[TH9GII+>Z]U;O[]U[KWOW7NO>_=>Z
MUP_^%7W_`&Y)^2'_`(?WQW_]_EL;W[KW7S`?Y>__`&7Q\(/_`!;[XU?^_GV7
M[]U[K[G7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NFW,_\`%GRO_:MK
MO_<67W[KW7P)\G_Q<LA_U'5?_N1)[]U[K[/O\AS_`+<[?R\?_%;MG_\`6[(>
M_=>Z)9\D_P#A5#_*L^+_`'QVI\>=YY;O;=V\>GMX9/8>[LWUIUIA-S[*?=.!
M=:7<.,PV>J]]8:7)'`9=9J"I<4Z1BKII50N@61O=>Z!#_H,9_E$?\Z_Y8_\`
MHE]M_P#VSO?NO=>_Z#&?Y1'_`#K_`)8_^B7VW_\`;.]^Z]U[_H,9_E$?\Z_Y
M8_\`HE]M_P#VSO?NO=;,W3G9E!W1U/UQV[B=M;RV;B>S=E[<WUB=K]AX:';F
M^<)BMT8JFS.-H=V;?@K\FN#SL=#61FIHVG>2FD)CDLZLH]U[H2??NO=>]^Z]
MU[W[KW7O?NO=?!I^1'_90'>?_B8NS?\`WM<W[]U[K[4W\KE5?^69_+U1U5T?
MX/\`Q75T8!E96Z,V,&5E-PRL#8@_7W[KW6H5_P`*$O\`A,2N6.]?G%_+2V%'
M%E-.0W3WI\3-I4`2/*,-=;E^P>A,)2($BR1'DGR6TZ=0M1ZI<4@E_P`AF]U[
MK4I_E?\`\U?Y2_RF^^E[-Z2RLN4V?F*RCQO='0^Z*NNI]B]I8*@J&2:@R]&J
MR2;>WAB4>48S-4\1K<;,S*RSTTE123^Z]U];K^7#_,K^,7\T'H#%]\?&_=/G
M>G%'C.RNL<[+24W8O4.\)Z8S3;7WMAH)I?&LOCD?'Y&`R8[*4Z&2FE8K*D?N
MO=6`^_=>ZU=/^%?G_;G3<7_BQO1O_N7N3W[KW6C/_P`)HO\`M^#\#O\`PZ>X
M/_@<>XO?NO=?8C]^Z]U[W[KW7O?NO=>]^Z]UKX_\*1_YG8_EQ_R_=TX[8.?&
M+^2GR@3-=-=)?9U*Q9C;-#6XY%[,[4I5'[T)V'M?(K%15"<P9W)XYB"@?W[K
MW7RP?A%\1NS_`)X?*SI7XI=2TLD^\NXMZ46!?*O3RU5#M3;<*RY3>>^LTL1#
M_P`%V7M6BK,G56(>2.F*)>1T4^Z]U]M;XQ?'3K+XC_'WJ'XT].8=<)UKTQL;
M";&VO2,(S5U5/BJ?_+LYEYHT1:S<&Y<M+/D<C4$!JFOJII6Y<^_=>Z*U_-?^
M`&T/YE_P8[H^+&X1046Z,_A_[U=.[KKH]0V1W/M.*HR&P-Q>5?W8,?45[/C,
MIX_W)</D*N);&0$>Z]U\7'*8WM3XX=RUV*KX]P=8=U=%]D34E2BO)C-T;![+
MZWW*8V,4L9UT6:VUN7#W1U)T30AE)X/OW7NOLP?R<?YB^V_YGWP/ZE^2%+-C
MJ;LJGI#UYWYMB@,<:[6[HVC1T,6ZXXJ-"?L\/N>"JILYC$NVC&Y.%"QD1P/=
M>ZM)]^Z]U[W[KW7O?NO=?__0NO\`^%9'_;E#OW_Q)?QZ_P#?P[5]^Z]U\Q[^
M7%_V\+^"/_BY'QD_]_5LGW[KW7W*O?NO=>]^Z]U5/_.)Z:_F`_)'X>[I^.W\
MO;/=6;"W]W*U5L[L[M#LO?6Y-E5>T.IZVAECW)C-AR;9V;NVMFW3O9)1C9*I
MOMA08V2I>)ON9()(?=>ZT,?^@,W^;#_SWWPU_P#1M=D__:5]^Z]U[_H#-_FP
M_P#/??#7_P!&UV3_`/:5]^Z]U11_,>_EQ]]?RN_D#0?&WY%Y;KC,[^R/76W.
MSJ>KZOW!F-R;;&WMSY7<6'Q\,M?G-M[6KDRB5>V*@RQ?:Z%0H0[:B![KW6UW
M_P`(=O\`F;?\PW_Q'/QX_P#>F[7]^Z]U]$+W[KW7O?NO=8YIH::&6HJ)8H*>
M"*2:>>:18H888E+RRRRN52.*-%)9B0`!<^_=>Z^._P#\*%/YFTW\S'^8)O?<
MVS<V^0^.?0XR'3/QZIX)BV,RVW<+DI#NSLN!!:.2H[/W1#)6PS%5E.&AQT,@
MU4_OW7NMIK_A';_*Z_T;=4[N_F9]N;<$6]>YJ3*=<?&NERE+:IP/4N-R1IM]
M=ATL51%Y*:K[$W-C?X;13+HD7%8N9T9Z?)<^Z]U:!W7_`,*L_P"4ET9V[V1T
MUG]X=U;KS_5V\<[L7/;@Z^ZLBW-LG(YW;5=+B\RVVMQ'=%`N<QE-DZ>6!*N.
M(03F(O"TD121O=>Z##_H,'_D^?\`*_\`)O\`]$A!_P#9I[]U[K2=_P"%"?RZ
M_EV_/CY5[;^7'P9JNR<=N[L3:R8/Y&;7WYUO%L>CR&ZMGT^.Q>S^Q,/64^;R
M\>2R>XMKZ,;DXBL)C.'IY[R/4S%?=>Z5?_":;^:$?Y=7SYP&U.Q-PG%_&?Y6
M2X+J/M_[ZJ,6%VCN2?(21=6]JU(<K!3)M+<63DHLA4.0D.$RM;*P9H8[>Z]U
M]=#W[KW7O?NO=>]^Z]UKA_\`"K[_`+<D_)#_`,/[X[_^_P`MC>_=>Z^8#_+W
M_P"R^/A!_P"+??&K_P!_/LOW[KW7W.O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=-N9_P"+/E?^U;7?^XLOOW7NO@3Y/_BY9#_J.J__`'(D]^Z]U]A'
M^59MWNG>'_"?WXE[2^.F\=K]=]X;H^&N-V]UGV!O*CR>1V]L;<^:AR>-H]X5
M>/Q"M75U3MI*EZRDA4%)*R&)9/VR_OW7NM6*M_X1*?+G)5M7D<C\Z.A*_(9"
MJJ*VOKZW9/9E565M952O/55=753R//4U-3/(SR2.Q9W8DDD^_=>ZB_\`0$/\
MK/\`O-WX]_\`H`]C_P#%??NO=>_Z`A_E9_WF[\>__0!['_XK[]U[HTWPE_X1
MI[QZ7^5?2/;OR<^2O4'</2O66]L?OK=O5FU=E;PH\AOZHVRLN5VWMJNJL[*F
M,3;=;N>FHSEHY%D-3C4FIU4&8.GNO=;[0````L!P`.``/H`/?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U\&GY$?]E`=Y_^)B[-_P#>US?OW7NOM4?RM_\`MV=_+S_\
M4A^*O_OC=C>_=>Z/=[]U[K38_P"%!?\`PFEV]\OJ;>'S-^!6V,/M'Y5P0UNX
M.TNEL<M%A-I_(WQ(]36YW;@)IL;MCNJ8!B[.8L?N.2WW#05I:JJ/=>ZT$OAO
M\TOEO_*W^3D/;?1V=W!U9VKL7*UFT^Q>O-VXW)TF%W3C\;DO#N3K'MK8U<V/
MGK<<:VD:.>FG6"NQ]7&)J>2FJX8Y4]U[KZRG\H7^<I\;/YM_3']Z.NZJGV#W
MULK'4/\`IM^/6:RD-1NG9-=-HISN+;DS)32;QZURU:;467@B7Q.ZT]9'3U/[
M;>Z]U7M_PK[5F_DY[D*JS!/D7T8SE5+!%-;N)`SD`A%+N%N;"Y`^I'OW7NM&
M7_A-%_V_!^!W_AT]P?\`P./<7OW7NOL1^_=>Z][]U[KWOW7NHF0R%!B:"MRF
M4K:3&XS&TE3D,CD:^HAHZ&@H*.%ZBKK:VKJ'C@I:2EIXV>21V5$1220`3[]U
M[KXU_P#/B_F6U_\`,\_F!=D=J[?RM54="=9/4=0?''&.TD=*>MMKY*K$V]?M
M"VF/)=G;@DJ<U(SJL\=)44M+(2*1+>Z]UMX_\)(?Y;VW_B]\7NQ/YI/R%I<;
MM7<_=.TL[2=6YC=9@QU-UU\8]I2OF-V]A5E77"(8>'L;,X`U35$FE5P.&IJB
M.3PUL@/NO=':K?\`A8!_)YI*RKI8\S\DJ^.EJJBFCKZ+I'_(ZZ."9XDK*3[O
M=M+5?:U2H)(_+%%+H8:T5KJ/=>ZC?]!@_P#)\_Y7_DW_`.B0@_\`LT]^Z]UH
MZ?S_`#Y2?R^?G!\QJ?Y:_!*I[$Q]9VUMF%?D%M/??7<>QH!V1MI*/%8W?N!E
MI\UEJ>O?>NVQ!%DH@D+)78UJIFEDK9"GNO=&0_X2\?S0_P#9"/G=C^F^RMQ?
MPWXV?,2IP'66]7R%68L-LGM)*R6GZE['D,TB4U#3)ELG+@\G,QCB7'Y;[F9B
M**,#W7NOK*>_=>Z][]U[KWOW7NO_T;K_`/A63_VY1[]_\27\>O\`W\.U??NO
M=?,>_EQ?]O"_@C_XN1\9/_?U;)]^Z]U]RKW[KW7O?NO=>]^Z]U[W[KW7O?NO
M=?+(_P"%DW_;VS:__BH'3O\`[W';WOW7NCZ_\(=O^9M_S#?_`!'/QX_]Z;M?
MW[KW7T0O?NO=>]^Z]UJ[?\*I/YGG^R0?!2J^/'6FXOX=\B/F=29[KS$/CZKQ
MY?9?2D,$5+VWO4-!*M105.:H,C%MW'2'0YER=140-Y*%K>Z]U\ZS^5#_`"_-
MY_S,OG'TW\6MM+D*+:^;RPW7W)NV@C5FV+TOM6HI:S?NY/+(#!#D9Z.6/&8O
MR`I+F,A21-Z7)'NO=?7L^5GQQ[FKO@ENKXH_R_MU=<_&W>,O6.$Z3ZMW=N.E
MW#_=[J'KN#'4>U<A4[5I=LTU7E4W3B=D0RTV%GNHI*YXZIW9H=+^Z]UHMM_P
MB/\`F2Q+-\SOC.S,2S,VV^TR6)-R23@[DD^_=>ZZ_P"@(WYD?]YF?&;_`-!K
MM/\`^L?OW7NO?]`1OS(_[S,^,W_H-=I__6/W[KW6I)\L_C%VC\,ODAW%\7>Y
ML;'C>QNE][939V>^V\QQF7BI62IPFZ,%+4103U.W-W8"JI<ICIG1&EH:N)V5
M22H]U[KZE7_"8[^:%_PX/\"L3UQV1N+^*?);XBPX#JGLMJ^J$N9WEL3[&>'J
M7L^?R.]1639K`XF7%9*=V>67+XBHJ)-(JH@?=>ZV1O?NO=>]^Z]UKA_\*OO^
MW)/R0_\`#^^._P#[_+8WOW7NOF`_R]_^R^/A!_XM]\:O_?S[+]^Z]U]SKW[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW3;F?^+/E?^U;7?^XLOOW7NO@3
MY/\`XN60_P"HZK_]R)/?NO=?9]_D.?\`;G;^7C_XK=L__K=D/?NO=6V^_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO@T_(C_`+*`[S_\
M3%V;_P"]KF_?NO=?:H_E;_\`;L[^7G_XI#\5?_?&[&]^Z]T>[W[KW7O?NO=:
MP/\`/G_X3L]7_P`S';N=^0_QTH]N=5?.?`XEI5RC+!A]E_(>DQE*$H]I]F20
MQB'';Q2F@6GQ.Y2I>,!*7(>6D6&6A]U[KYGNQM]_+S^69\KTW!MFK[`^-/RE
M^/V[JK%Y/'U])+A]P8'*TC"+*[<W+A:U),?N#;&?H7"5%)4)4XS*X^<-::"5
M&;W7NMR?YZ?SA^O_`.<M_P`)WOD965-#BMA_+/X[[S^.&X^_NHL;5::&KQ,W
M;FU=I1=M=>T]?-/D:_KC-U^?59X2\U5@L@RTM3))&])4UGNO=:^O_":+_M^#
M\#O_``Z>X/\`X''N+W[KW7V(_?NO=>]^Z]U[W[KW6IS_`,*ROYGA^(/PMI_B
M)UAN$T'?/S/Q^7V[F)<?4F/*;-^/%"ZT78N:9HF\E'/V%/*NVZ0N`)Z.;*/&
MRRTH(]U[K04_DZ?RZ-S?S/OG?U-\;J.#)4W6L%7_`*0>_=TX\21MM3I;:=90
MR[LFCK$XHLQN>:JIL'BW]6C)9.!RIC1R/=>Z^I1_-I^`WR1^8?P3H/@K\)>S
MNI?C%L+/P;=V-V+5[EQV[`B=%[0Q4%+B.J-C4FT:*I.,Q>7J,?14V1,K*CXB
ME>C"O'52Z?=>ZT\_^@(WYD?]YF?&;_T&NT__`*Q^_=>Z]_T!&_,C_O,SXS?^
M@UVG_P#6/W[KW7O^@(WYD?\`>9GQF_\`0:[3_P#K'[]U[K4+^2'Q_P"SOB=W
M[VS\<NW\0^WNSNEM]YS8NZJ*-I33MD<'6-'3Y?$5+QPO68+.T)AK\=5!0M50
MU,,R^EQ[]U[KZOW_``F^_F@K_,B^`>V:'L#<"Y3Y,?&-,+T_WB*NI$N8W/24
MF/=.M^UZI6/FF._]M8YHZZ=O\[G<;D2`J%+^Z]UL%^_=>Z][]U[K_]+81_X4
MT]:YKL_^2?\`-#&X&EEK*[:F(ZO[*G@@@,\PPO7?<FP-U[DJE`1VCBQ^W,;5
MU$SBVB")R3:_OW7NOD\?$'M#;'2/RR^,'<^]ADSLWJ/Y"]+]F[M&%I(\AF#M
MG8?8^V]TYT8J@EJ:.*MR1Q>*E\$+31+)+I4NH.H>Z]U],#_H,8_E#_\`*C\L
M/_1+;<_^V;[]U[KW_08Q_*'_`.5#Y8?^B6VY_P#;-]^Z]U[_`*#&/Y0__*A\
ML/\`T2VW/_MF^_=>Z]_T&,?RA_\`E0^6'_HEMN?_`&S??NO=>_Z#&/Y0_P#R
MH?+#_P!$MMS_`.V;[]U[K2*_X4,?S$?CY_,X^>.$^1OQJCW[%UY0?'_K[K6I
M3L;;5'M7/C<FV=S;_P`MDO'C:'-Y^%\<:/<E-XY3,&9]8T`*"WNO=;%?_"'C
MK/.11?S">XYX9HMMULGQ_P"L\54%#]O7YS&+V?NG/PQR%+&;$T&7QK.H;A:U
M21R+^Z]UO\>_=>Z3F\=W[9Z^VCNG?F]<WC]L[-V3MW-[MW9N/+3K2XK`;:VY
MC:G,9W-9*I?T4]!B\71RSS.>%C0G\>_=>Z^+'_-^_F';G_F<_._N'Y,Y&7(T
MNP)LB-B=%;7KRZ-M'I7:%364NRZ%Z5B11Y;/">?-91`649;*5(4Z`@'NO=?0
ME_X2J_RNO]DD^$<7R8[0V[_#OD5\S,=@][54.1I6BR^Q>BX4>NZMV:R3H)J&
MLW/3U;;DR2+H9OOJ.GG3RT(M[KW6TU[]U[KWOW7NO>_=>Z][]U[K1<_X6.?R
MPSOCKG8_\SCJ?;IEW/U7!A^JODS!C*0M-E.M\GDA2=:]CUR0(#)-LO<V3.%K
MIVURO0Y6BN5@H#;W7NM0S^2Q_,@SW\K_`.>W5?R!>JR,O4F=G'67R&VY1&:4
M9[IS=M=0IGJZ*AC/^6YK9%?2TN>QR"S2U>-6#4L<\E_=>Z^SYMO<>!WAMW`[
MNVKE\?N#;&Z<+B]Q[<SV)J8JW%9O`YNA@R>'R^,K(&>&KQ^2Q]5'-#*A*R1N
M&!L??NO=/7OW7NM</_A5]_VY)^2'_A_?'?\`]_EL;W[KW7RPOB?V5MOIGY3?
M&KN#>0R)VAU3W_TWV5NH8>DCK\L=M[%[%VYNC.#%T,M1215N1.,Q<O@B:6)9
M)=*EU!N/=>Z^F7_T&,?RA_\`E1^6'_HEMN?_`&S??NO=>_Z#&/Y0_P#RH?+#
M_P!$MMS_`.V;[]U[KW_08Q_*'_Y4/EA_Z);;G_VS??NO=>_Z#&/Y0_\`RH?+
M#_T2VW/_`+9OOW7NO?\`08Q_*'_Y4/EA_P"B6VY_]LWW[KW6Q;\5?DKUS\Q/
MCOU+\G>HH]Q1=:]S[4I]Y;/CW;BX<)N1,14U5521C+XJGKLG!15?FHWNB5$J
MZ;$,;^_=>Z,#[]U[J)7P-54-;2H0KU-)40*Q^@::%XU)_P``6]^Z]U\$#L#;
M63V9OS>VS\U"]/F-J;NW)MK+02(8I(,G@LS6XNOA>)B6C>.JI74J22"+>_=>
MZ^G5_)3_`)[/\JOJG^6-\1NE>X_EKL[J#M;ICJW&]<[\V1V!A-Y8S)4.;P5;
MD(S68ZLH]N9##9K#9.E>.HIZBDJ9;1R!)1%,KQK[KW5I_P#T$&_R8_\`O8)T
ME_R3O7_[$O?NO=>_Z"#?Y,?_`'L$Z2_Y)WK_`/8E[]U[KW_00;_)C_[V"=)?
M\D[U_P#L2]^Z]U[_`*"#?Y,?_>P3I+_DG>O_`-B7OW7NO?\`00;_`"8_^]@G
M27_).]?_`+$O?NO=6@]+]S]9?(?J[9O=/36ZJ;?/5W86*&=V5O"AH<KC\?N3
M"M43TL.6QL&:H,9D),=5R4S-!,T*QU$6F2,O&Z.WNO="A[]U[KWOW7NO>_=>
MZ^#3\B/^R@.\_P#Q,79O_O:YOW[KW7VJ/Y6__;L[^7G_`.*0_%7_`-\;L;W[
MKW1[O?NO=>]^Z]U[W[KW5"G\[+^1'T-_-KZY?=.,.&ZD^8FR,%+1]7]XQ8]A
M2;@HZ82U%%UUV]3X^%JW<6QZBI=A35:K+D<#+*TU*)8FJ*.J]U[KY1GR0^._
MR5^"?=?9GQQ[XVKNSI[M#!T\^UMZ;=EJJBEH=T[4KZJGKJ.LH,E02_PK>NP-
MR28VGK:*JA>HH:OPQRJ?)$-'NO=6=_\`":+_`+?@_`[_`,.GN#_X''N+W[KW
M7V(_?NO=>]^Z]TB^R.P]F=1]?;X[4[&W!0;4V!UOM+<.^=Z[FRDGAQV`VMM7
M%56;SV7K)+%A!08RBDD8`%B%L`20/?NO=?%)_FH_/G>?\ROYQ=U?*O=/WU#@
MMT9H;<ZFVI6R!CL7IS:CSXWK[:ZQQLT$-:,9JK\D8CXY\Q7UDX_SOOW7NOI&
M?\)??Y7?^R"?!''=O]E;=_AOR4^85+M[L_?*9&D6+,[)ZQ6CGJ>I>MI!+&M5
M0U,.'RLN:RD#".5,EE6IIE)HHR/=>ZV7O?NO=>]^Z]U[W[KW7O?NO=:#_P#P
MLD_EB?Q+$[#_`)HG5&WRU;A$P'3?RE@QU,Q:;#2S#']1=IUXC&D-C:V;^[&0
MJ'NS1U&'C`"0N??NO=:N_P#(K_F79/\`E?\`S]ZV[?S.2K(^B>PWAZE^1^&A
M,LL$_6&Y\A2`[NCHD8B?+]:9V*FSE.54SRP4M12(56KDO[KW7V6<7E,;G,9C
MLUALA19;#YB@I,IB<KC:F&MQ^3QN0IXZNAR%!64[R4]715E+,DD4L;,DB,&4
MD$'W[KW4_P!^Z]U__]/?3WGLW:W8FS]U=?[YP6-W3LK?&W,WM'=VVLQ3K5XG
M<.V=R8VIP^=PF3I7]-1093%UDL$R']4;D>_=>Z^?;\TO^$5/:0W]N/<OP(^2
M77-5UQELC5Y#!=7?(MMU;?W)LREJJF26+;]+V)L_;N]*7>%!CXG$<%35XW'5
M7C55F,TFJ9_=>ZKU_P"@.#^;G_SN_B-_Z.;=_P#]J?W[KW7O^@.#^;G_`,[O
MXC?^CFW?_P#:H]^Z]U[_`*`X/YN?_.[^(W_HYMW_`/VJ/?NO=>_Z`X/YN?\`
MSN_B-_Z.;=__`-JCW[KW7O\`H#@_FY_\[OXC?^CFW?\`_:H]^Z]T./2G_"*[
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M`*!8>_=>ZR^_=>Z][]U[KWOW7NO>_=>Z#WMKJS8?>75_8737:.WJ+=G7/:>S
M-Q[!WQMO(('I,SM?=>)JL+F:"2X+1--0UCA)%M)%)I="&4$>Z]U\SGL[_A&G
M_,RQW8^_*#J;>_QFW-U=2;NW#!UUN'=O9^Y]O[JS.R(\K5+M?([FP='UID:/
M$[@J<+X6K:>&HFABJ2ZQR.@5C[KW6[I_(S^-?SP^&OPBV[\4_G;6]9;BS?2>
M8J-N]*;OZWWSE=Z??=.U<?W^&VGN1\QM;;5315NPLC+44-`5$T;8<TD"Z/M3
MK]U[JY3W[KW50W\\_P"#_='\Q/\`EO\`;WQ4^/\`/LNF[0WQNGJ7,86;L#.U
MNW-KK2;*[+VSNW,BMRV/PV>JH)FQ6)E$*K3.'ETJ2H.H>Z]UH;_]`<'\W/\`
MYW?Q&_\`1S;O_P#M4>_=>Z]_T!P?S<_^=W\1O_1S;O\`_M4>_=>Z]_T!P?S<
M_P#G=_$;_P!'-N__`.U1[]U[KW_0'!_-S_YW?Q&_]'-N_P#^U1[]U[KW_0'!
M_-S_`.=W\1O_`$<V[_\`[5'OW7NO?]`<'\W/_G=_$;_T<V[_`/[5'OW7NOHB
M_P`K3XU=C?#O^7M\4/C%VY+MR;LGI?JK';,WA+M')U.:VV^7I<EDZJ1L/E*O
M'XFIK:0Q5:6=Z:$WN-/%_?NO='\]^Z]U[W[KW7SZ?YY/_"5[Y']I_)CM3Y>_
MR[*+:78>![MW)E^Q>Q/CWEMQX/8>[MK=C;@FERF\,KU_EMSU6)V;G]L;MSDL
M^1-)4U]!5T%95R0PK/!H\7NO=:TE=_PG]_G+X^KGHI_Y?/>\DU-(8Y'H:3:^
M3I&8`&\%?C=RU=!51\_JBD=?\??NO=1?^&"?YR/_`'KV^0/_`)Y<)_\`7WW[
MKW7O^&"?YR/_`'KV^0/_`)Y<)_\`7WW[KW7O^&"?YR/_`'KV^0/_`)Y<)_\`
M7WW[KW7O^&"?YR/_`'KV^0/_`)Y<)_\`7WW[KW5F_P#*4_X3(?,_O7YA;)B^
M>OQX["Z`^+'7K0[][*GWHM!C*_M*+$UL!Q74FUQCLK4UZR[OKK+E*Q/&*'#Q
MU+)*E4]*K^Z]U]2_!8/"[8PF'VUMO$X[`[>V]BL?@\#@\/1T^.Q.%PN)I(:#
M%XG%X^DCBI:#'8ZAIXX8(8E6.*)%50``/?NO=.OOW7NO>_=>Z][]U[KY?W;/
M_"0?^;%O7M/LS>6'S/Q/7$[M[`WGN;%K6=Q;LAJQCL]N/)96A%5"G5DJ15`I
MJI=:AV"M<7/U]^Z]U]&/X3=1;L^/WPU^)O1&_7Q,F^.EOC9T?U1O*3`5DV1P
M;[IZ]ZSVSM+<#X;(5%)03UV*;*XF4T\SP0O)%I8HA.D>Z]T9[W[KW7O?NO=>
M]^Z]U[W[KW52G\VW^3W\:OYM?21V1VG0P[*[HV=09%^DOD#@\93U.\.N\M5`
MS?PK)1EZ5]V==Y>L1#DL+/,B2?YZFDIJM4J%]U[K5H_D^_\`"9/^8K\"_P"9
MK\;/E3W%G_CAE^HNFMR]D56X:C9'9&Z,KNC(8[</4_8>Q,-5XC`9/KS#12/4
M97<M+))%+51-%`7))9=)]U[KZ`7OW7NO>_=>ZHM_G\?$;^8!\]/A_0?$KX-U
MW56W,3V?NJ"J^0NZ.R=_YK9555=?[6>CRV#V#MZ/"[5W)+74V[=T"&IRDKM`
MJ4N+%,5ECK)0GNO=:N/\N+_A(5\MM@?,KI/L?YTY3X]Y;XV];;GAW]O+9^PM
M][AWCF^P,EM:V4VILBKQ.2V+MV@&V,WN2&F_C#25!\F+CG@52\RLONO=?1?`
M"@*H"JH`50```!8``<``>_=>Z[]^Z]U[W[KW7O?NO=>]^Z]T%'>O2G7?R0Z:
M[/Z$[;P4.Y>M>WMD;BZ_WIA9@@-7@=RXV?&UCTDTD<OV>3HQ.)Z2I5?)2U44
M<J$.BD>Z]U\SS>W_``C4_FD8_>6[*#8>]?BUN38]%N7.4NS=PYSM#=>!S>=V
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MI35'+/:(ZZ@&%59`14$$5&00>H.V[WJ]T]WLXMPVOVX-Q8R5TR1V]TZ-0E31
ME8@T((-#@@CI;_\`#MG\[O\`[U-YG_T2OR._^N'M!_K0>QG_`(5M/^RJR_Z!
MZ6_ZZ_O'_P"$LF_[);S_`#](W%_\*&_EMTSW3LW8'S>^$N/Z>VWGZC$2YNEB
MQG96P>PL1MC+U[XT[RQ&&W^V0I-QX['2))(T"BG$_@DC6=)/HMF^[ERCO>QW
MNX\B\\->7488*=4,T+.HKX;-"%*,<9.JE02I'22#[P/,NT;W9;=SMR8;.WE*
MU[)HI%5C3Q`LM=8%#@`5((#"G6V]3SPU4$-33R++!411SP2K?3)#,@DCD6X!
MTNC`C_7]X@,I1F5A1@:'K*L$$`@XZR^]=;Z][]U[I-[QS%1MW:>Y]P4D44]3
M@MNYO,T\$Y<033XS&55;#%/XRLAAED@"MI(:QX-_:BSA%S>6MNS$))(JDCB`
MS`8KYYZ:GD,4$TH%65"?V"O5'7\G'^;!W+_,BW=WGM[M'K3K/8-+U7MK8V;P
M\^P)=TM49*HW3E-PT-7#DO[Q9?*QB"FCPZ-'X@C:F;42+6G?WI]H]E]L[/8;
MC:=SNKA[N656$OAT`C5"-.A5R=1K6O4+>T/NGN7N-/OT6X;=!`MHL17P]>?$
M,@-=3-PT8I3CY]7T^X`ZF[KWOW7NO>_=>Z(/_,A^=6WOY>WQJRG>N6VK-OS/
M5NY,/L786RHLFN%@S^\,_#D*NF&4R_VM?)C<+B\5B:NLJ9(X)976`1(`\BL)
M`]M.0KGW&YHAV"&[%O;K$TLLFG44C0J#I6HJS,RJ`2`*U.!3H#^X7.UKR!RW
M/OUQ;&:36L<<==.N1@2`6H=("JS$T/"G$CJB/:/\Z+^<-V/MO#[ZZY_E@C>.
MQ=T4:Y;:VY]M]7_(#<6#S6(G9A35N,SN,R`H,K3/I($T05'(-@/I[GR\]DO9
MK;+F:PW+W2\&_B;2Z/<6B,K#B&5EJI^1SU!]K[R>Z^X6\-[8>V;RV4@U(ZV]
MVZLIX$,ITD?,8Z4?_#MG\[O_`+U-YG_T2OR._P#KA[3?ZT'L9_X5N/\`[*K+
M_H'I_P#UV/>/_P`)9-_V2WG^?I/[K_G/?SB>O-N9K?'87\KX[1V1M:@GS6Z=
MS;AZM^0.W\'A,)1#R5V1RF<R5>:#%4=/"+O/,#'&.2#]/:FT]D_9G<;F"QV[
MW3\:^E8+&B7%H[,QX!55:L2?(9/3%U[Q^[%A;RWM][9O%9Q+J=FM[M551Q)9
MC0#YG'5ZO\MKYV8'^85\:L=WIC=I3;!S^/W/F=A[\V8^4&;IL)N[`T^-KIVQ
M.7^TH)<AA<IBLQ25=.\L$4L8F,3@M&7:!/<SD&X]N>9Y=AEO!<6[1++%)ITE
MHV+`:EJ=+*RLIH2#2HP:"</;SG>VY_Y;AWZWM3!)XC1R1DZM,BA20&H-0*LI
M!H*5IFE2?SW'W0XZ][]U[KWOW7NJ(OYR'\UGN'^6[N/H7#]7=;]:;\INU\)V
M!E,U-O\`DW0DN,DVA6[4I:./&_W=R^+3Q5*9^0RF4.;QKIMS>?/9?VEV;W,M
M>8)]UW.YMVM)(57PM'=X@D)U:U;AH%*4XGJ$/=_W3W/VXFV"+;MM@N/K%F)\
M37CPS&!32R\=9K6O`=$UH?YL7\[S)45'D<?_`"II*V@R%+3UM#64W6/>DM-5
MT=7"E135,$J9\K)#/!(KJPX*D'V-']I/8N-WBD]V`)%)!!GM:@C!![/+H+I[
MF^\\B)(GMA5&`(_2N,@Y'X^I7_#JG\\C_O4[5?\`HK>]O_K][K_K3^Q/_A6A
M_P!E%I_T!UO_`%R_>C_PE_\`U2N/^@^A._EZ_P`]#M#Y$?+2@^'ORF^/&(Z8
M["W+6[CP&!K=N2[JQE5@=Z[6Q.2SM=L[?.S=Y"JRV-J*W'XFH6*H2H5HJA$1
MX"LOD0J]QO8;:^6^4'YSY4YC>]VZ((SA_#8/%(RJ)(I(Z*0"PJ*94DAJBA7\
M@>]M]S#S7_4_F?E\6.Z.652-:Z712Q22.2K*2%-#4=U%TYJ-D_WC-UD/U[W[
MKW7O?NO=4W_SC/YD/:7\N'KKI;>75VPM@;\KNS-\;BVMEJ7?S[B2EQ])AMNK
MF8*C'?W=RF+F-3-,2C^5F71]`#S[F?V9]M-K]RMRWNRW3<+BWCM8$=3%HJ2S
ME2#K5A3[.HE]V_<._P#;O:]KO["QAG>><H1)JH`%!J-++_A_+JQWXQ=I9GO'
MXY=$]S;BQN,P^>[6ZCZ][#S.)PK538C&9/>&U<7GJV@QC5TL]8:"EJ*YDB,K
MO)H4:B3<^XUYHVJ'8N9=_P!EMI7>WM+R:%6:FIECD9`6I05(%304ZD+E[<I=
MXV#9-VGC5)KJTBE95KI!DC5R!7-`305S3H<_9%T<=5C?S9OG%V#_`"_?B]C.
M]>M=G[.WON"M[7VCL"7#;X?-IADQNXL3NC(5-<AP-?CJXUT$N"C6.\GCTNUP
M3;W*/M%R)M_N'S5)L.YWLT%LMI)+JBTZM2-&H'>K"A#GRK@=1U[H\Z7G(7*Y
MWZQM(II_J$CTR:M-&5S7M*FO://S/0Y?R_?D?NGY=?#SI#Y&[VP.W]L;H[1P
M&9R^6P.UFR+8#'38W=VX=NPQ8YLM4UF1,4E+ATD;RRN?([6-K#V0^X7+5KR?
MSEOG+=E<22VMK(JJSZ=9#1HYKI`'%B,`8Z.^2-_GYIY4V7?[J!(Y[F,L56ND
M4=E%*DG@H.2<]'']@SH5=>]^Z]U[W[KW7CQS[]U[K6N_F2?SRNS?C!\F]R_'
M3XM=/['[JJ.I]B3[F[KSNXXMWY*/:V7IZ9<UEZ*ECVAE*&.FQ.R]MU%--F*N
MH+)3U%486,;02:LFO;/V'VOFKE>VYDYKWJ>Q6\G"6R(8U\12=*D^(IJTCAA&
MHR574*AA3'CW$]ZMPY8YCN.7N6=FCOI;6#Q+EB';PS341V,*!$H78U`)*FA4
MUMT_EZ?,_:_SP^+FP>_,)346&W#D$J-N=F;0H:F2JCV7V1@5AAW)A(WG+5)Q
ME098J['M*3))CJR!F.LM:'O<;DJZY`YKW#EZX9GMU.N"0BGB0O70QIC4*%'I
M@.K`8IU*O(7.%ISSRS8;];`+*XTRH,^'*M-:^M#4,M<Z&4G/1W?8&Z&77O?N
MO=>]^Z]U[W[KW6NQ_->_G"_(;X'_`"FZ]^/?3?3?6'9D&_.K-H[QH9-V#><N
MY*O=.ZM\[SV?38#&4VW,WC::>*H;;U,($\;3//.PO;2!DA[2>S/+G/W*FX\Q
M[UO5U:M;W<D9\/P@@CCBBD+L71B/C:N:``?/K'WW1]WM]Y&YIL.7=IV6WNO'
MM8Y!J\0N7>25-("LHI^F*<34GY=`3_PZI_/(_P"]3M5_Z*WO;_Z_^SW_`%I_
M8G_PK0_[*+7_`*`Z+/\`7*]Z?_"7_P#5*X_Z#ZQR_P`UG^>+#')-)_*>JQ'$
MCR.5ZK[X<A$4LQ")G6=R`/H`2?P/>Q[3>Q3$*/=H5/\`R\6G_0'53[F>]"@L
M?:\T`\H;@G]@>O1G/Y4G\Z?<?SM[GW9\<N[.G,+U/VMAMLYO=>!K-J9#-O@\
MQ#M?)4&,W/MG+8#<R29K;VY<0V068`U,Z2QQS*RPO$`X7]V_9"VY!V6SYEV/
M>GN]H>58W$@74NM2R.KIVNC4I\(()4@L#@0>UOO)+SUN][R]N^SBTW>*-G&D
MMI;0P5D*O5E=:U^(U`:H4@:M@7WCSU._7O?NO=>]^Z]U4S_-\_F`]E_R[.A^
MO>U^L-D[&WUF-X]KT?7];C=^/GDQE'C:G:>Y\^U=2?W>R.,JVKEJL'&@#R&/
MQNW%['W+OLY[>;9[D<P;EM&Z7T]O##:&4&+1J+"2-*'6K"E')P*U`ZB[W9Y\
MOO;WE^RWBPLHIY9;M8BLFJ@!CD>HTE36J`9-*$]"W_+6_F`[#_F&_'K&]HX.
M"AVWV/MR:#;7<G7-/6-4R;,WBM.95J*`SM][4[1W-3H:O$U,@)>+7`[&>GG"
MD_N;[>7_`+<\QR[3<,TNVR@O;3$4\2.O`TP)$/;(H\Z,!I9:FOMWSWM_N!R]
M#NUJ!'>(0D\5:F.2GEYZ'^)#Z54G4K4L+]QUT/.@/^2'R#ZW^+/2?87?/;&7
M&(V3UW@9\Q7F/0V0R]:62FPVVL)3NR"LS^Y,M/#14<-P'GG7450,P/.6N7MS
MYKWS;N7]HAUW]S(%'HHXL['R1%!9CZ`TJ<=$_,&^[=RUL]_OFZS:+&WC+,?,
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M$`]`7W$YVMN0N6KG>Y462Z+".&,GXY6X#!!HJAF:A&!0$$CJM?\`EC_SL.PO
MEE\D\E\8_E)U+LWH[?.XME4.Z^HQ@8]V8M]RUAP\.[)\!E:#>&0KIUJL_L7(
M0YG#RQ&-*FD@E_69(;R=[I>QVW\H<LQ\T\J[O-?[?%.8[C48VT#48PZF-5%$
ME4QR`U(8CA1NHZ]MO>:\YLYADY:YDVA+'<9(5D@`#KKJ@DTD.S&K1$2(10%0
M>.I>MBOZ^\;^I_Z][]U[KWOW7NO_T=B/_A1=_P!NSMX_^);Z?_\`>F/N>ONW
M?]/0LO\`GDN/^.=0K]X'_IV6[?\`-:'_`*N#HDO\HG^;)\"_BY\"NG^E>[N[
M)=G=D[6R/8M1G=OKU]V1G5HHL]V'N;.XMAE-N[3RN)J/N<5D(9?VYF*%]+`,
M"/8Y]X?:+W`YJ]P-ZWS8]B\;;)5A"OXT*U*0QHW:\BL*,",CH%>TWNMR%R[R
M#L>S[SOPAW&'QM:&*9J:II&7*QLIJK`X/GU99_P_1_*R_P"\DYO_`$4W<G_V
M`^XQ_P!8#W7_`.F8'_91;?\`6WJ1_P#7P]K_`/IJ%_YPW'_6KK7%_FX]_;)_
MFP_+?XV;*^"&)WOW?D=K[-R.U,ED<9L/=&'A;)[EWC25QFE@SF*QV3H=N;<H
M:7SUV3JX:>@ITE)$EE<^\E/9[EZ^]HN3^9K[G^:"QCEF$BAI48Z4C(XHS*7<
MFBHI+DBE,@=8\^ZV^V7NQS3RUM_(<4]])`A#LL3JH+/YZE4JJTJ78!`#6M`2
M-ZS#TDF/Q&+H)BC2T6.H:25HR2C24U-%"Y0D`E"R&UP#;W@5,XDFED7X68G]
MIKUFXBZ41?0`=./MOJW7O?NO=(;M#_F6G8?_`(8V[?\`W09#VOVK_DI[=_S7
MC_X^.DU[_N'=_P#-)O\`CIZU`_\`A*[_`,S.^8?_`(8/4'_O0;X]YD?>P_Y)
M?)O_`#T7'_'(NL1_NM?[F<Z?\T[;_CT_6YK[PHZS!Z][]U[KWOW7NM;/_A3V
M`?A/TP?R/DWMZW^QZS[.]Y,_=9_Y7G>_^E6__5^#K'7[S/\`RH>W?]+*/_JS
M/U9I_*,_[=I_#+_Q"6W/^M]=[B_W@_Z>;SI_SW/_`(!U)OM?_P!.^Y1_YXD_
MR]6,>XVZ'O5?O\UG_MV[\U?_`!7GL3_W32^Y#]IO^GE\D?\`2QB_X]T!O<S_
M`)4#FW_GBD_P=56_\)?F8_"[O-2S%5^4.<TJ22%U=4]5$Z1]%N>3;W+/WJ`/
MZ[[":9_=2?\`5^?J)?NP$GDK>P3@;FW_`%8@ZV5/>,?62?7O?NO=>]^Z]UIL
M?\*J/^/U^&_]?[G=WV']?]RO7'O-/[IO^X'.O_-:U_X[/UB!]Z/_`'.Y&_TM
MS_QZWZVJ^J>T>LH.KNMH9NQ=B12Q;!V='+&^[]O*Z2)MW&JZ,IR-PRMP1[Q,
MW7:=T;=-R9=MN"IN)/\`0W_C/]'K*FPO[$6-D#>PU\)/QK_"/GTO6[8ZL569
MNRM@*J@LS-O+;H"JHNS,3D;`*!R?Q[0?NC=CC]UW'_.-_P#H'I7^\+#_`)3H
M?][7_/UI=XG>&SNP/^%-F+W3U_G,-NG:];WHM)2YW;=339'#UU=@?C1+@=P2
M4=?0-)25BTN?Q=5%+-&S(TL;'4?K[S9FL[W;ONNR6FXV[Q72V-2K@JP#WNI*
M@Y%492`?(CK#:&ZM;[[S!N+*X26W-R`&0AE)2U"M0BH[65@?F#UO!^\%>LU.
MO>_=>Z][]U[K5>_X5-"_1?Q.`^I[?WR!_P"@*GO*_P"ZC_R7^;?^>.+_`*NG
MK&+[SY`Y;Y=)_P"4QO\`C@Z'WX@_SO/Y;?4_Q3^-W5^^>\LWBMZ=>=&]6[+W
M9BX^HNW,C'CMQ[:V7AL/FJ&/(8S959CJZ.ER-)(BS02R12!=2L5(/L/\X^Q7
MN;NW-G,VZ6.PH]E<W\\L;?46XJCRLRFC2@BJD&A`(X'HZY6]\/;7;.6>7MNO
M-]=;NWLH(W'T]P:.D2JPJ(R#0@BH)!\NC%_\/^_RL?\`O('/?^B5[K_^P'V&
M_P#@>O=C_IG8_P#LIMO^MO1]_K^^UO\`TT$G_9-<_P#6KJH#^=O_`#2_A+\R
M_AQB>I/CUVIE-Z;\I>Z]B[QGQ%9UUV+M6%-OX7"[QH\C6_Q/=>U\-C&>"HRT
M`$0E,KZR54A6(F3V-]J.>>2N=)=XYBVE(+`V,L8830R=[/&0-,;LV0IS2F./
M43>]'NKR/S?R8=GV#=FFW#ZJ-])AF3M59`3J>-5_$,5KU>5_)._[=;_$/_PR
MMU?^_.WQ[@?WQ_Z>KSA_S6C_`.K$74Z^T'_3M>4_^>=O^KLG5IWN*.I)Z][]
MU[KWOW7NB2?S#/F#M[X-_%3LWOK+-25.XL7C?[N]9;>JWLNZNS]QI-1;1P_B
M%GFHZ:J#U]>%(9,;15#@W4>QQ[<\FW//G-VU\OPAA;.VN=Q_H<"9D;Y$BB)Z
MNRCSZ!W/O-EOR5RMNF_S%3-&FF)3^.9L1K3B17N:F="L1PZIQ_D'_"&;+=*]
MS?-'Y)8L[U[`^:L6[L)&=V0"KJLKT[N'(UTV],KD%E.H_P"F'<TT]1,I4"3&
MT=(Z'1,09G^\%ST(=[V3DGEB7P-MV,QO^F:!;A%'A*O_`#SI0#.'9P<KU$GL
M9R8\FS[OSES)%XVZ;WX@/B#)MW)UEN']NV6%*%51AACT2GX+[SSO\G#^:[V5
M\).S,M5P?''Y!Y[#T&R,_EY2N/A3<%352=$]@O4S%($FF^YEVIG95*QBL!DD
M.BD6PYY]LK?WH]H]LYYVR%3S+MT;&5%X]@'U45!FF!/$,G30#+GH&\DW<WM%
M[J;ER3N,S#ES<7'@LW`%B?IY,^M3#(10:JDXC'6Y\#?_`(W]?>$_67W7?OW7
MNO>_=>Z][]U[K2D_GWRQ0?S<_AO//+'#!#L/XXRS332)%###'\D-^/+--+(5
MCBBB12S,Q"JH))`]YP?=_!;V=YS502QN+R@'G_B<..L,O?(A?=_E`L0%%K;9
M/_/3<=;CO^E7J\7![(V$""00=X;=N"#:W_%Q^M_>%_[IW7_HV7'_`#C?_-UF
M#^\+#_E-A_WM?\_7"3MKJJ&.267LSKZ**)&EEEDWGMQ(XHXP6DDD=LD%1$52
M22;`#WL;/NQ(`VNX)/\`PM_^@>O'<=O`)-]"`/Z:_P"?K3&_E0YW!;N_GY?(
M/=.TLA19[;&=W'\QL]A,WB'6JQ63PV3WO-/09>AJH+PS8[(1U*/#,IT2K*I4
MG4+YK^[<$]G]WWENTO(VCNXXMN1E;#*RQ`%2#D$4((XBAZP]]J[BVO/??FRZ
MLY5DM9);UE9<JRF1B&!&"#6H(P>/6[U[P7ZS.Z][]U[KWOW7NM:3_A4*2/A?
MTD02"/DAC""/J".M.P^1[R=^ZO\`\KMOO_2L;_J_#UCK]Y<5Y)V@'_HZ1_\`
M5F?JM?/;,[7_`)-':/Q+_F%])8O*;@^*WR8Z@Z=IN]M@X]GCQM!N#=&PMO9S
M>&SZD$M2T3Y>L\^?VE62V%/D8ZBB8^"ZU$FPWVT^]6U\W^W.^RI'S;M=Y<?2
MS'B4CE=(Y!YG2*17"CXD*N.[*QW-9;C[/;ERMS_LD#/RIN5I;B[B7@K/$C2+
MZ#4:RPMBC!D-$%'W.>HNV]@=Z]8[([?ZMW#2;JV!V'M^AW+M?.T;#QU6/KT)
M,51&27HLCCZA7IZNFD"S4M5%)%(JNC`83[SM&X;!NE]LV[6S1;A;2%'4^1'H
M?,$4*L,,I#`T(ZR_VK<['>MNL]UVVX$MC<1AT8>8/\P0:A@<JP((!!'6J_\`
M*K?FZ_YWO\PK;'PHZ9SE?!\)_C+GFW1WAO\`PDY&,W=E<-5OB=QYZBKHA+1U
M<L\IFVYM($2*TLM=E`)*<#QY7\I;?:>Q?MU=<\;W;J>>-TCT6L3#NC5AJ1",
M$4Q-<<,".+#\<9>:;VY]Y^?8.2]GG8<E[8^NZE7X9&!HQ#<">,4/')>6CI\*
M!_D.8K$8'^;-\],!M[%TN$V_@-H]U8'`X6BU?9XC"87Y%;3Q>)QE-K)D:&AQ
M])'&I8EB%N>3[,O?Z6:X]HO;ZXN93)<22VKNQXLS6<C,Q^9))Z0>Q\,-O[J^
MXUO;0B.VC%PJ*."JMV@51\@``/LZW*/>%G67'7O?NO=>]^Z]UTWTX^OX_P!?
MWH]>ZTY.[<E5_P`ZW^<'M?H?!U4^7^'?Q!J<K)NZMHY9'PFX<;MG,4,?8V7C
MJ("].\_9^\Z.DVUCI58EL12-5Q<>4>\T-BB7V/\`9JZY@G4)SGO(7PP?B1G4
M^"M#FD$9:9P1_:-H/EUB5O4A]X_=RUV&)B_)^SEC(172^EAXIKP/BR!8E(/]
MF!(OGT.'_"@OXH[FZPR_27\R[X[T[[5WWTAGME;7["KMNTGA&)I,%E*>;J'?
MDM/3(D"T>W<R!@JT,-$M'6T4+#Q1$>R'[NW-MKND.^^U_,C>+M]_'*\(<_$6
M4_41`G-77]5?1ED;XFZ./?SE>ZVV39?<KEX>%N-A)&LI04HH8>#)08[6I&U0
M:AHU^%3U?K\&?ECM'YK_`!AZN^0>U#34LV[,,M'O/;T$PEDV?V'A0M#O/:U0
M"[RHN.RZ.]*TEFGH)8)[:95]X^\]\HWG(_-.Z\N7=2L+UB<_Z)"V8W'EE:!J
M<'#+Q!ZG3DOFFSYRY;VS?[,C]9!K4'^SE&)$/GAOAK\2%6X,.C;^PAT*>O>_
M=>Z__]+8C_X47?\`;L[>/_B6^G__`'IC[GK[MW_3T+'_`)Y+C_CG4*_>!_Z=
MENW_`#6A_P"K@Z+9_)I_ET?!_P"0'\O7I;M/N;XT]:]A]A[@R79<&:W;N''U
MT^7R<6([)W3B<:M5+#D(8V%%C*.*!+*+1QC\W)$WO5[D<]<O>XV^;5LO,]U;
M;=&L!6-"`JZH(V:E0>+$G[3T'O9[D'DS>?;S8-QW3EVVGOI/&U.RDLVF>117
M/DH`^P=6C?\`#0'\LT?]R:=-_P#GJR?_`-=?<5?Z\?N?_P!-I>_[TO\`T#U)
MG^M9[>?],E:?[R?\_6LK_/#Z2ZT_EO\`R4^)7:WPBV^?CKNC+;8WEN#()U]E
M<QC,9/F-@;GVL^)K7Q\E?4)X\E2YV6ER-/?[2OIXT26)O67R@]B-]W/W+Y8Y
MOVCGJX_>5HDL:CQ54L%E1]0K0<"H9#\2$D@C%,:O>[:K#V[YCY2W?DRW_=]Z
MZ,6\(L%)C=:56M,ZJ,.#``,#FN[IMVOFRNW\'DZD(*C)8?&5\XC!6,35E%!4
M2B-220@>0V%SQ[P:N8UBN)XE^%78#[`2.LSK>0S6\$K`!F12?S`/3Q[9Z>Z]
M[]U[I#=H?\RT[#_\,;=O_N@R'M?M7_)3V[_FO'_Q\=)KW_<.[_YI-_QT]:@?
M_"5W_F9WS#_\,'J'_P!Z#?/O,C[V'_)+Y,_YZ+C_`(Y%UB/]UO\`W,YT_P":
M=M_QZ?K<U]X4=9@]>]^Z]U[W[KW6MI_PI[M_LE'2X_/^S-[>M_L.L^SO>3/W
M6?\`E>=Z_P"E6_\`U?@ZQU^\U_RH>W?]+*/_`*LS]69?RC/^W:?PR_\`$);<
M_P"M]=[B_P!X/^GF\Z?\]S_X!U)OM?\`].^Y2_YXD_R]6,^XVZ'O5?O\UG_M
MV[\U?_%>>Q/_`'32^Y#]IO\`IY?)/_2QB_X]T!?<W_E0.;?^>*3_``=56?\`
M"7T'_9+^];C_`+FAS?\`[ZCJKW+7WJ/^5WV'_I5+_P!7Y^HE^[!_RI6]_P#2
MS;_JQ!ULJ^\8NLE.O>_=>Z][]U[K3:_X52L4WQ\-7'U7:'=S<_FV6ZW-O]X]
MYI_=._Y)_.O_`#6M?^.S]8??>E4-><D*>!2Z_P"/6_1D=E?\)COB7N?9VT]R
MU7?OR'@J=P[9P&<J(*<]9""&?*XJDR$T4(DV++((DEJ"%#,S!;7)//L+WWWH
M^<+:]N[9.7]M*QRNH)\>I"L1G]49QT*K7[M/)\UM;S-OFYZGC4X:'B0"?]!/
M2F_Z!<?B)_WD%\C?^2^K_P#[`?:7_@JN<O\`IGML_9/_`-;NG_\`@9>3O^CY
MN?\`O</_`%IZ/!\&/Y(_Q-^"O:,'=FT<QV1V=VABL?E,7M7/]DY3`R4&SJ;-
M4K8_*5>`P6VMOX*A7,UF,FEI35U!G>.GF=8A&79B!>?/?+F_G[:CL=[#;6NU
M,RLZ0J]9"IJH=G=SI#`-I734@$UH.AKR1[,\I<C;D=XL7N+C<PI"O,RG1J!5
MB@1$[BI*DFN"0*5/5QWN&.I;Z][]U[KWOW7NM5[_`(5-&W17Q/(^H[?WS;_T
M!4]Y7_=1_P"2_P`V_P#/'%_U=/6,7WG\\M\NCR^L;_C@Z.C\,/Y3?\NGL?XB
M?&'L#>_Q3Z\W#O+>W0?4VZMU9ZLJMV+5YK<.>V/A,GF,K5+3[CA@%1D*^IDE
M<(B(&<Z5`L/8(YU]W/<C;><>:MOL>;+B.R@W"XCC0".BHDK*JBJ$T``''H<<
MH^V/(-[RIRS>77*]L]U+86[NQU59FB0LQ[N)))/1F/\`AF?^6#_WAWUG_P"=
M>\?_`+)_88_UZO=+_ILKG]D7_6OH1?ZT_MU_TR=K_P`:_P"@NJ7OY[O\O7X8
M?%SX3X?LGH#X_P"S>L=\U/>FP-KS[DP,^X):Y\!E<'O6JR.,*Y3-9"F\%548
MV!F_;U7C%B.;S9[!>XO.W-7/,NV<P<PS75@+"5]#!`-:O$`W:H-0&/GY]0W[
MZ<A\G\O<BG<-EV&"WO?K(EUKJKI*R$C+'C0=7%_R3O\`MUO\0_\`PRMU?^_.
MWQ[AGWQ_Z>KSA_S6C_ZL1=2][0?].UY3_P">=O\`J[)U:=[BCJ2>O>_=>ZZ/
MT-OK;WX]>ZT5_P"=5\DNR?G]\U:?XO\`QUV+OCN_KKXJ-E:?*;0ZTQ&;W'4[
MRWW3UE!0]I[EFCVW25M7%A]MEX=MT];H9:><54D3$5*ZL]/8_EC;/;WD=N:N
M9=PM[#<MVTE9)V5!'$03`@+D#4^9BM<C0".P]82^\W,>Y\^<Z1<J\M[=/?6&
MU$F2.%78O(&`F;L#$!#2(,5[6#$$A\GDVO\`S8_YL>R=M;?V;M+^4!G,!M7:
MF$Q>V]MX+'=<=^0T&'P.$H8,;B<71Q?PH^.EH:"FCB0<V51[`5W[1>TE]=7-
M[=^\<4EU-(SNS36A+.Q+,Q[N)))/0^MO=+W.M+>"TMO:"X2VB1411#<@*J@!
M5`T<```/EU6)_,V[3^?'SQPNS-_]R?RV>Q>D\GT=CMR5]1VKMSKSM^%J?8<M
M.,KE\=N:JS^)6AIL'A*VB&2BJBRM0L)F#!99#[E3VMVCV_Y`GO=OV;W,MKZ*
M_9%$#S6QK+72I0(U2S`Z"H^+MKE1U%_N?N7/?/%K9WVX^VMW936(9O'$5QB*
MFI@Y9`-*D:@2>WN_B/6T=_)B^=T?S?\`B#MVIW9ETKN\.F#C^M.WXY)=5?F*
MJBH1_=/L"5"2[0[YP-.)9I>%;*TU:J@*@]XJ>]?()Y$YRN4M(=.Q7M9K>G!0
M3^I%_P`VF-`/]]M&3DGK)?V?YY'/'*-M/<S`[U:4AN!^(D#LE/\`S445)H`9
M%D`%`.K<O</]2KU[W[KW7O?NO=:0'_"B':U'OK^:%\9=C9&HJ:/';VZ9Z4V=
MD*RB$1K:2AW1WOV3@JRJHQ.DL'W=-35[/'Y%9-:C4"+CWG5]W*\?;_:KF>_B
M4-+!>W,@!X$I:P,`:9H2*&GEUA/]X&RCW+W2Y:L)G98IK&W0D4J`UQ<#%:BO
M5@F3_P"$M_Q5DQV03$?(KY`4>6>BJEQ=7DJ7K7)8^ER#0N**HK\?3;/QE17T
M4%1I:6&.IIWE0%5DC)#".H_O6<VB6,S<M[<T.H:@OC*2*Y"DR,`2.!*L`<T/
M#J19?NR<I&.00[]N2S%3I+&)@#Y$J(U)%>(#*2,5''K6WW-\)=G_``]^7/\`
MLO/\R*F[3Z^ZZR0F&"[BZ4CPN0Q^1PTU?]IA^RL/2;CV]FUW5L=])3)T=,L6
M9QDA(:&26/[>7)FVYYO><^3_`.L?MDUI<[DGQV]SK!#4JT+%'7PY?X&:L;^3
M!3J&.DO(]ER=S;^X/<GZR#;)/[.YMV4K3502@-&^M/X@-,B_PEAHZW3OY9?\
ML3X8?#JB?O7XY;NW!W5F>U=G4]%ANYMR[DP&XJ2HV)D*NFRIH=EQ[5Q6(P%!
MC\M54-.]5*(Y:J1Z98VD15:/WA#[H^Z?.W.DJ[!S+9QV,-I,2ULB.A$J@K63
MQ&9R5!(45"@,30X/697MQ[:\F<G1-O'+=P]W+=14%P[H]8R0U$**JZ6*@G!-
M12HX=6Z^X?ZE3KWOW7NO>_=>ZUH_^%0W_9%_2?\`XL?C?_?:=A^\G?NK_P#*
MZ[[_`-*QO^K\/6.WWEO^5*V?_I:1_P#5F?JVOK+HSK;Y*?RX^E.D.V\#%N+8
M/8GQ2Z8P6<H6TI54VOK3:TV/S.)J620X_.X')115E#4J"U/5P1R"^FWN(-UW
M[<^6/<K?=^VB<Q[A;;O<NI\C^O("K#S1E)5U\U)'GU*FW;+MW,7M]LVR[K`)
M+"XVNW5AY_V,9#*<T92`RMQ#`$<.M/;=V_\`^8+_`"N*_P"0O\I_9BY?=U#\
MB,UB,?T!NO'QY!,]+@^PLQ_!:G<74(@8T])D^S<4?X1EZ;7HPV8BJ)X668--
M)F59[?[=>ZL?+GNY?:(9-MC8W<9TZ=<*Z@EQ7)$#?J1M2LD94,"M%&)5WN'/
M_MC+OGM5M\;SQ;BZBSD%=025M):'T,J]C+7LD#%3J!9MMC^5S\`]M?R^?C)@
M.MD3'Y'M;=PI-X=W[NHU1_XYOBHI!&F$Q]5H$LFUMDT<AQ^.4D*X66I*K)4R
MCWB#[J^X-U[B<TW&YDLNT0UCM8S^&('XB/\`?DI[W],)4A!UE3[:<BVW(7+5
MOMBT;<Y:27$@_%(1\(/FD?PIPKW/0%SU0-_(O_[>]_S"O^U/W]_\$SMSWD+[
M\_\`3G/;G_3VG_:%)U!GLI_T]OW+_P!-=?\`:8O6XW[PPZRTZ][]U[KWOW7N
MJ:?YW?SM/PN^(6;Q&S\PM!W=W\F5ZUZS-/.$R&WL7/0*-^]@Q#_.0G:V!K!#
M22K8IE:^D;D*WN:?8OD'^N_.4$U[#JV+;RLT]1AR#^E#\];BK#SC1QQ(ZB+W
MGYY')?*%P+62F]7P:&"A[EJ*22#S[%-%(X.R&E`>M=#^7!W7_,1_EX=>[OP_
M4O\`*[[$[%RG:N9QFY\]V7NGK;NB'-9?!T6+2':F`HUP^'6ACV_B4JZJJA*W
M>:?(2NY/H"Y)>YFQ^W'N/N5E/NWNI;6T5HC(D*3VQ56+?J,=3UUM15-<`(`/
M.N/_`+;;O[@>W^V74%A[6W=Q<74@D>9H;@,R@=BX2FE:LP^;G-*4.YVQ_,Z_
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M/I_OA_O'^'O`_K-GKOW[KW7_T]L#^;E\2.V/FU\-=P=$=+2[3AWSD]^]?[CI
MGWKFJS`8(8[;69-?DA+D:'$9NH6I,!_:3P$.W!(^ON4?9_G#:>1N=;;?][$Q
ML$MY4/AJ':KK08+**5XYZCKW4Y5W+G/DZ^V':6C%[))&P+DJM$8,<@'_``=4
M6=.?RU?^%`/Q\Z\P?4_3'R@ZHZ_ZZVW)DY<'M3#]CQS8_&R9G)U>9R;029/I
M6OK3]YE*^:9@TK`/(;6''N>MZ]SON]<Q;E/N^]<J7=QN4H75(T.3I4*M:7`&
M%`&!P'4'[+[>>_?+VVV^T;1S1:0[=%JT('!"ZF+')A)RS$Y/GT)_^R>_\*4_
M^\T^O/\`T8>,_P#M$>RK^N?W9?\`IB+G_G"?^VKHT_JK]XW_`*;*U_WI/^M/
M06/_`"+/YD7R[[KVCO?^89\H-E[AVKMQ:#&9'(8G=.<WQO&7:%/D#D:_:NS<
M0NS-F;6VS_%Y'D$E46'CDE,QBG90A-1[]>VG)VQWEA[<\JSQ7<M6`9%BC\0C
M2'D;Q))'TX[:9`TAEK7HJ/LC[A<W[W9W_N)S/%+:0T'8S,Y0&I5%")&FK^*M
M0<E6I0[@M%1T^.HJ3'TD?BI*&EIZ.EBU,WCIZ:)((8]3DLVB-`+DDGWAO([2
M.\CFKL23]IR>LM$18T5$%$4``?(<.I7NG5NO>_=>Z3.]<35Y_9N[<%0&$5V:
MVSGL31&H=HH!5Y+%5='3&>14D:.'S3+J8*Q"W-C]/:JQF2WO;.XDKX:2HQIQ
MHK`FGY#IFXC:6WGB7XF1@/M((ZH$_D@?ROODU_+XWI\@<]W]4=8ST'9FUM@X
M?;8Z_P!VY7<LZUFVLKN6LR7\2BR.U]O+2PF'+1>-E:4LVH$+:YR$]]/=3ECW
M%LN7K?E]+H26LLK/XL:H*.J!=-'>N5->'4$>RGMGS#[?7',4N]R6[+=+"$\-
MRW]F9":U44^,4ZV(?>./4^]>]^Z]U[W[KW5;G\U#X'57\POXM5?3&`W7B]E;
M\V_O'!=B=?;@SM-55.WUW%A*7*XJ;%9\4$<^1I\3F<)G:N%IZ>.66GF,<HCD
M"-&TE^U'/Z^W/-:;W/:-/820O#,BD!]#%6#)6@+*R*:$@$5%16HCSW.Y&/N!
MRO)LD=TL-VLRRQLP)76H9:-3.DJ["HJ0:&C`%30]U_\`RW?^%!_4FR]N=:=:
M?+C8&TMA;+QD6"VIMO#=O9&+%8;#4A?[6BH8JGIZ:HCIX]1*AV9@#8GW/VX^
MYGW=MXOKG=-SY.N)MPG;7([6ZZF8\2:7%*]0EM_('O\`[396NV;?S;;1V,"!
M$428"C@!6&M/MSTL/]DB_P"%)'_>;6T__1QU7_VFO:+^O/W9_P#IAIO^R<?]
MM'2S^J/WBO\`IL[?_G(/^M722WY_+B_X4)]J[,W+UOV-\N]A;JV)O;$5FV]V
M[<R_;^1EQ>:P.3C-/D,?7QTW3T,\E+40,5=496*W`/M9M_N5]W3:;VUW/;>3
M;B*_@</&ZVZZE9<@BMQ2H/#I)?\`(/O_`+K9W6VW_-UL]E.A1U,F"IX@TBK3
M[,]7M_RK/@=6_P`O3XLTO3.XMV8O>N_=Q;SSO8V_\Y@8*RGVZNX<Y1XG$P8C
M;XR,<&0J,5A\)@:2$5$\4,M3,))#'&K+&L!^[//Z>XW-C[W;VCP6$<"0Q*Y!
M?0I9BSTJ`S,[&@)`%!4TJ9K]L.1C[?\`*T6R2W2S7C2M+*R@A=;!5HM0"554
M45(!)J:*"`+)O<9]2)U[W[KW7O?NO=:]'\\/^6)\E_YA6X_CUE>@*CK*"EZQ
MV]V5C-R_Z0-V97;4K5.ZZ[:%1BOX8F.VQN%:N(1X.?RES$4.FP:YMD7[%>Z?
M+'MS:\QP\P)=%[J2%D\*-7%(Q(&U5=*?$*<?/J`_>KVTY@]P+GEJ79)+=4M!
M,'\1BO\`:&(BE%-?@-?RZOLV'AJS;FQMF;>R)A.0P.U-NX:O--(TM.:S%X>C
MH:HP2LD320^>!M+%5)6QL/I[Q_OYDN;Z]N(Z^')*["O&C,2*_.AZG6UC:&UM
MH7IK2-0:>H`!Z5?M)T_U[W[KW7O?NO=>]^Z]U[W[KW5(/\[K^7QW]_,$ZRZ*
MVCT%/U_!ENNM_P"YMR[A;?\`N7([:I#C<MMA<12#'38[;VX'JJG[L>M&2,*G
M()^GN=/8SW$Y?]N]TWZ\Y@6X,-S;HB>$@<U5]1K5TH*?;U#/O/R#O?/VT;18
M[(\*RP3L[>(Q44*@"E%->K/OBAUIN7IGXP_'KJ/>1QC;MZQZ7ZUV%N9L+5RU
M^(;/;4VAB<)E3BZZ>EH9JR@-;1/XI7AB9TL2BDV$6<V[G;;US3S'O%EJ^CNK
MZ>5-0HVB21F74`2`:$5`)H?,]27RUM]QM/+NP[7=Z?JK:SAB?2:KJCC56H:"
MHJ#0T%1Y#HP'L/='?547\X_X9=Q_.OXEXKI7HZ79L.\Z/N'9>^9GWSG:W;V%
M_@>`P^[:&O"5U!A<[.U<9\U!XX_"%9=1+BP!EKV8YUV;D+F^7?-]68V1LY(A
MX2AVU.T9&"RBE%-37TQU&'NYR?NO/'*7[CV=HA=_4QR5D8JNE5D!R`<U88IP
MKT/_`/+?^/N__BM\)>@OC_VB^WY-_=;;<SF*W&^ULG4YC`-4Y#>FY<]3G&Y*
MKQ^*J*J+[#+1:BU/&1)J6Q`!(>]RN8MOYLYXY@YAVH2#;[F1&3Q%"O18D0U`
M+`94^9Q3H_Y!V*]Y:Y/V/8MQ*&]MHF5M!JM2[L*$@>1'EQZ.][`W0PZ][]U[
MHOWRFI>_LAT#V?B?B^FUE[USFV*O`=>9+>><J=O;>VYE\T4QLNZZO(4F*S50
MU5MB@J9:VD@%,ZU%7#%&Y5&9@(>5&Y?CYAVN;FHR_N".4/,L:AW=5SX84LHI
M(0%8U%%)(J:=$?,@WM]CW&/EL1_OMXRL1D;2J,V-9-&R@)912C,`#0$D5D_R
M8OY7^ZOY?VQ.SMU]W5NUMP_(?MW<"4^=S&V,K6[BQV#V#@I)9\-A://93$XB
MOK*_/YJKJ<GE',*K+(:9"7,&HRC[V>Z=K[B;AM5IL<<L7+EG'55=0C-*V&8J
MK,`$4!$%<=QX-3J-_9_VUN.0K#<KG>98Y>8+R3O926"QKE5#&A)9B68^?8#E
M:]7;^X-ZF3J'D<?0Y?'UV*RE'2Y'&9.CJ<?D<?6PQU-'7T-;"]-5T573S*\4
M]+54\C)(C`JR,000?=XY)(9(YHG*RHP*D&A!!J"#Y$'(/571)$:.10T;`@@B
MH(.""/,'S'6M)\*OY4?S&_E_?S$-X]K=(Y7JS-?#;?>>SFVLWM3)[\SF.WH.
MI,]5',[=5L$VSZO'5&Z^K,Q*B4CFM'WM+!,GDB^[?1D[SQ[M\F>XGMQ8[1OL
M-W'SI;QJZR+$IC^H0:7[O$!$<Z@ZAI["5-&T"N.O)GM=S7R%[@;ANFRSVS\H
M7+LK1M(PD$3'4N"I!>$TH2>\!A5?$)&S,H(%B23SR>;\^\7AUD9UW[WU[KWO
MW7NM<?\`FB_RL?E#\O\`Y]?'CY)]1U'5L77'5^V>G\3N5-W[PRV$W(]7L?N'
M=&^<Y_#,51;5S%-5PG"9>$0,U3&9)]2$(`&.2?M9[K\K<G>WO,7+&[I='<[J
M6X9/#C5DI+;QQ+5C(I!U*:]IH*'/6/7N3[7\Q\V<_P"P\S;9);#;K6"%6#N0
MY:.:5VH`I%*.M#7C7&,['!%^#]/>-G60O1./FY\'^D_GETWD^HNX\,@DB6IR
M&P=_8RGIQO'K/=;P".#<>V*V9?\`-R&-$KJ&0_:Y&F7Q3+PCH,N1N>M]Y`WN
M+>-EG[302Q,3X<T?FC@?GI8=R'(\P0GSER9LG/&S3;/O,%5-3'(`-<3^3H?V
M:AP88(X4I9_ER?`[^;;_`"Y>Q<CL_$;GZ&[J^*&6W16'-=?93L_=.!KHJ*:M
M:(=A==45=L/)Q;'W;5T86HK,6:B7'U[7BF?RB.LCF_W+Y_\`:'W*VZ.]FM+^
MQYM2(:9E@1P2!_8S$2KXL8.%>@=/B44JAA[VZY']TO;R^DL$O+.^Y4:4_I-*
MRL`33Q8ZHWAO3N9*E6-5)K21=FM;Z1JX:W(O>Q_I?\V]XO=9&]<O?NO=>]^Z
M]U3=_.M^"?>7S\^.O6_5W0TVQ8=S;5[?H]\95M_;BR&V\8<)!LW=N"<4E7C\
M#N"6>N^_S4-HVB1?'J;5<!3-'LAS[L7M]S'NFZ[^LYMIK(Q+X2!VU&2-\@LE
M!13FIS3'42^\7).\<]\N[=M6RO"+B*]65O$8J-*QR+BBM4U<8QBIKY&S#X];
M&S?6/0/1_6NYS0-N/K[J#K78^X#C*B2LQC9O:FS,+@<J<?52T]++54)KJ"3Q
M2-%&SQV)12;",.8[^#=>8=^W.UU?2W-[/*FH4;3)(SKJ`)H:$5%30^9ZD78;
M.;;MCV7;KG3]1;VD,;T-1JCC56H:"HJ#0T%1Y=/>Y>H.J]Y;XV#V9NSKS9^X
M^PNJWS<G6^],SM_&Y#<NQWW)1+CL\VV<O4T\E;B#E:)!'-X774H'YY]L6N\[
MK96&X;7:;C-%MUWI\:)7(270:IK4&C:3D5Z>N-JVV[O;'<;JQBDO[;5X4C*"
M\>L4?0Q%5U#!IQZ$;Z>RWI?UKW_RR_Y9/R5^)7S[^6'R4[7J.LY>N.Z,=VI3
M;.CVGNS*9K<B2[Q[EP^_,/\`QG%5FV,12T*#!4,@F*5,WCGL@#`ZAD3[H>Z/
M+/.'M]RCRSM*W0W.Q:`R>)&JI^G;/$VE@[$]Q%*J*C..'4$^W7MQO_*O/G.'
M,FY/`=OOS/X81B7'B7"RKJ!4`=H-<X.,];"'O';J=NO>_=>ZZ()%@;'^OOW7
MNM<KOG^5K\I?FG_-%VA\C?DY5=6Q_#WJG+T5+L3KO%;PS&>W+E-E[*>7,X'#
MY?;\NU\=BJ:?L3>Q%?G3][)XZ!OM%:411-[R2Y?]UN5>2/:J\Y:Y62[_`*YW
M:$RS-&J(LDG:[*^LL1#'VQ=HJXUT%2.H`WWVSYCYQ]R[+F+F22V_JE9L!%"'
M9F9$JRAETA:RR=TG]`E*G2IZV-%&E0O'`MP+"WX`'X`'O&W[>/4_]<O?NO=4
M`?SH/Y3'8GSJSG3W=/QLR&S=L]\[!>3:FY*W=>=R&U*//;%CEJ,_MK)09S$8
M/-U<>Y=D;H\AI+Q+K@R$G[BF"-3D+[)>[VW<@P;ULG,T<TO+]Q^H@C42%)<(
MX*LRC1(E-630H,=Q/4$^\?M7?\\2[-N_+LL46^VQT,SL4#1993J4$ZD>H'"H
MD)KV@&XKXSQ=ZTW1/6-!\EX-K1]Z8G:]#ANR*O9>9J,]MK.Y_$!L<^Y\=D*K
M%86=3N>FIHZ^>`TT8IJBHDB74J*YA?F<["V_[I)RPTIV%Y2T(E4(Z(W=X9`9
MAV$E`:G4`&-":"7>7OWR-EVY.85C&]+&%E,;:D9EQK!H/C`#E:=I8J*@5(Z^
MR+HYZ__4W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
'U[W[KW7_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
